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Kv10.1, also termed EAG1 (Ether-à-go-go1), is a voltage gated potassium channel,
initially thought to be expressed in the central nervous system. Prolonged or increased
expression of Kv10.1 has been found in over 70% of all human tumour tissues, where
its presence correlates with poorer prognosis. In peripheral tissues, Kv10.1 is
expressed specifically during the G2/M phase of the cell cycle, and downregulation
of the channel extends the G2/M phase duration both in cancer and normal cells.
In this project, we elucidate the mechanisms of Kv10.1-mediated regulation at
the G2/M phase. We show that Kv10.1 has a dual effect on mitotic microtubule
dynamics. It interacts functionally with ORAI1 and through modulation of the
cytosolic calcium oscillations changes the microtubule behaviour. Inhibition of either
Kv10.1 or ORAI1 conductance stabilises the microtubules. In contrast, siRNA-
mediated downregulation of Kv10.1 increases the dynamicity of mitotic microtubules,
resulting in a stronger spindle assembly checkpoint, greater mitotic spindle angle,
and a decrease in the occurrence of lagging chromosomes.
In general, understanding of Kv10.1 modulation of the microtubule architecture
will help to find out how exactly a cancer tissue benefits from the presence of Kv10.1.
Keywords: Kv10.1, cell cycle, G2/M phase, DNA damage activated-checkpoint,







1.1 Structure and gating mechanism of Kv10.1
Ion channels are transmembrane proteins, which passively transport specific
inorganic ions between cell membranes down their electrochemical gradient. An
electrochemical gradient is a result of the asymmetrical distribution of ions across
cell membranes, and it is maintained by ATP-pumps (Subramanyam & Colecraft,
2015).
Ion channels are classified depending on the nature of gating, the selectivity of
ion permeation, the number of gates (pores) and localisation of proteins (Hille, 2001).
Among them are potassium channels – transmembrane (TM) proteins defined by a
high affinity for K+ transport and present virtually in all cells.
Potassium channels are formed by principal subunits (α-subunits), which deter-
mine channel structure, and auxiliary subunits (β-subunits), which modify channel
properties (Rettig et al., 1994). More than 90 genes in human genome encode
α-subunits of potassium channels, which depending on the structure and function
are grouped into eight families (Wei, Jegla, & Salkoff, 1996). These families are
further subdivided into the following groups: i) calcium-activated six/seven TM, ii)
voltage-gated six TM and iii) two TM potassium channels (Tian et al., 2014).
Voltage-gated potassium channels (Kv channels) make up the considerable portion
of the ion channels and are encoded by 40 genes. One of such channels is Kv10.1
or often termed EAG1 (Ether-à-go-go 1). It is a member of the EAG family and is
encoded by the KCNH1 gene (potassium voltage-gated channel subfamily H member
1 gene), located on chromosome 1q32.1–32.3 (Gutman et al., 2005; Occhiodoro et
al., 1998). Kv10.1 shares about 70% identity in amino acid sequence with another
member of the EAG family, Kv10.2 (EAG2, KCNH5 ; Ju & Wray, 2002).
Structurally, the EAG family is similar to other Kv channels. The functionally
active channel is a tetramer made of four α-subunits arranged circumferentially and
1
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forming the central conduction pore. Each α-subunit comprises of six, S1-S6 TM
segments (Figure 1.1). The S5 and S6 segments form the ion-permeation pore (pore
Figure 1.1: Schematic representation of
the tetrameric organisation of a Kv chan-
nel. All four α-subunits are arranged circumferen-
tially with their S5 and S6 segments constituting
the permeation pore (top). A structural folding
model and a simplified view of one of the four
α-subunits are shown (bottom). Adapted from
(Barros, Domı́nguez, & de la Peña, 2012).
domain, PD) with the activation gate
localised at the cytoplasmic end of the
S6 segment. The S5 and S6 segments are
linked by an S5-S6 pore loop (P-loop).
The second gate of the channel, ion se-
lectivity filter gate is localised in the P-
loop. The S1-S4 segments constitute the
voltage-sensing domain (VSD), where S4
is the voltage-sensing component and is
enriched with positively charged residues,
such as arginine and lysine (Barros et
al., 2012; Bezanilla, 2008; Stühmer et al.,
1989; Swartz, 2004; Yellen, 2002). The
PD and VSD are connected by the S4-S5
linker. It was proposed that changes in
membrane potential are sensed by the
S4 segment resulting in the movement of
the VSD coupled to the S4-S5 linker; the latter acts as a lever on the S6 segment and,
thus, mechanically closes the pore (Long, Campbell, & Mackinnon, 2005a, 2005b;
Long, Tao, Campbell, & MacKinnon, 2007).
However, experiments utilising “split” channels constituting of separate fragments
of VSD and PD show that the covalent bond with the S4 segment affects the closing
properties of the channel at negative potentials, whereas disconnecting from S5
segment attenuates the activation and deactivation kinetics. Overall, we suggest that
an inward movement of the S4 helix, but not the S4-S5 linker, closes the channel,
while also proposing that activation of the channel by the voltage sensor involves
more than one mechanism (Tomczak et al., 2017).
Moreover, our suggested model is in agreement with the recently published single-
particle cryo-EM (cryo-electron microscopy) structure of mammalian Kv10.1 in its
inactive, bound to CaM (calmodulin) form (Figure 1.2; Whicher & MacKinnon,
2
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Figure 1.2: Model of rat Kv10.1 structure bound to CaM based on single-particle
cryo-EM. The domains of the channel are colour-coded as indicated in the panel given at the
bottom. The positioning of only one subunit within the functional channel is shown in colour on
the left as cartoons. On the right the transmembrane (shown as a cartoon) and the cytoplasmic
domains (shown as a surface) are given with indicated length and width. The N- and C- termini
are labelled in orange and cyan, respectively. The grey lines indicate the cytoplasmic membrane.
Adapted from (Whicher & MacKinnon, 2016).
2016). Unlike other Kv channels, the S4-S5 linker of Kv10.1 contains only five amino
acids, thus affecting its structure and positioning. The latter facilitates CaM binding
and channel pore closing independently of the VSD (Whicher & MacKinnon, 2016).
The EAG family is also characterised by long N- and C-terminal cytoplasmic
domains (Wray, 2004) as illustrated in Figure 1.3. The C-terminal tail is located
directly beneath the TM domain (Barros et al., 2012). It consists of a CNBHD (cyclic
nucleotide-binding homology domain), which, however, has no affinity for cyclic nu-
cleotide binding with only exception of the Drosophila variant (Brüggemann, Pardo,
Stühmer, & Pongs, 1993; Marques-Carvalho et al., 2012). The C-terminus also has
TCC (tetramerising coiled coil) domain. The TCC is involved not only in the correct
tetramerisation but also in the stability and selectivity of the multimerisation (Jenke
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Figure 1.3: Sketch of Kv10.1 α-subunit cytoplasmic domains. A PAS (Per-Arnt-Sim)
domain and its preceding PAS-cap, and a CaMD (calmodulin-binding domain) are localised at the
N-terminus. At the C-terminus, a CNBHD (cyclic nucleotide-binding homology domain), a NLS
(nuclear localisation signal), CaMBD, and a TCC (tetramerising coiled coil) domain are localised.
Adapted from (Urrego-blanco, 2014).
et al., 2003). A binding site for CaMKII (calcium/CaM-dependent protein kinase
II) has been identified at the C-terminus of the Drosophila Eag. This interaction
results in a stable complex between CaMKII and Eag and activation of CaMKII
independently of CaM and autophosphorylation (Sun, Hodge, Zhou, Nguyen, &
Griffith, 2004; Z. Wang, Wilson, & Griffith, 2002). Also, multiple signalling modules,
such as NES (nuclear export sequence) and NLS (nuclear localisation sequence) are
present on the C-terminus of Drosophila Eag. It has been suggested that the NES
and NLS may play an essential role in perinuclear localisation of these channels
(Chen et al., 2011).
The N-terminal tail of Kv10.1 contains a PAS (Per-Arnt-Sim) domain (Adaixo,
Harley, Castro-Rodrigues, & Morais-Cabral, 2013; Haitin, Carlson, & Zagotta, 2013).
PAS domains are suggested to function as sensors during some cell signalling events,
for instance, hypoxia (McIntosh, Hogenesch, & Bradfield, 2010). Several studies have
demonstrated that the utmost region of the C-terminus and the PAS domain are
involved in controlling the gating kinetics of the EAG channels (Stevens, Ju, & Wray,
2009; Terlau, Heinemann, Stühmer, Pongs, & Ludwig, 1997; Wray, 2009). Thus, the
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control of EAG channel gating also involves cytoplasmic domains of the channel.
Summarising, these intracellular domains are indispensable for the functioning of
the channel. Moreover exposure of these domains to different cytoplasmic cues can
alter channel behaviour.




The discovery of the EAG family was first associated with the observation of
trembling appendages in etherised D. funebris (Luers, 1936) and D. melanogaster
males (Catsch, 1948). Catsch named the gene locus responsible for the mutation
Shaker. Later, it was shown that this locus comprises a gene complex: three diffe-
rent gene loci located on the X chromosome in Drosophila, including Ether-à-go-go
(Kaplan & Trout, 1969). Further, through electrophysiological studies it was demon-
strated that the Shaker genes encode potassium channels with rapidly inactivating
voltage sensitive currents (de la Pompa, 1994; Kamb, Tseng-Crank, & Tanouye, 1988;
Papazian, Schwarz, Tempel, Jan, & Jan, 1987; Tempel, Papazian, Schwarz, Jan, &
Jan, 1987; Warmke, Drysdale, & Ganetzky, 1991). Subsequently, the excitability of
neurones carrying different mutations of Eag1 channel were intensively studied. It was
shown that the motor neurones bearing mutations in Eag1 gene spontaneously fired
repetitive action potentials and were described with increased transmitter release
(Han, Tokay, Zhang, Sun, & Hou, 2017).
Normally, in mammals, Kv10.1 is detected only in the central nervous system
(Occhiodoro et al., 1998). For instance, in rats, the olfactory bulb, cerebral cor-
tex, hippocampus, hypothalamus, and cerebellum are positive for Kv10.1, which
substantially overlaps with the regions characterised for humans (S. Martin et al.,
2008). Initially, post-synaptic localisation of Kv10.1 was suggested (Jeng, Chang, &
Tang, 2005; Jow & Jeng, 2008). However, Gómez-Varela et al. proposed the possible
pre-synaptic localisation of the channel; using single-particle-tracking techniques
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with quantum dots, they demonstrated that the endogenous Kv10.1 laterally diffuses
within the pre-synaptic membrane of neurones isolated from hippocampus of E18
rats (Gómez-Varela et al., 2010). Later, this pre-synaptic localisation of Kv10.1 was
also confirmed by Mortensen et. al. The authors showed that Kv10.1 is specifically
expressed in the pre-synaptic terminals of the parallel-fibre Purkinje cell synapse,
and it does not contribute to the somatic AP (action potentials) in the cerebellum.
However, when applying repetitive stimulations the Ca2+ influx into axonal boutons
was increased in Kv10.1 KO (knockout), whereas a single stimulation did not have
any effect. The Ca2+ release dependency on the frequency of stimuli indicates that
the Kv10.1 acts as a modulator of local AP specifically during high-frequency burst
firing when other potassium channels are inactive. Thereby, Kv10.1 may shape the
excitability and firing dynamics of neurones, such as of Purkinje cells (Mortensen et
al., 2015).
Kv10.1 may also be involved in the action of antidepressants (Dreixler et al., 2000;
Garćıa-Ferreiro et al., 2004b; Mathie, Wooltorton, & Watkins, 1998). Imipramine, an
important antidepressant agent, modulates the aminergic transmission in the central
nervous system (Deng, Luo, Vorperian, Petzold, & Nelson, 2014; Knapp, Breese,
Mueller, & Breese, 2001). In sympathetic neurones, imipramine preferentially blocks
delayed-rectifier K+ currents, including Kv10.1 (Wooltorton & Mathie, 1993). This
blockade is voltage-dependent and counteracted by intracellular tetraethylammo-
nium, indicating that the imipramine binding site is localised at the inner end of the
selectivity filter (Garćıa-Ferreiro et al., 2004b).
Genome-wide genetic linkage analysis identified a susceptibility locus for schizophre-
nia on chromosome 1q32 region (Gurling et al., 2001), similar to the KCNH1 gene
(Occhiodoro et al., 1998). Interestingly, histological and electrophysiological exami-
nation of the cerebellum of KCNH1 KO mice revealed clear differences compared to
the WT mice (Ufartes et al., 2013). However, the KCNH1 KO mice showed only
mildly hyperactive, but otherwise normal behaviour and no sign of schizophrenic-like




Myogenesis is a strictly regulated process of differentiation of fibroblasts into
highly ordered multinucleated muscle. The first step of myogenesis is the commit-
ment to a myoblast phenotype, followed by formation of multinucleated myotubes
through myoblast fusion, and maturation of myotubes into muscles (E. Cooper, 2001).
Myoblast fusion is accompanied with irreversible cell cycle arrest, which is tightly
controlled by environmental cues (Chal & Pourquié, 2017; Hindi, Tajrishi, & Kumar,
2013). Interestingly, changes in membrabe potential, such as hyperpolarisation, can
precede or accompany myoblast fusion. The hyperpolarisation of the membrane is
attributed to two types of K+ currents – a non-inactivating delayed rectifier and an
inward rectifier (J. H. Liu et al., 1998). The non-inactivating delayed rectifier K+
current is akin to the current of rat Eag channels (Bijlenga et al., 1998; Occhiodoro
et al., 1998). Moreover, ectopic expression of human KCNH1 in undifferentiated
myoblasts generates a current greatly mimicking the one observed during myoblast
fusion (Bijlenga et al., 1998; Occhiodoro et al., 1998). These findings indicate
implication of Kv10.1 in muscle fibre development.
Disassembly of the primary cilium
Virtually all quiescent cells have a primary cilium, an antenna-like solitary
structure protruding into the extracellular matrix. The primary cilium, initially
thought to be a rudimental structure, is a conserved MT (microtubule)-based organelle
critical for sensing and reacting to the changes in chemical and mechanical properties
of the extracellular environment. Depending on the cues, the cell will change its
behaviour, for instance, cell polarity, proliferation or differentiation. The protruding
part of the cilium, termed the axoneme, is formed by MTs. The length of the
axoneme is regulated by modulating the MT polymerisation and depolymerisation
(Mirvis, Stearns, & James Nelson, 2018).
The primary cilium is assembled on the mother centriole (Nam, Naylor, & van
Deursen, 2015). On the other hand, in dividing cells, centrioles serve as an MTOC
(MT-organising centre), which requires detachment of the mother centriole from
the plasma membrane. Therefore, the primary cilium and the mitotic spindle are
mutually exclusive (I. Sánchez & Dynlacht, 2016). Thus, during cell division the cilium
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undergoes cycles of assembly (G0 phase) and disassembly (before mitosis). The cycles
of assembly and disassembly are highly regulated, and failures in these processes can
result in diseases collectively termed ciliopathies (Hildebrandt, Benzing, & Katsanis,
2011; Reiter & Leroux, 2017). Ciliopathies manifest as various developmental and
degenerative disorders caused by mutation in a single gene. Of such disorders are
polycystic kidney disease, Meckel syndrome, Joubert syndrome and Bardet–Biedl
syndrome (Hildebrandt et al., 2011). Therefore, understanding cilium tasks and the
mechanisms required for its assembly and disassembly are of utmost importance.
The process of assembly is well characterised (reviewed in Mirvis et al., 2018), yet
the exact mechanism of ciliary disassembly is still unclear. Primary cilium disassembly
occurs in two waves, the first wave occurring at the G0/G1 phase transition and
a second wave prior to mitosis. The first wave of the ciliary disassembly seems
to be regulated by the mitotic kinase Aurora A (Figure 1.4). The scaffolding
protein NEDD9 (neural precursor cell expressed, developmentally downregulated
9, also known as HEF1) recruits Aurora A to the basal body which leads to the
activation of the kinase and subsequent phosphorylation and activation of HDAC6
(histone deacetylase 6). Active HDAC6 destabilises the MTs within the cilium via
Figure 1.4: Schematic representation of the mechanism of ciliary disassembly at
G0/G1 transition. Quiescent cells normally display a primary cilium, which is disassembled upon
stimulation by growth factors. HEF1 (enhancer of filamentation 1) is recruited to the basal body of
the cilium leading to the localisation and activation of Aurora A. Active Aurora A phosphorylates and
activates HDAC6, leading to the destabilisation and depolymerisation of ciliary MTs (the centrioles
are shown in blue where mother centriole is the basal body; gray line – cytoplasmic membrane;
yellow circles – the ciliary pocket region enriched with PIP2 (phosphatidylinositol 4,5-bisphosphate);
red and blue circles – Ca2+ and K+ ions, respectively).
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deacetylation of tubulin and promotes ciliary disassembly (Pugacheva, Jablonski,
Hartman, Henske, & Golemis, 2007). At the same time, it has been shown that the
first wave also includes ciliary “decapitation”, driven by construction and constriction
of an actin ring around the tip of the primary cilium (Phua et al., 2017).
The so-termed “second wave” of primary cilium disassembly, which occurs right
before mitosis, is mechanistically similar but not identical to the first wave of the
disassembly. Besides the requirement of Aurora A and NEDD9 localisation and
activation at the basal body, other proteins are necessary for the process, e.g. PLK1
(Polo-like kinase 1), KIF2a (Kinesin Family Member 2A; Miyamoto et al., 2015;
G. Wang et al., 2013).
After stimulation with serum during ciliary disassembly, Aurora A requires
interactions with Ca2+ and CaM for full activation at the basal body (Plotnikova et
al., 2012). Interestingly, we have shown that Kv10.1 localises at the centrosomes,
Figure 1.5: A cartoon illustrating Kv10.1 mediated resorption of the primary cilium
prior to mitosis. During G2/M transition PLK1 is relocated to the basal membrane through
PCM (pericentriolar matrix), leading to phosphorylation of HEF1. In turn, HEF1 scaffold protein
enhances the recruitment of Aurora A at the basal body. However, for full activation Aurora A
requires presence of Ca2+/CaM. On the other hand, Kv10.1, which is expressed in the cells exactly
at the G2/M transition, is localized at the centrosome. According to the suggested hypothesis,
Kv10.1 via modulating ORAI1 activity drives Ca2+ entry necessary for Aurora A activation.
Simultaneously Kv10.1 hyperpolarises the adjacent membrane resulting in the dissipation of PIP2
(phosphatidylinositol 4,5-bisphosphate) clusters. All these events thus lead to the resorption of
the cilium (the growing MTs are depicted in light green; the duplicated centrioles are shown in
blue (mother centriole) and orange (daughter centriole, newly synthesised); grey line – cytoplasmic
membrane; yellow circles – the ciliary pocket region enriched with PIP2; red and blue circles – Ca2+
and K+ ions, respectively).
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and over- or downregulation of the channel affects primary cilium disassembly
(A. Sánchez, Urrego, & Pardo, 2016a). Mutations in Kv10.1 ciliary localisation
domain sequence abolished the effects both on the disassembly and Kv10.1-induced
tumour growth in vivo (A. Sánchez et al., 2016a). Putting our findings in the light
of current knowledge, we proposed an updated model of primary cilium disassembly
(Figure 1.5). Kv10.1 activity leads to membrane hyperpolarisation locally serving a
driving force for Ca2+ entry, which in turn changes the distribution of phospholipids
in the cytoplasmic membrane around the base of the cilium. Therefore, both the
Ca2+ ions and modulation of the lipid composition may contribute to the primary
cilium disassembly (Urrego, Sánchez, Tomczak, & Pardo, 2017).
1.2.2 Cancer cells
Expression and regulation of Kv10.1
The maintenance of cell number in a given tissue is achieved by an equilibrium
between the cell division and the cell death. Hence, abnormalities in any of these
processes can lead to the accumulation of a cell mass, a process known as tumourige-
nesis (Ashkenazi, Gentry, & Jackson, 2008).
Ion channels play a critical role in cancer. In particular, potassium channels,
including Kv10.1, are of the utmost interest. Potassium channels are described to be
implicated in such processes as cell division, differentiation, regulation of cell volume,
malignant angiogenesis, migration, metastasis and apoptosis (Figure 1.6) (C. Wang,
Li, Fu, Bouras, & Pestell, 2004).
Diverse tumours have been characterised with an altered expression of the K+
channels (Lang & Stournaras, 2014). Particularly, ectopic expression of Kv10.1 in
more than 70% of human tumours, is associated with worse prognosis (Agarwal,
Griesinger, Stühmer, & Pardo, 2010; Asher et al., 2010; Ding, Luo, Jin, Yan, & Ai,
2007; Ding et al., 2008; Hemmerlein et al., 2006; Mart́ınez et al., 2015; Mello de
Queiroz, Suarez-Kurtz, Stühmer, & Pardo, 2006; Ousingsawat et al., 2007; Wadhwa,
Wadhwa, Dinda, & Gupta, 2009). Moreover, Kv10.1 transfected into mammalian cells
was capable of inducing a transformed phenotype, and subcutaneous implantation of
the Kv10.1-expressing cells into immunodeficient mice rapidly caused invasive tu-
mours, suggesting a role of Kv10.1 in the regulation of cell division (Pardo et al., 1999).
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Figure 1.6: The misregulation of K+ channels expression leads to tumour develop-
ment and progression in multiple ways. Alterations of the expression of K+ channels, be
it at the chromosomal aberrations, transcriptional, translational or post-translational levels, can
substantially affect diverse cellular processes such as cell cycle, apoptosis, adhesion, migration and
many others. As a result the tissue homeostasis is disrupted favouring tumour development and
progression. Adapted from (Pardo & Stühmer, 2013).
Expression of K+ channels is controlled at all levels: transcriptional, translational
and post-translational (Pardo & Stühmer, 2013). The current literature attributes
the abnormal expression of Kv10.1 to the alterations in the p53-miR34-E2F1 regula-
tory pathway (Figure 1.7). The promoter region of KCNH1 has E2F1-responsive
elements, the 3’ untranslated region contains miR34a-regulated sites. E2F1 increases
Kv10.1 expression, whereas miR34a suppresses its expression on both transcriptional
and post-transcriptional levels. miR34 is a known transcriptional target of p53,
which increases expression of miR34. Therefore, p53 indirectly suppresses Kv10.1
via increase of miR34, and vice versa, loss of p53 will result in E2F1 accumulation
and miR34a reduction, and subsequently in Kv10.1 aberrant expression (Lin et al.,
2011). This review of events is in agreement with the findings describing Kv10.1
regulation through human papillomavirus (HPV) and oestrogens (Diaz et al., 2009):
the oestrogen receptor interacts with p53 (R.-G. Liu, Wang, Song, Chen, & Li, 2006),
HPV inhibits p53 (Scheffner, Werness, Huibregtse, Levine, & Howley, 1990) and
activates E2F1 (Hwang, Lee, Kim, Seo, & Choe, 2002). In glioblastoma drug-resistant
cells, miR296-3p downregulation is concurrent with an increase in Kv10.1 expression
(Bai et al., 2013). Interestingly, miR296 also interacts with p21 and downregulates
the p53-p21 axis (Yoon et al., 2011). Importantly, the E2F1 transcription factor
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Figure 1.7: The overview of Kv10.1 expression regulation and its implication in
cancer development. The major cell cycle regulator E2F1 triggers the transcription of KCNH1
gene. The negative regulators of E2F1, like the tumour suppressor p53 and pRb therefore, inhibit
Kv10.1 expression. Kv10.1 functionally cooperates with Rab proteins, CTTN, and so can facilitate
cell migration; Kv10.1 through the stabilisation of HIF1α mediates tumour vascularisation. Finally,
Kv10.1-mediated membrane potential changes can alter the calcium signalling and boost cell cycle.
(AKT, protein kinase B; ERα, oestrogen receptor-α; HPV, human papillomavirus; miR, microRNA;
Rab, Ras-related in brain; CTTN, cortactin; HIF1α, hypoxia-inducible factor 1α; VEGF, vascular
endothelial growth factor). Adapted from (Pardo & Stühmer, 2013).
binds directly to KCNH1 promoter and activates the transcription (H. Lin et al.,
2011; Urrego, Movsisyan, Ufartes, & Pardo, 2016).
Genomic amplification is another mechanism of Kv10.1 overexpression (Spitzner,
Ousingsawat, Scheidt, Kunzelmann, & Schreiber, 2006), which, however, has been
described only for a small proportion of cancers and alone cannot explain the recur-
rence of observed abnormal expression.
The expression of Kv10.1 is also a subject of an epigenetic regulation. For in-
stance, in head and neck cancer the histone acetylation maps are altered resulting in
the aberrant expression of Kv10.1 (Menéndez et al., 2012).
The expression and activity of Kv10.1 are also modulated post-translationally. In
addition to the full-length form of Kv10.1, three splice variants have been identified
in human brain samples. One of the splice variants is longer than the canonical
protein and shows no evident differences from the normal full-length Kv10.1. In
contrary, the other two splice forms, E65 and E70 are shorter and do not form a
functional Kv channel since they lack all transmembrane segments. Moreover, both
these shorter variants significantly inhibit the conductance of full-length channel
(Ramos Gomes et al., 2015).
Human Kv10.1 conducting activity is regulated by EGFR (epidermal growth
factor receptor) tyrosine kinase, which along with other protein tyrosine kinases
mediates processes namely cell proliferation and differentiation, cell metabolism,
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embryogenesis, and oncogenesis (W. Wu et al., 2012). Moreover, the channel current
is inhibited by an increase in intracellular [Ca2+] (Stansfeld et al., 1996), via interac-
tion of calcium/CaM with three CaMBDs (CaM binding domains) localised at the
C- (Gonçalves & Stühmer, 2010; Schonherr, Löber, & Heinemann, 2000) and the
N-termini of Kv10.1 (Lörinczi et al., 2016; Ziechner et al., 2006).
We have previously reported that pVHL (von Hippel-Lindau protein) promotes
Kv10.1 ubiquitination (Downie et al., 2008), possibly directing the channel for proteo-
lysis, compatible with the reduction in Kv10.1 current density upon pVHL expression
and vice-versa, an increase in Kv10.1 current upon pVHL inhibition reported by
others (Murata et al., 2002). pVHL is a tumour suppressor protein, mutation of
which leads to von Hippel-Lindau syndrome, characterised by the occurrence of
benign and malignant tumours in pancreas, adrenals, kidneys, reproductive organs
and the central nervous system (reviewed in Varshney et al., 2017). pVHL functions
as CRL2 (Cul2-Rbx1-Elongin B/C) E3 ubiquitin ligase substrate recognition receptor
(reviewed in Cai & Yang, 2016). Interestingly, the most studied role of CRL2-VHL
complex is the degradation of the α-subunits of HIF1α (hypoxia-inducible factor 1
α; reviewed in Q. Zhang & Yang, 2012). It is intriguing to find out whether Kv10.1
interacts with and so modulates the activity of HIF1α regulator under mild hypoxia
(Downie et al., 2008).
Kv10.1 in cell cycle and proliferation
Kv channels play a crucial role in cell division, a hallmark of cancer (Hanahan &
Weinberg, 2011; Spitzner et al., 2006). The first indications that Kv10.1 is implicated
in cell cycle came from the studies carried in Xenopus oocytes: spontaneous or
mitosis-promoting factor induced maturation produced a dramatic reduction in the
current amplitude of heterologously expressed rat Eag (Brüggemann, Stühmer, &
Pardo, 1997). Furthermore, the electrophysiological behaviour of human Kv10.1
expressed in CHO (Chinese hamster ovary) cells changes profoundly during the cell
cycle, which can be explained by a massive rearrangement of the cytoskeleton occuring
at G2/M transition (Camacho, Sánchez, Stühmer, & Pardo, 2000). Strengthening
these findings, recently we have shown that Kv10.1 is specifically expressed during
late G2 and M phases (Urrego et al., 2016).
13
Introduction
Evidence of the importance of Kv10.1 permeation for cell proliferation comes from
the observation that a small-molecule or monoclonal antibody-mediated block of the
currents has an antitumour effect in breast and pancreatic cancer mouse xenograft
models (Downie et al., 2008; Gomez-Varela et al., 2007). Moreover, in melanoma cells
treatment with imipramine, a known inhibitor of ion channels (including Kv10.1),
causes a significant decrease in DNA synthesis and cell proliferation rates without
considerable effects on apoptosis (Gavrilova-Ruch et al., 2002).
Further proofs of the role of Kv10.1 in cell proliferation are obtained from siRNA
(small interfering RNA) transfection studies. For instance, downregulation of KCNH1
decelerates cell proliferation in several human tumour cell lines (Weber et al., 2006),
while its activation in human melanoma cells by arachidonic acid enhances the
proliferation (Gavrilova-Ruch, Schönherr, & Heinemann, 2007). Spitzner et al. have
shown that spontaneous transformation of colon carcinoma T84 cells is accompanied
by an increase in the proliferation rate and amount of Kv10.1 and Best1 (bestrophin
1, Ca2+-activated Cl- channel); silencing of Kv10.1 and Best1 reduces proliferation of
the transformed cells suggestively by regulating calcium signalling and cell volume
(Spitzner et al., 2008).
Kv10.1 in cell migration
Migration and invasion are the prerequisites of metastasis, a critical event in
cancer progression. During these processes, tumour cells detach, move and adhere at
a new location (B. Martin et al., 2013). Potassium channels are implicated in every
step of these processes (Becchetti & Arcangeli, 2010; Schwab, Fabian, Hanley, &
Stock, 2012), which they achieve in at least three ways: modulating the cell volume,
membrane potential and interacting with migration complex (Ouadid-Ahidouch,
Ahidouch, & Pardo, 2016).
Inhibition of Kv10.1 has been shown to diminish the migration of leukaemia
(Agarwal et al., 2010) and breast cancer cells (Hammadi et al., 2012) in vitro. The
underlying mechanism is suggested to be through the increase of K+ permeability,
which in turn hyperpolarises the cytoplasmic membrane and, thus, facilitates ORAI1
(calcium release-activated calcium channel protein 1 channel)-driven calcium entry
Agarwal et al., 2010; Hammadi et al., 2012; Pardo & Stühmer, 2013).
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Kv10.1 may also influence cell migration, possibly, by rearranging the cytoskeleton.
Interestingly, Kv10.1 electrophysiological properties are modulated by interactions
with cytoskeletal components (Camacho et al., 2000). As shown in MCF-7 cells,
Kv10.1 colocalises with FAK (focal adhesion kinase) at focal adhesion, which is
driven by the interaction with cortactin (Herrmann, Ninkovic, Kohl, Lörinczi, &
Pardo, 2012). However, the interaction with cytoskeleton regulatory molecules is
better characterised for another member of the EAG family, hERG1 (human EAG
related gene 1). hERG1 is suggested to promote cell migration via interaction with
β1-integrins and FAK proteins (Arcangeli et al., 2004; Cherubini et al., 2005, 2002).
Kv10.1 in angiogenesis
Angiogenesis is the process of new blood vessels genesis from pre-existing ones
(Ronca, Benkheil, Mitola, Struyf, & Liekens, 2017). Early in 1971, Sherwood et
al. proposed the idea of viewing a solid tumour as an ecosystem: the cancer
cell creates favourable conditions for endothelial cells to divide, thus promoting
neovascularisation, needed for the cancer cells to grow (Sherwood, Parris, & Folkman,
1971).
Kv10.1 is also implicated in angiogenesis. A strong positive correlation has
been found between Kv10.1 and HIF1α (Lai et al., 2014). Upon expression of
Kv10.1, even a subtle drop in the partial pressure of oxygen activates HIF1α,
leading to the activation of VEGF (vascular endothelial growth factor among many
other downstream targets Downie et al., 2008), and, consequently, neovascularisation
(Ferrara & Davis-Smyth, 1997; Koong et al., 2000; Semenza, 2013; Takahashi, Kitadai,
Bucana, Cleary, & Ellis, 1995). Consistently, Kv10.1-positive tumour cells display
significantly increased secretion of VEGF and vascularisation (Downie et al., 2008).
Thus, expression of Kv10.1 can be seen as an advantage for tumours making them
more resistant to hypoxia. However, resistance to hypoxia seems not to be the
only benefit for the cancer cells expressing the channel, as Kv10.1 promotes tumour





Cell death is a tightly regulated process, of which several forms have been de-
scribed. One of the most prominent ways is apoptosis, the programmed cell death.
Yet cancer cells developed mechanisms of escaping the cell death tilting the balance
towards “overcrowding” the tissue. Therefore, developing these evading mechanisms
is the game-changing factor critical for cancer treatment (Bortner & Cidlowski, 2014;
Tan, Tan, & Muhammad, 2015).
The voltage-gated delayed rectifier potassium channels among many others are
involved in the induction of apoptosis (Bortner & Cidlowski, 2014; Lang et al., 2007).
One of the characteristics of apoptosis is a loss of cell volume, also known as cell
shrinkage (Bortner & Cidlowski, 2007, 2014) and termed AVD (apoptotic volume
decrease; Maeno, Ishizaki, Kanaseki, Hazama, & Okada, 2000). The changes in
intracellular ionic composition, in particular loss of potassium ions, is the corner-
stone of AVD and subsequent triggering of the apoptotic mechanism (Bortner &
Cidlowski, 2014; Cain, Langlais, Sun, Brown, & Cohen, 2001; Thompson, Langlais,
Cain, Conley, & Cohen, 2001). Although the exact mechanism of AVD driven by
potassium depletion is not entirely understood, direct block of potassium channels is
shown to protect cells from apoptosis (X. Wang, Xiao, Ichinose, & Yu, 2000).
However, the role of Kv channels in the regulation of apoptosis is contradictory.
For instance, the voltage-gated potassium channel Kv1.3 is directly involved in
apoptosis. It has been demonstrated that inhibition of Kv1.3, which is localised at
the inner mitochondrial membrane, through interaction with BAX (Bcl2-associated
X protein) or through selective inhibitors of Kv1.3 leads to hyperpolarisation of the
membrane, followed by rise in reactive oxygen species and, subsequently, cytochrome
c release (Leanza et al., 2012, 2017, 2015; Szabó et al., 2008). Growth arrest and apop-
tosis have been observed in osteosarcoma cells treated with CRAd5.TRAIL/siEAG1
adenoviral vector which simultaneously downregulates Kv10.1 and overexpresses
TRAIL (TNF-related apoptosis inducing ligand; X. Wu et al., 2013).
The tumour-specific expression of Kv10.1, meaning its low abundance in the
peripheral tissue, makes it a promising indexing tool for anticancer drug delivery.
For example, a single-chain antibody raised against Kv10.1 (scFv62) and fused with
human soluble TRAIL induces programmed cell death in sensitised Kv10.1-positive
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prostate cancer cells while sparing the healthy ones (Hartung & Pardo, 2016; Hartung,
Stühmer, & Pardo, 2011).
1.3 Cell cycle: stages and checkpoints
1.3.1 Overview of the cell cycle
During cell division, highly coordinated series of events are completed that are
collectively termed the cell cycle (van den Heuvel, 2005). The cell cycle consists of
four phases: S (Synthesis) and M (mitotic; mitosis and cytokinesis) phases which are
separated by so-called G (Gap) phases, G1 and G2 (Figure 1.8; G. M. Cooper, 2000).
Figure 1.8: Simplified representation of
the cell cycle. The cell cycle in eukaryotes con-
sists of four discrete phases: M, G1, S, and G2.
Cells grow throughout interphase, which includes
G1, S and G2. DNA replication takes place in S
phase, and sister chromatid segregation and cy-
tokinesis – during M phase. The availability of
growth factors is the decision-maker for a cell to
commit into a new cycle. This point is located in
late G1 and is known as the “Restriction point”.
If the cell is deprived of growth factors during G1,
the cell leaves the cycle and enters a quiescent
state termed G0. The relative length of each phase
shown in the diagram is common for a rapidly
dividing mammalian cell.
The four phases G0, G1, S and G2
correspond to the morphologic “inter-
phase”. During interphase, a series
of changes take place both in a newly
formed cell and its nucleus before it again
becomes capable of the division. It is also
known as the preparatory phase or inter-
mitosis. S phase consists of an accurate
duplication of the genome. During G1
phase cells transition from the comple-
tion of M phase to the S phase of the
next cycle. In G2 phase, which is be-
tween S and M phases, cells complete
the final preparatory steps necessary for
the M-phase cells (G. M. Cooper, 2000).
Mitosis (nuclear division) is the most
dramatic stage of the cell cycle, corre-
sponding to the separation of sister chro-
matids and formation of genetically iden-
tical two daughter cells (Figure 1.9). The M phase consists of the following steps:
• prophase – chromatin condensation takes place; the centrosomes are separated
towards the opposite poles of the nucleus by the action of kinesins, such as
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Eg5; in late prophase the nuclear envelope breakdown takes place (Agircan,
Schiebel, & Mardin, 2014; Dekker, 2014; Schlaitz, 2014);
• metaphase – alignment of sister chromatids along the metaphase plate; mitotic
spindle assembly checkpoint (Bastians, 2015; Holland & Cleveland, 2009);
• anaphase – the cohesin ring is opened, chromatid cohesion is lost, and by
pulling forces of the spindle the sister chromatids are driven to opposite sides
of the cell (Lara-Gonzalez, Westhorpe, & Taylor, 2012);
• telophase – reformation of the nuclear envelope; decondensation of chromosomes;
reappearance of nucleoli (Larijani & Poccia, 2009).
Figure 1.9: Simplified view of different
stages of mitosis.
After completion of mitosis, roughly
equal shares of the cytoplasm, organelles,
cell membrane and, normally, equal
number of chromosomes are distributed
between newly forming two daughter
cells. This process is known as cytoki-
nesis (D’Avino, Giansanti, & Petronczki,
2015), and together with mitosis they de-
fine the M phase, which lasts only about
an hour. Therefore, approximately 95% of the time a cell spends in interphase
(G. M. Cooper, 2000).
Besides the described Gap phases, environmental and developmental cues can drive
the G1 cells into a quiescent, non-cycling state termed G0 (Figure 1.8; G. M. Cooper,
2000). Normally, external triggers, such as availability of growth factors, will de-
fine whether a cell commits to a new cycle of division or exits it. Time-wise, this
decision-making point is located in late G1 and is known as the “Restriction point”
(Pardee, 1974). If the cell is deprived of growth factors during G1 phase, the cell
will then exit into G0 phase. However, if there are sufficient growth factors available,
then the cell passes the Restricition point and continues cycling. From here on, the
progression through each following phase is no longer dependent on the extrinsic




The normal propagation of each phase of cell cycle, especially the transitions
from one phase into another, is regulated by mechanisms termed “checkpoints”.
A checkpoint will halt a cell in a given phase until the condition of passing the
particular checkpoint is met (Kastan & Bartek, 2004). Due to the complexity of
cell cycle, in the following sections, I will describe only the major events happening
at a given phase and mostly focus on the checkpoint mechanisms which ensure the
errorless propagation of the cell cycle.
1.3.2 Regulation of the G1/S transition: pRb-E2F axis
Figure 1.10: Mechanism of G1/S tran-
sition. Upon stimulation with growth factors the
expression of cyclin D and E increases, which
results in complexing of cyclin D(E) with and ac-
tivating CDK4(6). This complex phosphorylates
and targets pRb for degradation, thus releasing the
E2F1 factor from the inhibitory complex and acti-
vating the transcription of E2F1-dependent genes.
Several viral oncogenes have been described to se-
quester pRb from the E2F1 complex and thereby
facilitate the G1/S transition (“P” in green circles
and the blue arrows – activating phosphorylation;
“P” in red circles and the red arrows – inactivating
phosphorylation; the grey arrow – proteolysis; the
red line indicates the restriction point, “R”).
As already mentioned, the decision
of committing to a cell cycle is contin-
gent on the availability of growth fac-
tors. Upon mitogen cues, several sig-
nalling pathways that regulate cyclin D1
expression are activated (C. Wang et
al., 2004). For instance, activation of
the Ras-MAPK pathway through tyro-
sine kinase receptors or integrins leads
to cyclin D1 accumulation (Poon, 2016),
which is crucial for the activation of the
pRb-E2F1 axis (Figure 1.10).
The pRb (retinoblastoma protein) –
E2F1 pathway regulates the transcrip-
tion of the genes necessary for G1/S
transition, the Restriction point (Pardee,
1974). In the absence of mitogens, pRb
directly binds to the transactivation do-
main of E2F1 and the promoter regions of the genes necessary for G1/S transition,
thus repressing gene transcription (Adams & Kaelin, 1995; Macaluso, Montanari, &
Giordano, 2006). Progression through the Restriction point, therefore, depends on
pRb inhibition.
pRb phosphorylation is a cell cycle-dependent phenomenon and leads to its inac-
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tivation. In early G1 phase, mitogens induce rapid expression of cyclin D1 (Hitomi
& Stacey, 1999), which couples with the kinases CDK (cyclin-dependent kinase)
4 or CDK6. Cyclin D1/CDK4(6) complexes phosphorylate and inactivate pRb,
consequently leading to conformational changes and release of the E2F1 transcription
factor from the inhibitory complex (Dowdy et al., 1993). Released and activated
E2F1 transcription factor, then, drives the expression of an array of genes, including
cyclin E1. Expression of cyclin E1 is periodic and reaches its maximum during
the transition from G1 to S phase (Ohtsubo, Theodoras, Schumacher, Roberts, &
Pagano, 1995). In the middle to late G1 phase, cyclin E1 pairs with CDK2 forming
an active complex, which in turn phosphorylates pRb. Therefore, the concentration
of liberated E2F1 increases, leading to a further accumulation of cyclin E1. Moreover,
E2F1 activity is modulated by cyclin E1/CDK2-mediated phosphorylation. This
constitutes a classical feedback mechanism: cyclin E1 stimulates its transcription
(Möröy & Geisen, 2004).
Some DNA viruses often found in certain tumours can also modulate pRb activity.
For example, in tumour cells, pRB/E2F1 interaction is broken by binding of tumour
virus oncoproteins, such as HPV E7, adenoviral E1A to pRb, and, thus, activating
E2F1 (Moran, 1993).
1.3.3 The DNA damage-induced checkpoint
DNA replication is a complex process, and despite the high fidelity of it some
errors still occur, making a mechanism to control and correct the errors indispensable.
Such mechanism is the DNA damage-activated checkpoint, which recruits the DDR
(DNA damage response) machinery in order to spare time for the cell to repair the
lesions and then resume the cell cycle progression (Shaltiel, Krenning, Bruinsma, &
Medema, 2015).
DDR is a kinase cascade, which detects (sensor proteins), signals (mediators)
and causes cell cycle arrest (effectors) to ensure that DNA lesions are repaired
(J. W. Harper & Elledge, 2007). The type of DNA lesion dictates which arm of DDR
should be activated. Double-strand breaks (DSBs) activate ATM (ataxia telangiecta-
sia mutated kinase), which preferentially phosphorylates CHK2 (checkpoint kinase;
J.-H. Lee & Paull, 2005). Single-strand breaks (SSBs) activate ATR (ATM and Rad3
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related kinase), which targets and activates CHK1 (Zou & Elledge, 2003).
The recent findings show that DDR and cell cycle machinery are intertwined,
meaning that depending on the cell cycle phase one or the other arm of DDR will be
activated independent of the type of DNA lesions. This allows to choose the target
proteins of the DDR in a cell cycle phase-specific manner (Shaltiel et al., 2015).
G1 phase DNA damage-activated checkpoint
The major DNA damage-activated checkpoint in cells passing through G1 phase
is the ATM(ATR)-CHK2(CHK1)-p53/MDM2-p21 pathway. This checkpoint induces
prolonged or even permanent arrest in G1 phase (Figure 1.11; Chen & Poon, 2008).
The expression of ATM and CHK2 is relatively constant, whereas a moderate
periodicity is observed in case of ATR and CHK1. Their expression gradually
increases during G1 phase and reaches higher levels closer to the G1/S transition
phase, where the kinetic activity is more needed (Gately, Hittle, Chan, & Yen, 1998;
Lukas et al., 2001). ATM and ATR, along with CHK1 and CHK2 phosphorylate the
p53 transcription factor and activate it (Awasthi, Foiani, & Kumar, 2015; Bartek
& Lukas, 2003; Kastan & Lim, 2000). Additionally, the ubiquitin ligase MDM2
(mouse double minute 2 homolog), one of the major negative regulators of p53,
Figure 1.11: Mechanism of DNA damage checkpoint activation and cell cycle arrest
in G1 phase. The detailed description is given in the main text; “P” in green circles and the
blue arrows – activating phosphorylation; “P” in red circles and the red arrows – inactivating
phosphorylation; the dashed arrow in grey – translocation; the red arrow with flat end – inhibition;
the dashed arrow in blue – indirectly activating phosphorylation.
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is inactivated by ATM, ATR, CHK2 and CHK1. Therefore, the activating and
inactivating phosphorylations of p53 and MDM2, respectively, result in the sustained
increase of active p53. In this context, the crucial target of p53 is the p21. The
p21 inhibits the cyclin E1/CDK2 complex, the driver of the G1/S transition, and
thereby causes an arrest in G1 phase. As mentioned above, this complex is required
for the activation of E2F1 and, subsequently, initialisation of DNA synthesis. In
summary, the G1 DNA damage-activated checkpoint actuates the two pivotal tumour
suppressor pathways controlled by p53 and pRb (Kastan & Bartek, 2004).
Intra-S phase DNA damage-activated checkpoint
Figure 1.12: Intra-S phase DNA
damage-activated checkpoint leading to ar-
rest in S phase. The detailed description is
given in the main text; “P” in green circles and
the blue arrows – activating phosphorylation; “P”
in red circles and the red arrows – inactivating
phosphorylation; the dashed arrow in grey – pro-
teolysis; the dashed arrow in blue – activation
involving more than one step.
Once the restriction point is passed,
the cell progresses into the S phase,
where the DNA replication and cen-
trosomal duplication take place (Nigg
& Stearns, 2011). These events are
tightly coordinated to eventuate only
once per cell cycle (Huang & Zhang,
2011; Sclafani & Holzen, 2007). Al-
though these two processes occur in dis-
tinct compartments of the cell and are
spatially separated by the nuclear mem-
brane, yet they use the same licensing
proteins and are subject to the same reg-
ulators such as cyclinE1/CDK2 and cy-
clinA2/CDK2 (Ferguson & Maller, 2010;
Huang & Zhang, 2011; Jackman, Kub-
ota, den Elzen, Hagting, & Pines, 2002).
Cyclin A2 starts accumulating at the
G1/S transition and reaches its utmost level during the S phase (Henglein, Chenivesse,
Wang, Eick, & Bréchot, 1994). At the beginning of S phase, it complexes with CDK2,
which is believed to finish the work of cyclin E1/CDK2: propagation of DNA synthe-
sis from already assembled replication complexes, and hindering the formation of new
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ones. Therefore, cyclin A2/CDK2 complex prevents DNA re-synthesis. Together,
cyclin E1 and A2 start and guide, respectively, the DNA replication (Coverley,
Laman, & Laskey, 2002).
If the DNA replication has already started, but some DNA lesions persist, the
replication fork will stall at the damage site. The latter will turn the DDR machi-
nery on, preferentially through ATR, slowing the S phase progression (Figure 1.12;
Awasthi et al., 2015). Active ATM and ATR will phosphorylate CHK2 and CHK1,
respectively, as described earlier. However, during S phase, CHK1 and CHK2 phos-
phorylate and so inactivate the phosphatase CDC25A (cell division cycle; Sørensen
et al., 2003). CDC25A is necessary for actuating the cyclin A2/CDK2 and cyclin
E1/CDK2 complexes (Donzelli & Draetta, 2003; Girard, Strausfeld, Fernandez, &
Lamb, 1991; Nyberg, Michelson, Putnam, & Weinert, 2002). Thereby, activated
intra-S phase checkpoint will slow down the replication until the DNA lesion is
repaired.
G2 phase DNA damage-activated checkpoint
The propagation from G2 to M phase is accompanied by dramatic changes in
cell architecture: NEB (nuclear envelope breakdown), chromosome condensation and
bipolar mitotic spindle assembly. The effector kinase in this stage of the cell cycle is
CDK1 in a complex with either cyclin A2 or cyclin B1. Cyclin B1/CDK1 complex,
also termed MPF (mitosis-promoting factor) is considered to be the driving force
of G2/M transition. The translocation of this complex into the nucleus is driven
by cyclin A2/CDK1 complex; shortly after that, the NEB takes place (Gong et al.,
2007).
CDK1 activation requires a series of phosphorylation and dephosphorylation
events and complex formation with mitotic cyclins A and B (Figure 1.13). Cyclins
A2 and B1 have an oscillatory pattern in expression. As already mentioned, cyclin A2
accumulates starting from S phase until early mitosis, whereas cyclin B1 is expressed
in late G2 and is a subject of ubiquitin-mediated proteolysis during conversion from
metaphase to anaphase. CDK1 is primarily inactive; upon binding to cyclin B1, the
kinase is phosphorylated mainly by WEE1 at Tyr15 and thus maintained inactive
(Ma & Poon, 2011).
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Figure 1.13: Simplified mechanism of G2 arrest caused by activation of DNA
damage-induced checkpoint. The detailed description is given in the main text; “P” in green
circles and the blue arrows – activating phosphorylation; “P” in red circles and the red arrows –
inactivating phosphorylation; the dashed arrow in grey – translocation; the dashed arrow in blue or
red – activation or inactivation, respectively, involving more than one step.
The actuation of cyclin B1/CDK1 is triggered by cyclin A2/CDK1 complex.
Cyclin A2/CDK1 has been shown to activate Bora (aurora borealis), a cofactor neces-
sary for Aurora A activation (Vigneron et al., 2018). One of the multiple substrates of
this kinase is PLK1 (Polo-like kinase 1; Mac̊urek et al., 2008; Seki, Coppinger, Jang,
Yates, & Fang, 2008), which targets and activates CDC25C phosphatase (Roshak et
al., 2000). CDC25C is responsible for removing the inhibitory phosphorylation at
Tyr15 on the cyclin B1/CDK1 complex (Lindqvist, Rodŕıguez-Bravo, & Medema,
2009). Besides, PLK1 phosphorylates and inhibits the WEE1 kinase (Watanabe et
al., 2005). Moreover, the now fully active cyclin B1/CDK1 complex phosphorylates
both WEE1 and CDC25C leading to their inactivation and activation, respectively
(Perry & Kornbluth, 2007). Thereby, the activation of cyclin B1/CDK1 complex
represents an example of a positive feedback loop (Poon, 2016).
Despite the careful control during G1 and S phases, some DNA lesions can
still remain, or new ones may occur. Therefore, DDR is also activated during the
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G2 phase (Figure 1.13). Cyclin B1/CDK1 complex is the decisive target of the
DNA damage activated checkpoint during G2 phase. As before, the same kinase
cascade is activated. However in this case the effector kinases CHK1 and CHK2
inhibit CDC25C and activate WEE1 via phosphorylation. This leads to tilting the
equilibrium towards the inactive cyclin B1/CDK1. Also, DDR has been shown to
inactivate PLK1 (Bruinsma et al., 2017; Bruinsma, Raaijmakers, & Medema, 2012;
Smits et al., 2000). Hence, due to the activated DNA damage pathway the complexes
cyclin A2/CDK1 and cyclin B1/CDK1 will not function preventing the premature
start of the mitosis and arresting the cells in G2/M phase.
In summary, the DNA damage-activated checkpoint retards the cell cycle progres-
sion at different phases giving the cell sufficient time to eliminate all DNA lesions
and, thus, ensures genomic stability.
1.3.4 The mitotic spindle assembly checkpoint
The closing phase of the cell cycle, the M phase is the most critical stage,
which ensures correct distribution of genetic information between the newly forming
daughter cells. The unresolved errors during this phase can generate genomic
instability, which underlies the “hallmarks” of cancer (Hanahan & Weinberg, 2011).
The process of chromosomal segregation is orchestrated by an intertwined network
of kinases, phosphatases, ubiquitin ligases and cytoskeleton components, and requires
rearrangement of the entire cell architecture. That includes NEB, remodelling of the
actin skeleton and endoplasmic reticulum, fragmentation and dispersing of the Golgi
apparatus, fission of mitochondria, condensation of chromosomal DNA and bipolar
mitotic spindle formation (Jongsma, Berlin, & Neefjes, 2015).
Despite this complexity, the entire process can be narrowed down to one primary
regulative mechanism, which is known as SAC (spindle assembly checkpoint). The
aim of SAC is to ensure biorientation of chromosomes at the metaphase plate
by modulating the kinetochore-MT attachments. Once this condition is met, the
checkpoint is turned off and the chromosome movement to opposite poles is initiated
(Musacchio & Salmon, 2007).
The formation of bioriented chromosomes at the metaphase plate is achieved by
an error-correction process coined “search and capture” (Heald & Khodjakov, 2015;
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Figure 1.14: Mechanism of action of spindle assembly checkpoint. The detailed
description of the cartoon is given in the main text. “P” in green circles and the green arrows –
activating phosphorylation; the red arrows – inactivating phosphorylation; the dashed arrow in red –
inhibition involving more than one step; the arrow in grey – cleaving activity of separase; the dashed
arrow in blue – conformational change leading to activation of MAD2; the semi-transparent red
circle – cohesin.
Kirschner & Mitchison, 1986; Mazia, 1987). Several kinases are relocated to the
kinetochores – a protein complex assembled on a centromere region of each chromatid
which ensures attachment of MTs (Cleveland, Mao, & Sullivan, 2003). Some of these
proteins are CDK1, PLK1 and the CPC (chromosomal passenger complex). The
CPC is comprised of Aurora B, Borealin, INCENP (inner centromere protein) and
Survivin, which also controls later stages of M phase, i.e. cytokinesis (Poon, 2016).
These proteins together ensure that each chromosome is connected to the MTs
emerging from the opposite poles and the force applied by the MTs on them is equal
from both sides creating tension between the two sister chromatids. If no tension is
achieved, then the kinases present here, mainly Aurora B, will be capable of reaching
the assembling tips of MTs and destabilising the kinetochore-MT attachments by
phosphorylation. The process of MTs catching the chromosomes will be continued
until the tension is achieved, leading to the spatial inhibition of Aurora B and




The chromosome attach to and align at the equatorial region of the mitotic
spindle stochastically, that is some chromosomes are faster than others. Hence,
anaphase should be prevented until every single chromosome is correctly positioned.
This check is carried out by SAC (Lampson, Renduchitala, Khodjakov, & Kapoor,
2004; Musacchio & Salmon, 2007).
The central effector of SAC is a diffusible complex called the MCC (mitotic
checkpoint complex, Figure 1.14; Poon, 2016). SAC contains the APC/C (anaphase
promoting complex/cyclosome) activator CDC20 and the proteins MAD2L1 (mitotic
arrest deficient 2 like 1, also termed MAD2), BUBR1 (BUB1-related protein 1, also
known as MAD3) and BUB3 (budding uninhibited by benzimidazoles 3 homolog;
Musacchio & Salmon, 2007). These proteins are recruited explicitly to kinetochores
lacking MT attachments (Moyle et al., 2014; Skoufias, Andreassen, Lacroix, Wilson,
& Margolis, 2001; Waters, Chen, Murray, & Salmon, 1998). MCC sequesters CDC20
by binding to it with MAD2, which leads to transitioning of MAD2 from an open
less stable (O-MAD2) to the closed stable conformation (C-MAD2; Poon, 2016). It
is believed that C-MAD2 acts like a prion and converts more O-MAD2 to C-MAD2
without further need of MCC (Mapelli, Massimiliano, Santaguida, & Musacchio,
2007).
Most importantly, the SAC ensures maintenance of APC/C in the inactive state
by sequestering its substrate recognition subunit and activator CDC20. Therefore,
the polyubiquitylation and degradation of two key substrates, cyclin B1 and securin is
prevented (Musacchio & Salmon, 2007). The importance of keeping cyclin B1/CDK1
complex active has already been discussed above.
The sister chromatids are held together by cohesin, which, in order to license
chromosome movement, needs to be cleaved. Cohesin is removed by a protease,
termed separase. However, separase activity is halted by another protein, known
as securin (Peters, 2006). As mentioned earlier, the APC/C ubiquitinates securin
and sends it to proteasomal degradation, thus starting the chain of degaradation
events needed for chromosome segregation. Therefore, by keeping CDC20 inhibited,





1.4.1 The dynamic instability of microtubules
As already described, maintenance of genomic integrity is dependent on the
properly assembled mitotic spindle. MTs form the mitotic spindle. They are divided
into the following subsets: astral MTs ensure the spindle interactions with the cell
cortex; kinetochore MTs tether the chromosomes to the mitotic spindle; interpolar
MTs interdigitate between the spindle poles forming an array of antiparallel MTs
named the “spindle midzone” (Fraschini, 2016).
Each MT consists of thirteen protofilaments arranged in a circle, and each protofila-
ment is a polymer of αβ-tubulin dimers assembled in a head-to-tail fashion (Fraschini,
2016). As a result of the directionality in the organisation of each protofilament,
Figure 1.15: Microtubule dynamic in-
stability.The MT growth (polymerisation) and
shrinkage (depolymerisation) are driven by hy-
drolysis of the GTP bound to β-tubulin. New
GTP-bound αβ-tubulin dimers are incorporated
into growing MTs by hydrolysing the GTP which
is already incorporated in the MT (at the tip), thus
keeping the GTP intact. Once this GTP-cap is
lost, due to the intrinsic instability of GDP-bound
dimers, the MT growth will be rapidly switched to
the shrinkage – a catastrophe. The rescue, which
is a switch from shrinkage to growth, is possibly
explained by the presence of “GTP islands” or
“rescue factors” in the MT lattice. Adapted from
(Akhmanova & Steinmetz, 2015).
the ends of MTs acquire distinct proper-
ties. One of the ends (β-tubulin) is cha-
racterised by fast polymerisation, also de-
scribed as growing properties, and there-
fore, is called the plus-end (or plus-tip).
The opposite end (α-tubulin) is slow
growing and is called the minus-end (or
minus-tip).
The exquisite property of MTs is
their ability of a fast switch between
growth and shrinkage (depolymerisa-
tion), described as dynamic instability
(Figure 1.15; Mitchison & Kirschner,
1984). The switch from growth to
shrinkage is denoted as a catastrophe,
whereas the opposite way is called res-
cue (Gardner, Zanic, & Howard, 2013).
The GTP-cap model explains the cur-
rent understanding of dynamic instabil-
ity. The growing of the MTs is an energy-
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consuming process. The addition of each new αβ-dimer is driven by hydrolysis of
a GTP molecule bound to β-tubulin at the plus-end. It is generally accepted that
the stability of the newly formed MT tip is achieved by a so-called GTP cap, which
contains the conformationally more stable GTP-tubulin, whereas the MT shaft
contains the intrinsically unstable GDP-tubulin that is the MT grows as long as the
GTP cap is present (Akhmanova & Steinmetz, 2015).
The dynamic instability of MTs is essential for the proper functioning of the
mitotic spindle. First, changes in the growth state itself create pulling and pushing
forces, indispensable for the positioning and orienting the mitotic spindle (Grill &
Hyman, 2005; McNally, 2013; Tolić-Nørrelykke, 2008; H.-Y. Wu, Nazockdast, Shelley,
& Needleman, 2017). Moreover, different MT-interacting proteins bind the ends
of MTs with different affinity, which, for instance, contributes to the directional
movement of MT-bound motor proteins (Goodson & Jonasson, 2018). The movement
of MT-bound motor proteins generates forces that allow adjacent MTs to slide in
relation to one another – a feature important for bipolar mitotic spindle formation
and segregation of chromosomes (Fraschini, 2016). Last but not least, the dynamic
instability underlies the “search and capture” model described above (Heald &
Khodjakov, 2015).
The switch between rescue and catastrophe events is a strictly regulated process.
As depicted in Figure 1.16, a long list of proteins, including MAPs (microtubule-
associated proteins), +TIPs (plus-end-tracking proteins), -TIPs (minus-end-tracking
proteins), are involved in the control of MT dynamics. Moreover, the activity of these
proteins is tightly coordinated with cell cycle progression. An example of +TIPs is
the family of MT polymerases XMAP215 (Xenopus microtubule-associated protein),
which recruits and incorporates αβ-dimers in the plus-end of the MT (Brouhard et
al., 2008). Therefore, misbalance in the activity of the members of this family can
result in errors during mitosis. For instance, the MT polymerase ch-TOG (colonic
and hepatic tumour overexpressed gene protein, also termed CKAP5) has been
shown to be involved in the regulation of kinetochore-MT attachment stability, and
changes in its activity can potentially lead to the formation of lagging chromosomes
(Cheeseman, Harry, McAinsh, Prior, & Royle, 2013; Miller, Asbury, & Biggins, 2016).
The end-binding proteins (EBs), which belong to +TIPs can moderately increase
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Figure 1.16: The complexity of regulation of microtubule dynamics. The diagram
maps only some signalling pathways and the crosstalk between them, however, it can already be
appreciated how strict and redundant the control of MT dynamics is. In all cases, the entire process
is narrowed down to the modulation of the polymerisation of MTs via recruiting rescue factors,
changing the activity of XMAP215 MT polymerase or MCAK MT depolymerase. Also, involvement
of cell cycle kinases, e.g. Aurora B and CDK1, is shown. Illustration reproduced courtesy of Cell
Signaling Technology, Inc. (www.cellsignal.com).
MT polymerisation rates in vitro, possibly by influencing the stability of MT ends
(Akhmanova & Steinmetz, 2015; Lansbergen & Akhmanova, 2006).
MT depolymerisation, or shrinkage, is regulated by the kinesin family of MT
depolymerases, which are kinesin-13, kinesin-8 or kinesin-14 (Akhmanova & Stein-
metz, 2015; Walczak, Gayek, & Ohi, 2013). Likewise, changes in the activity of these
proteins are prone to generating errors during mitosis. Depletion of the kinesin-8
KIF18A attenuates chromosome movements and delays the anaphase onset (Mayr et
al., 2007; Stumpff, von Dassow, Wagenbach, Asbury, & Wordeman, 2008; Stumpff,
Wagenbach, Franck, Asbury, & Wordeman, 2012). A member of the kinesin-13 family
MCAK (mitotic centromere-associated kinesin) has been shown to be implicated in
the alignment of chromosomes at metaphase (Illingworth, Pirmadjid, Serhal, Howe,
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& Fitzharris, 2010) and sister chromatid segregation (Maney, Hunter, Wagenbach,
& Wordeman, 1998). Moreover, it has been shown that the major players of cell
cycle Aurora B-PLK1 signalling regulates MCAK at kinetochores, thus ensuring
the prompt correction of erroneous kinetochore-MT attachments and preventing
formation of lagging chromosomes during anaphase (Shao et al., 2015).
1.4.2 Microtubules in the presence of calcium
Almost fifty years ago, studies carried out in vitro demonstrated that pure tubulin
failed to polymerise in the presence of [Ca2+] (Barnes, Engel, & Dousa, 1975; Olmsted
& Borisy, 1975), and inhibition of polymerisation was readily reversible by addition of
EGTA (ethylene glycol-bis(beta-aminoethyl)-N,N,N’,N’-tetraacetic acid). Strikingly,
incubation of brain extracts in the presence of 1 mM CaCl2 and MAPs (MAP1 and
MAP2) resulted in the irreversible loss of tubulin polymerisation, despite the followed-
up addition of EGTA (Sandoval & Weber, 1978). The authors showed that addition
of MAP2 was sufficient to rescue tubulin polymerisation and that the observed effect
was possibly due to the proteolytic action of a calcium-dependent protease specific
for high-molecular-weight MAPs. Moreover, the presence of a calcium-dependent
regulator (later identified as CaM; Sugden, Christie, & Ashcroft, 1979) was shown to
facilitate the effect of [Ca2+] on MTs in depending on the concentration, yet it did
not affect the polymerisation rate when the reaction was performed in the absence
of calcium (Nishida, Kumagai, Ohtsuki, & Sakai, 1979). Interestingly, when the
polymerisation of tubulin was carried out in the presence of MAPs and calcium/CaM,
the observed effect was similar as Nishida et al. had shown; yet when the MAPs were
removed, the CaM enhanced the degree of pure tubulin polymerisation, probably by
withdrawing Ca2+ from tubulin (Y. C. Lee & Wolff, 1982). Later, it was shown that
not only the presence of MAPs is important for the calcium-dependent effect, but
also of Tau-proteins (Erneux, Passareiro, & Nunez, 1984; Safinya et al., 2016).
It is clear that the effect of calcium on tubulin assembly in vivo will strongly
depend on the MAPs and TIPs as well as other ions and proteins present (Humeau et
al., 2018; O’Brien, Salmon, & Erickson, 1997; Qin, Li, Yuan, & Mao, 2012; Santella,
1998). Besides, calcium also causes morphological changes in MTs (V. Buljan,
Ivanova, & Cullen, 2009; V. A. Buljan et al., 2018; Safinya et al., 2016; Sataric,
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Sekulic, Sataric, & Zdravkovic, 2015; Vater, Böhm, & Unger, 1997). The picture gets
even more complicated since the MTs change the cytosolic [Ca2+] by modulating the
SOCE (store operated calcium entry; Martin-Romero, Lopez-Guerrero, Pascual-Caro,
& Pozo-Guisado, 2017; Russa et al., 2008).
The importance of calcium in the cell cycle and apoptosis is well known and is
summarised in Table 1.1 (Humeau et al., 2018)).
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The Aim of the Work
The Aim of the Work
Kv10.1 is explicitly expressed during the G2/M phase of the cell cycle. Moreover,
the downregulation of Kv10.1 results in extended G2/M phase possibly through
activation of the G2/M checkpoint. Nevertheless, the mechanism of Kv10.1-mediated
cell cycle regulation, particularly at the G2/M transition, is still unknown.
In this context, this study aims to explain the molecular mechanism of the role
of Kv10.1 in the regulation of G2 and M phases of the cell cycle. We hypothesise
that Kv10.1 is involved in the regulation of at least one of the checkpoints acting at
G2 and M phase. To confirm this hypothesis we utilised transient downregulation
of Kv10.1 and specific blockers of the channel conductance. The objectives of the
study were as follows:
1. Identification of the regulatory pathway or pathways which are affected by the
loss of Kv10.1.
2. Finding the possible candidate or candidates which can interact either directly or
through interposed factors with Kv10.1 and together modulate the progression
through G2/M.
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HeLa cells (ACC 57), acquired from the German Collection of Microorganisms
and Cell Lines (DSMZ), were maintained in RPMI (Roswell Park Memorial Institute)
1640 Medium (GIBCO) supplemented with 10% heat-inactivated FCS (fetal calf
serum; Biochrom) at 37◦C and 5% CO2.
hTERT RPE1 (ATCC CRL4000) were obtained from ATCC and maintained in
DMEM/F-12 (Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12; GIBCO)
supplemented with 10% heat-inactivated FCS and 0.01 mg/ml hygromycin B at 37◦C
and 5% CO2.
2.1.2 Passaging of cells
HeLa and hTERT RPE1 cells were routinely passaged once they reached 80 –
90% confluency. The cells were washed with DPBS (Dulbecco’s Phosphate Buffered
Saline; GIBCO) and trypsinised by incubating with Trypsin-EDTA (0.05%:0.02%,
w:v; Biochrom) for 5 min at 37◦C. The trypsin activity was neutralised by addition
of the corresponding full growth medium at 3:1 (v:v) ratio of added Trypsin-EDTA.
The cells were then harvested by centrifuging at 300 xg for 2 min, resuspended with
fresh medium and plated at the required density.
2.1.3 Cell count
The cell count was determined using Neubauer’s chamber. Briefly, an aliquot of
cell suspension was mixed with Trypan Blue (Sigma) at 1:1 (v:v) ratio, resuspended
using a pipette, and 10 µl of the suspension was introduced into the chamber. Only
Trypan Blue-negative cells were counted inside of the four large squares. If the cells
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were on the borderlines of the squares, only the ones crossing the upper and left
border lines were counted. The cell concentration was then derived from the counted
cell number using the following formula:
Concentration (cell/ml) = number of cells * dilution factor * 10000
number of squares
The final dilution was adjusted in order to obtain 1 ∗ 106 cells/ml.
2.1.4 Plasmid DNA purification
Visualisation of growing MTs and overexpression of Kv10.1 was achieved by
transfecting the cells with pEB3 (end-binding protein 3)-tdTomato (a gift from Erik
Dent; plasmid #50708, Addgene; Merriam et al., 2013) and hEAG1-ptracer (Pardo
et al., 1999), respectively.
Before the purification, pDNA was first inoculated into bacterial cells and grown
to yield higher amounts of the pDNA. In brief, 1 µl of a pDNA was added to 50
µl of DH5-alpha competent cell suspension, gently resuspended with a pipette, and
incubated for 5 min on ice. Then heat-shock was applied to the cells by first incu-
bating them for 1 min in a 42◦C water bath, then for 10 min on ice. After that, the
cell suspension was extended onto an agar coated dish with the respective antibiotic
and incubated at 37◦C, overnight. The choice of the antibiotic was defined by an
antibiotic resistance gene present on the pDNA being introduced into the bacterial
cells. Thus, only bacteria carrying the plasmid will be able to grow under such
conditions (Voß, 2007). The cells inoculated with pEB3-tdTomato were cultivated
in the presence of kanamycin (25 µg/ml), and hEAG1-ptracer – ampicillin. On the
following day, a single colony of bacterial cells was collected and further incubated
in 100 ml of liquid LB (Luria Broth; 1% NaCl, 1% Tryptone, 0.5% yeast extract)
medium with the respective antibiotic at 37◦C and 300 rpm for 12 – 16 h.
The pDNA was purified using NucleoBond Xtra Midi EF endotoxin-free plas-
mid DNA purification kit (MACHEREY-NAGEL) following the manufacturer’s
instructions. In brief, the bacterial cells were centrifuged for 15 min at 6000 xg and
4◦C. The harvested cells were resuspended in 8 ml of Resuspension Buffer RES-EF
containing RNase A and lysed with 8 ml of Lysis Buffer LYS-EF by gently inverting
the tube 5 times and incubating at RT (room temperature) for 5 min. Meanwhile,
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the NucleoBond Xtra Column was equilibrated with 15 ml of Equilibration Buffer
EQU-EF. The resulting crude lysate was neutralised with 8 ml of Neutralisation
Buffer NEU-EF, mixed gently by inverting the tube several times, and loaded onto
the NucleoBond Xtra Column. Once the column emptied by gravity flow, the Nucleo-
Bond Xtra Column and NucleoBond Extra column Filter were first rinsed with 5 ml
of Filter Wash Buffer FIL-EF. After that, the filter was discarded, and the column
was washed first with 35 ml of Wash Buffer ENDO-EF, and then with 15 ml of Wash
Buffer WASH-EF. After each step the column was let empty as before. The plasmid
DNA was eluted with 5 ml of Elution Buffer ELU-EF into 15 ml centrifuge tubes
(Beckman Coulter). The eluted plasmid DNA was precipitated with isopropanol
at RT, vortexed thoroughly and pelleted by centrifuging for 30 min at 15000 xg
and 4◦C. The supernatant was decanted carefully, and the DNA pellet was washed
with 70% ethanol. Afterwards, the plasmid DNA pellet was allowed to dry at RT
under a laminar hood, and reconstituted by dissolving it in an appropriate volume of
endotoxin-free H2O-EF. Plasmid DNA yield and purity was determined by measuring
the absorbance in the UV-range, and the plasmid integrity was confirmed by agarose
gel electrophoresis. The purified pDNA was aliquoted and stored at -20◦C.
2.1.5 siRNA and pDNA transfection
Complexation, cell entry and intracellular delivery of nucleic acids define the
underlying principle of transfection. The complexation step is based on the inter-
action of positively and negatively charged particles. Due to the polyphosphate
backbone, nucleic acids are negatively charged and, therefore, can interact with
positively charged transfection reagents. As a result positively charged transfection
complexes are formed which both protect nucleic acids from nuclease degradation
and ease cell entry. Positively charged transfection complexes can interact with the
negatively charged heparan sulphate proteoglycans present on the outer surface of
the cytoplasmic membrane of adherent cells. The exact mechanism of entry of the
transfection complexes into the cell is unclear, but it is believed that the interaction
with cytoplasmic membrane triggers their inclusion via endocytosis. An ability of
transfection reagents to induce rupture or fusion of the vesicular membrane and so
release the nucleic acids into the cytoplasm determines their effectiveness. Most
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nucleic acids can already function in the cytoplasm. In the case of generating stable
mutations, the nucleic acids should be delivered into the nucleus and integrated into
the cell genome (Dalby et al., 2004; Kim & Eberwine, 2010).
Transient downregulation of Kv10.1 in HeLa and hTERT RPE1 cells was achieved
by siRNA transfection. The following siRNA sequence directed against KCNH1
was used: 5’-TACAGCCATCTTGGTCCCTTA-3’ (HP Custom siRNA, Qiagen). A
commercial negative control (scrambled, Scr) siRNA (cat # AM4635, Ambion) was
used as a control for siRNA interference. The cells were plated at least 24 h before
the transfection, and were 50 – 70% confluent at the moment of transfection. Opti-
mal downregulation or overexpression was achieved by using different transfection
reagents depending on the cell type and the target protein.
siRNA interference using Lipofectamine RNAiMAX
siRNA transfection in hTERT RPE1 cells was carried out using Lipofectamine
RNAiMAX transfection reagent (Invitrogen). Briefly, two working solutions were
prepared. Solution one contained the respective siRNA at a final concentration of
30 nM in 125 µl OptiMEM-I+GlutaMAX-I (GIBCO) per well of a 6-well culture
plate. For the second solution, 3 µl of Lipofectamine was mixed with 122 µl of
OptiMEM-I+GlutaMAX-I per well. Both solutions were briefly vortexed and spun
down. Diluted siRNA was then added to the lipofectamine-containing solution,
pipette-mixed and incubated for 15 min at RT. The transfection mixture was added
to the cells growing in a 6-well plate in 2 ml normal growth medium, resulting in
the final volume of 2.25 ml per well. The cells were incubated in the presence of the
transfection mixture for 4 h at 37◦C and 5% CO2. The medium was subsequently
changed, and after 48 h, the transfected cells were used for the experiments. The
efficiency of the siRNA interference was tested by immunoprecipitation and WB
(western blot) at least for one experimental repeat of experiments of different designs.
siRNA interference using INTERFERin
Transient downregulation of Kv10.1 in HeLa cells was achieved using INTER-
FERin transfection reagent (Polyplus-transfection SA) following the manufacturer’s
instructions. For this, the amount of siRNA corresponding to 30 nM final concen-
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tration was added to 190 µl of OptiMEM per well of a 6-well plate; 10 µl/well
of INTERFERin was then added to the diluted siRNA solution and immediately
vortexed for 10 sec. The siRNA-INTERFERin mixture was spun down and incubated
for 10 min at RT. The final volume of the transfection mixture, 200 µl/well, which
was added dropwise to the cells growing in 2 ml standard growth medium. The cells
were incubated with the transfection mixture for at least 2 h at 37◦C and 5% CO2.
Subsequently, the medium containing the transfection mixture was removed and the
cells were further cultivated in fresh medium.
pDNA transfection using jetPRIME
In order to overexpress a protein of interest in HeLa and hTERT RPE1 cells,
pDNA (plasmid DNA) was introduced into the cells using jetPRIME transfection
reagent (Polyplus-transfection SA). The procedure in brief was as follows: 1 µg
of DNA was mixed with jetPRIME buffer and 2 µl of jetPRIME. The volume of
jetPRIME buffer was adjusted to 400 µl final volume. Immediately after that,
the mixture was vortexed for 10 s, spun down and incubated at RT for 10 min.
Afterwards, 100 µl of the transfection mixture was added dropwise to each well of a
4-well µ-slide (ibiTreat, #1.5, Ibidi), and incubated for 4 h at 37◦C and 5% CO2.
Then, the cells were supplemented with fresh growth medium and incubated at least
24 h at 37◦C and 5% CO2.
pDNA and siRNA co-transfection with jetPRIME
Transient overexpression of one protein and simultaneous downregulation of
another protein was achieved by co-transfecting pDNA and siRNA, using jetPRIME
(Polyplus-transfection SA). In brief, HeLa and hTERT RPE1 cells were seeded in a
6-well plate 24 h before the co-transfection. The numbers below are given per well of
a 6-well plate. On the day of transfection, the pDNA and siRNA were diluted with
jetPRIME buffer to obtain 1 µg/well and 30 nM final concentrations, respectively.
Then, 10 µl of jetPRIME transfection reagent was added to the diluted samples,
vortexed for 10 s, spun down and incubated for 10 min at RT. Meanwhile, the
medium in each well was replaced with 2 ml of the appropriate growth medium.
The transfection mixture was added to the each well dropwise. The cells were
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incubated with the transfection mixture for 4 h at 37◦C and 5% CO2, and then the
medium was substituted with a fresh one. The cells were used in experiments 48 h
post-transfection.
2.1.6 Cell cycle synchronisation
Synchronisation in G0 phase by serum deprivation
One of the commonly used methods for synchronising cells in the G0 quiescent
phase of the cell cycle is the serum deprivation or starvation approach. It is based on
the requirement of mitogens for cells to progress through the restriction point (Pardee,
1974). Once cells pass the restriction point, they enter the S phase and complete the
cell cycle without further stimulation by mitogens (Reed, 1997; Zetterberg & Larsson,
1985). Due to the absence of mitotic signals, the cells, which are in G1 phase at the
moment of starting serum deprivation, exit from the cell cycle into a non-dividing
state, termed G0 and characterised by low metabolic state. Cells that already have
passed the restriction point will proceed further through the cell cycle until they
reach the G1 phase again, where the absence of mitogens in the environment will
force them to enter the G0 phase (Iyer et al., 1999).
This method was used to synchronise hTERT RPE1 cells at the G0/G1 border.
The cells were cultured until 65 – 70% confluency in T-75 flasks in the corresponding
growth medium. The synchronisation of the cells was then started: the serum
containing growth medium was removed and the cells were washed twice with growth
medium with no FCS. Thus, the residual mitogens are eliminated, and the cells
were then exposed to serum-free medium: DMEM/F-12 supplemented only with
0.01 mg/ml hygromycin. The cells were starved for 60 h at 37◦C and 5% CO2. The
hTERT RPE1 cells synchronised in such manner were used for intracellular calcium
imaging.
Synchronisation at G1/S border by double thymidine block
To study the different stages of the cell cycle, HeLa cells were synchronised by
double thymidine block. At the basis of thymidine block lies the negative regulation
of nucleotide synthesis caused by disruption of the nucleotide pool sizes. Treatment
of cells with an excess of thymidine (2 mM) leads to allosteric inhibition of class I
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Figure 2.1: The principle of double thymidine block. A, Regulation of class I ribonu-
cleotide reductase (RNR1). Class I RNRs activity is regulated by binding ATP (activation) or
dATP (inactivation). Active enzyme reduces the substrates according to the corresponding effector
molecules (dTTP, dGTP, dATP, ATP) bound to the allosteric sites. In this manner, the substrate
specificity regulation ensures equal production of dNTPs necessary for DNA replication. Disruption
in this balanced state leads to the inhibition of the enzyme and cell cycle arrest at G1/S border
(Jordan & Reichard, 1998). B and C, The mechanism of the double thymidine block is illustrated.
B, The cells which at the beginning of the synchronisation were already in S phase, or G1 or late
G2 at the end of the first block with thymidine will become arrested at different stages of S phase.
Wash-out of the thymidine and exposure to a fresh growth medium allows the cells to exit the S-phase
and reach late G2 or early G1 phase (J. V. Harper, 2005). C, Subsequently, the second block
with thymidine results in the arrest of the cells at the G1/S border (the dashed arrow indicates
the propagation of the cells arrested in G1/S and early S phase and the solid arrow indicates the
propagation of the cells in late S phase during the release from the first block; R is the restriction
point; J. V. Harper, 2005).
RNR (ribonucleotide reductase), resulting in inhibition of DNA synthesis and arrest
of the cells at the G1/S border (Figure 2.1; Cory & Sato, 1983). The necessity of
two consecutive exposures to the excess of thymidine is depicted in Figure 2.1. In
brief, during the first block with thymidine excess, which in case of HeLa cells lasts
16 h, some of the cells will be arrested at the G1/S border. However, those cells that
were already in S phase when thymidine was applied, will be arrested along S phase.
Following release from the thymidine block for 8 h, the cells that were arrested at the
G1/S border will progress until G2/M, and the cells arrested at different stages of S
phase will cycle until G1 phase. Thereby, during the second exposure to the excess of
thymidine for another 16 h, a vast majority of the cells will accumulate at the G1/S
border (J. V. Harper, 2005). Of note, the length of each step described above is
strongly dependent on the cell cycle duration of cells in question, and time intervals
given here correspond to the experiments using HeLa cells. HeLa cells blocked at
G1/S in such manner were then released into fresh growth medium with 10% FCS,
and cell samples were collected every 2 h between 0 – 6 h and 10 – 14 h, and every 1
h between 6 – 10 h (G2/M phase) after the release and further used for biochemistry.
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Synchronisation in prophase by dimethylenastron
The MT dynamics were investigated in HeLa and hTERT RPE1 cells synchronised
in prophase. It has been shown that the small-molecule DME (dimethylenastron)
can be a useful tool for studying MT dynamics in fixed or live cells (Ertych et al.,
2014). DME is an analogue of monastrol, which inhibits a motor kinesin Eg5 (also
known as KIF11; Müller et al., 2006). Eg5 is essential for bipolar spindle formation
by generating forces needed for establishing and maintaining the bipolar spindle and
contributing to its elongation (Mann & Wadsworth, 2019). Inhibition of Eg5 with
DME leads to the arrest of the cells in prophase and formation of monopolar spindles
(Mayer et al., 1999). Interestingly, cells with altered MT dynamics form asymmetric
monopolar spindles. It should be noted that the treatment with DME itself has no
effect on the assembly rates of MT plus-tips (Ertych et al., 2014). Quantification of
these structures can already hint at the potential alterations in MT dynamics, which
should be further validated by a direct measurement of MT dynamics.
Asynchronously growing HeLa and hTERT RPE1 cells were incubated with 2.5
µM DME for 4 h at 37◦C and 5% CO2. Afterwards, the cells were either used for
live cell imaging or fixed for further immunofluorescence staining.
Synchronisation in metaphase and anaphase by thymidine-nocodazole
treatment
Enrichment of the cell populations in metaphase and anaphase was achieved by
sequential treatment with thymidine and nocodazole, followed by either treatment
with the proteasome inhibitor MG132 or release into the growth medium, respectively.
As already described above, treatment with an excess of thymidine only once results
in the arrest of the cells at the G1/S border and along S phase.
The second part of the protocol is based on the MT depolymerising property of
nocodazole (methyl [5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl] carbamate), also
known as oncodazole (Friedman & Platzer, 1978; Hoebeke, Van Nijen, & De Braban-
der, 1976; Ireland, Gull, Gutteridge, & Pogson, 1979). MT formation is an important
structural feature of cells, especially during mitosis. They participate in the exact
organisation and function of the mitotic spindle, and are critical for assuring the
integrity of the segregated DNA (Abal, Andreu, & Barasoain, 2003). It has been
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shown that nocodazole interacts and chemically modifies tubulin by preventing its
polymerisation, and the presence of MAPs does not amplify the inhibitory effect of
the drug (J. C. Lee, Field, & Lee, 1980). Several other drugs, such as vincristine
and colcemid, similar to nocodazole interfere with MTs and cause arrest in G2/M
(Florian & Mitchison, 2016). However, interaction of nocodazole with MTs is rapid
and readily reversible, which makes it potentially useful for synchronisation of the
cells (Zieve, Turnbull, Mullins, & McIntosh, 1980). In addition, nocodazole as an
agent for synchronising cells at G2/M has been shown to be most efficient and less
harmful for the cells when applied to a presynchronised population, e.g. metabolically
blocked G1/S cells (Nüsse & Egner, 1984).
In brief, HeLa cells were first incubated with 2 mM thymidine for 16 h at 37◦C
and 5% CO2. Then, thymidine containing medium was removed, and the cells were
rinsed twice with DPBS and released into a fresh growth medium for 4 h, allowing
them to enter the G2 phase. Afterwards, HeLa cells were treated with medium
containing 2 ng/ml nocodazole for an additional 4 h, followed by a washing step as
described above. HeLa cells synchronised at prophase in such manner were further
used either for enriching them in metaphase or anaphase. In case, of anaphase, the
cells were further incubated 40 min with a standard growth medium.
Regulation of transition through different phases of cell cycle is achieved via
ubiquitination-mediated degradation of cyclins (Gilberto & Peter, 2017; Zheng,
Wang, & Wei, 2016). Of particular interest is the regulation of the transition from
metaphase-to-anaphase via APC/C mediated degradation of cyclin B1 (Poon, 2016;
Reed, 2006). Proteasome inhibitors can be a valuable tool for studying this step of
cell cycle (D. H. Lee & Goldberg, 1998). MG132 (carbobenzoxy-Leu-Leu-leucinal), a
peptide aldehyde, is one of such inhibitors, and it effectively blocks the proteolytic
activity of the 26S proteasome complex (D. H. Lee & Goldberg, 1996; Rock et al.,
1994). Therefore, in our experiments accumulation of cells at metaphase was achieved
by additionally incubating HeLa cells with 15 µM MG132 for 2 h at 37◦C and 5%
CO2 after the thymidine-nocodazole treatment.
Cells synchronised at metaphase and anaphase were further fixed and immunos-
tained for assessment of chromosomal alignment at metaphase and presence of lagging





Cells were harvested by trypsinisation and centrifuged for 2 min at 300 xg for
protein isolation. Afterwards, the supernatant was removed and the cell pellets were
lysed in non-denaturing lysis buffer (1% Triton X-100, 50 mM Tris-HCl, 300 mM
NaCl, 5 mM EDTA) containing protease and phosphatase inhibitor cocktail (Roche)
for 30 min at RT in 1:3 ratio (v:v). For nuclear protein extraction, a modified RIPA
buffer was used: 1% (v:v) NP-40 (Nonidet P-40, octylphenoxypolyethoxyethanol),
0.1% (m:v) Na deoxycholate, 300 mM NaCl, 50 mM Tris-HCl. After the lysis, the
samples were centrifuged at 18000 xg for 15 min at 4◦C. The supernatant was then
recovered and stored at -80◦C until further use.
2.2.2 Protein concentration determination
Protein concentration was determined with the BCA (bicinchoninic acid) assay.
This assay, also termed Smith assay after its inventor Paul K. Smith (P. K. Smith et
al., 1985), determines the total concentration of proteins in a solution (0.5 µg/ml to
1.5 mg/ml). The BCA assay mainly consists of two reactions: first, the reduction
of bivalent copper ions to monovalent state by peptide bonds in a temperature-
dependent manner (Wikipedia, n.d.). Therefore the amount of reduced Cu2+ is
directly transferable to the amount of proteins present in the solution. The second
reaction is the complexion of two bicinchoninic acid molecules with a monovalent
copper ion. This complex depends on the availability of tyrosine, cysteine/cystine,
and tryptophan in the measurable proteins, and at high temperatures (37 to 60◦C)
is purple-coloured with the absorbance peak at 562 nm. Hence, the protein concen-
tration can be determined by measuring the absorbance and extrapolating it from
the absorbance values of protein solutions with known concentration (Walker, 1994;
Wikipedia, n.d.).
BCA Protein Assay was performed following the manufacturer’s instructions,
calibrated with bovine serum albumin (BSA; Thermo Fisher Scientific). In brief, an
aliquot of the protein sample was diluted 5 times with respective lysis buffer to obtain
40 µl final volume. Then, 10 µl of the diluted protein sample was pipetted into a
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well of a 96-well plate, in triplicates. The reaction buffer was prepared by mixing 50
parts of solution A (contains sodium carbonate, sodium bicarbonate, bicinchoninic
acid and sodium tartrate in 0.1 M sodium hydroxide) with 1 part of solution B
(contains 4% cupric sulfate), and 200 µl of that was added to each well. The reaction
mixture was then incubated for 30 min at 37◦C. Afterwards, the samples were cooled
down to RT, and the absorbance at 562 nm was measured on Wallac 1420 VICTOR2
microplate reader (PerkinElmer, Inc., USA).
2.2.3 SDS-PAGE
Proteins were separated according to their molecular weight using SDS-PAGE
(sodium dodecyl sulphate polyacrylamide gel electrophoresis). In order to disrupt
higher order protein structures and prevent disulphide bridge formation, NuPAGE
Reducing agent and NuPAGE LDS Sample buffer (Invitrogen) were added to the
samples (50 µg total proteins in 30 µl final volume) in 1:10 (v:v) and 1:4 (v:v) ratio,
respectively. The samples were then denatured at 70◦C for 10 min.
The denatured samples were resolved on 4 – 12% NuPAGE Novex Bis-Tris Mini
Gels (1.0 mm, 12 well; Invitrogen) at 200 V in MOPS electrophoresis buffer. For
high molecular weight proteins, 3 – 8% NuPAGE Novex Tris-Acetate Gels (1.5 mm,
10 well; Invitrogen) and Tris-Acetate electrophoresis buffer (Invitrogen) were used.
The molecular weight of the protein of interest was identified with the following pre-
stained protein standards: ColorPlus (New England BioLabs) or All Blue (Bio-Rad)
– for low- and mid-range molecular weight proteins, and Hi-MARK (Thermo Fischer
Scientific) – for high molecular weight proteins.
2.2.4 Immunoblotting
Once protein samples were separated by SDS-PAGE, the proteins were transferred
onto an NC (nitrocellulose) membrane using a tank (wet) electro-transfer procedure.
Low- and mid-range molecular weight protein. The protein samples were blotted
onto a pre-cut NC membrane (0.2 µm; Invitrogen) at 50 V for 2 h at RT. The
following transfer buffer was used: 10 mM NaHCO3, 3 mM Na2CO3, 0.01% SDS and
20% methanol.
High molecular weight protein. The protein samples were blotted onto a pre-cut
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NC membrane (0.45 µm; GE Healthcare) at 35 V and 4◦C, overnight. The composi-
tion of the transfer buffer was the same, except that it contained 15% methanol.
After the accomplishment of the transfer, the NC membranes were rinsed with
ddH2O (deionised water). The membranes were then treated with Blot Signal En-
hancer (Thermo Scientific) according to the manufacturer’s instructions. In brief,
the membranes were first incubated with Solution 1 for 2 min at RT and protected
from light; then rinsed with ddH2O 5 times, and incubated with Solution 2 for 10
min at RT. After that, the membranes were again rinsed with ddH2O five times and
twice with TBS. The membranes were stored in TBS at 4◦C or further processed.
The membranes were incubated with 0.1% casein (Roche) in TBST (20 mM Tris,
150 mM NaCl and 0.1% Tween 20) for 1 h at RT and gentle agitation, which will
later prevent non-specific binding of the antibody probes to the membrane surface.
Taking into account that casein can be phosphorylated, and thus it can compete
with the phosphorylated antigen for antibody binding, 5% BSA in TBST was used
for detection of phosphoproteins. Proteins of interest were identified by incubating
the NC membranes with a primary antibody (Table 2.1) diluted in the corresponding
blocking buffer overnight at 4◦C with gentle agitation. On the following day, the
primary antibody solution was recovered, and the excess was removed from the
membranes by washing 5 times with ddH2O and twice with TBST. Afterwards,
the membranes were incubated with HRP (horseradish peroxidase)-conjugated se-
condary antibody diluted in blocking buffer for 45 min at RT with gentle agitation
(Table 2.1). Then the membranes were washed as above, and incubated with 5 ml of
a chemiluminescent HRP substrate (Millipore) for 5 min at RT with gentle agitation
and protected from light. The substrate triggers secondary antibody-conjugated
HRP-catalysed chemiluminescence reaction. The emitted light was then detected
with a ChemiDoc XRS system (Bio-Rad) controlled by Quantity One 1-D Analysis
software v4.6.9 (Bio-Rad). Images were acquired starting from 1 s of exposure time
until 10 min of total exposure and taking 10 images per membrane. If a saturated
signal was detected, then the image acquisition was terminated.
After detection of the protein of interest, the antibodies bound to the membrane
were removed with Restore Plus Western Blot stripping buffer (Life technologies).
Restore Plus Western Blot stripping buffer was added to each membrane (approxi-
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mately 20 ml for an 8 × 10 cm blot) and incubated for 30 min at RT with gentle
agitation. The complete removal of enzyme conjugates was tested by additionally
incubating with an HRP chemiluminescence substrate. If no signal was detected
during a 5 min exposure, the membranes were ready for re-probing with new primary
and secondary antibodies, preceded by a blocking step.
Table 2.1: List of primary and secondary antibodies used for im-
munoblotting
Antibody Source Dilution Cat.
Number
Manufacturer
p-ATR (Ser428) Rabbit/polyclonal 1:1000 2853 Cell Signaling
p-BRCA1 (Ser1524) Rabbit/polyclonal 1:1000 9009 Cell Signaling
p-CHK1 (Ser345) (133D3) Rabbit/monoclonal 1:1000 2348 Cell Signaling
CHK1 (FL-476) Rabbit/polyclonal 1:1000 sc-7898 Santa Cruz
Biotechnology
p-CHK2 (Thr68)(C13C1) Rabbit/monoclonal 1:1000 2197 Cell Signaling
CHK2 (DCS-270) Mouse/monoclonal 1:1000 sc-56296 Santa Cruz
Biotechnology
p21 Waf1/Cip1 Mouse/monoclonal 1:1000 05-345 Merck Millipore
p-histone H2AX (Ser139) Rabbit/monoclonal 1:1000 sc-101696 Cell Signaling
CDC27 (AF3.1) Mouse/monoclonal 1:1000 sc-9972 Santa Cruz
Biotechnology
p-CDC25C (S216) Rabbit/monoclonal 1:1000 ab32051 Abcam
CDC25C Rabbit/polyclonal 1:1000 sc-327 Santa Cruz
Biotechnology
CDC20 Rabbit/polyclonal 1:1000 ab26483 Abcam
Aurora B/AIM1 Rabbit/polyclonal 1:1000 3094 Cell Signaling
BUB3 Mouse/monoclonal 1:1000 sc-376506 Santa Cruz
Biotechnology
MAD2L1 (D8A7) Rabbit/monoclonal 1:1000 4636 Cell Signaling
pVHL Mouse/monoclonal 1:200 556347 BD Pharmingen
Actin (C-11) Goat/polyclonal 1:1000 sc-1615 Santa Cruz
Biotechnology
Kv10.1 Rabbit/polyclonal 1:1500 9391










Donkey/polyclonal 1:10000 NA934 GE Healthcare
ECL Anti-Mouse IgG,
HRP Linked
Sheep/polyclonal 1:10000 NA931 GE Healthcare
Anti-Goat IgG (H+L),
HRP Conjugate
Rabbit/polyclonal 1:10000 172-1034 BIO-RAD
2.2.5 Immunoprecipitation
Due to the low endogenous levels of Kv10.1, the efficiency of Kv10.1 knockdown
in HeLa and hTERT RPE1 cells was tested by immunoprecipitation and WB. The
samples were immunoprecipitated with protein G magnetic beads (New England
BioLabs) following the manufacturer’s instructions. In brief, 300 µl of cell lysate
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containing 1000 µg of total protein was incubated with 15 µl of protein G magnetic
beads for 1 h. Afterwards, the supernatant was recovered using a magnetic separation
rack (New England Biolabs). This step pre-clears the sample from components that
bind non-specifically to the magnetic beads. Then, 3 µg of anti-Kv10.1 monoclonal
antibody (Kv10.1-33.mAb) was added to and incubated with the pre-cleared samples
on a vertical rotator at 4◦C, overnight. On the following day, the Kv10.1/antibody
complexes were recovered by addition of 30 µl of protein G magnetic beads per
sample, and incubation for 4 h at 4◦C on a vertical rotator. Afterwards, protein G
magnetic beads/antibody/Kv10.1 complexes were pulled by placing the samples into
a magnetic separation rack. The supernatant was removed and stored at -20◦C.
Figure 2.2: Kv10.1 silencing
was defined by immunoprecipita-
tion. An example image from two in-
dependent experimental repeats is given
(the arrow indicates the Kv10.1 corres-
ponding band).
The beads were washed 3 times with 500 µl
of cold Immunoprecipitation buffer (0.1% Triton
X-100, 50 mM Tris-HCl, 300 mM NaCl, 5 mM
EDTA) with protease inhibitor cocktail (Roche).
Afterwards, the magnetic bead/antibody/Kv10.1
pellets were resuspended in 16.25 µl TBS buffer,
2.5 µl NuPAGE reducing agent (Invitrogen) and
6.25 µl NuPAGE LDS Sample buffer (Invitro-
gen), and incubated for 10 min at 70◦C. The
latter resulted in the denaturation of the anti-
body and Kv10.1 and disruption of the magnetic
beads/antibody/Kv10.1 complexes. The protein
samples were resolved on 4 – 12% NuPAGE Novex
Bis-Tris Mini Gels (Invitrogen) at 200 V and im-
munoblotted on 0.2 µm NC membranes as described in sections “SDS-PAGE” and
“Immunoblotting”. An example of an immunoblot image from Kv10.1 immunopre-
cipitation is illustrated in Figure 2.2.
2.2.6 Densitometry
The changes in expression of the protein of interest were estimated by applying
densitometry analysis to the acquired immunoblotting images. Careful consideration
was given to the preparation of the samples in order to get a reliable end result. The
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densitometry analysis was performed on ImageLab software version 4.1 (Bio-Rad).
Briefly, the “Lane and Bands” tool was used for selecting and defining each band
on an immunoblotting image using the “Lane profile” intensity histogram. The
background-subtraction was done using the rolling disk (size 8 mm) tool of the
software. The molecular weight was determined by interpolating the migration
distance to that of the markers using the “MW” analysis tool. The normalised
volume intensity of each signal was then calculated by dividing its measured volume
intensity by the corresponding actin value.
Relative Intensity = Band Volume Intensity of the protein of interest
Band Volume Intensity of a corresponding house-keeping protein
2.3 Single-cell gel electrophoresis
Figure 2.3: An outline of the steps of
single-cell gel electrophoresis.
One of the commonly used methods
for detection of DNA lesions is single-cell
gel electrophoresis, also known as comet
assay. It is a microgel electrophoresis
technique, which allows to quantify DNA
damage on a single-cell level; the struc-
tures observed under the microscope
have a resemblance to a comet, hence the
alternative name (Neri et al., 2015). The
alkaline variation of the method allows
to detect SSBs, DSBs and alkaline labile
sites (Singh, McCoy, Tice, & Schneider,
1988; Speit & Rothfuss, 2012). The sen-
sitivity of the assay lies in a range of a
few hundred to several thousand breaks
per cell, thus low endogenous damage levels can also be distinguished (Langie, Az-
queta, & Collins, 2015).
The alkaline protocol described by A. Azqueta and A. Collins (2014) was used for
detection of endogenously occurring DNA lesions in HeLa and hTERT RPE1 cells.
HeLa and hTERT RPE1 cells were plated in a 6-well plate, and transfected either
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with Scr -or KCNH1 -siRNA on the following day. The comet assay was performed 48
h after siRNA interference. The protocol is outlined in Figure 2.3, and the detailed
description of each step follows. The entire procedure was carried out under dim light
in order to prevent additional DNA damage, and all incubations, unless otherwise
stated, at 4◦C, to prevent activation of the DNA repair mechanisms. The buffers
and their compositions are given in Table 2.2.
Preparation of comets slides. The comet slides were prepared four days before
the lysis step. CometSlide 2 Well (Trevigen; two slides per condition) were placed in
ethanol at -20◦C for 24 h and then air dried overnight at RT. This step ensured the
cleanliness of slides to facilitate the adhesion of an agarose layer on them. A 0.5%
solution of the NMP (normal melting point) agarose was prepared by dissolving it
in DPBS using a microwave. The NMP agarose solution was kept on a water bath,
and the clean comet slides were submerged in it. The excess of NMP agarose was
allowed to drain on a filter paper. Solidification of the agarose layer was done at 60 –
65◦C for 20 min, and after that the slides were kept at RT until use.
Lysis. Prior to lysis, a 1% solution of LMP (low melting point) agarose in
DPBS was prepared in the same way as the NPA solution and kept at 37◦C. The
cells growing in a monolayer were washed once with cold DPBS, then harvested
by trypsinisation and placed on ice. An aliquot of the cells (30000 cells) was then
resuspended in 100 µl cold DPBS, pipetted thrice using a blue tip, and immediately
mixed with 100 µl of LMP agarose. A 100 µl aliquot of the cell-agarose mixture was
spread onto a well of each comet slide and placed at 4◦C for 20 min until the agarose
layer was solid.
The slides were then carefully submerged into 50 ml of lysis buffer (enough to
cover the slides), and incubated for 1 h. This step removes cell membranes, soluble
cytoplasmic and nuclear components and renders supercoiled DNA.
Denaturation, electrophoresis, neutralisation and fixation. Comet assay results
can vary depending on temperature, the distance between electrodes, and buffer
height in the tank during electrophoresis. Hence, standardisation of each of those
parameters is required to increase reproducibility.
Immediately after the lysis, the slides were placed side by side and in the same
direction onto a levelled electrophoresis tank filled with 280 ml of cold electrophoresis
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Table 2.2: Composition of buffers used in the comet assay
Step in the protocol Name of the solution Composition
Agarose solution for pre-coating of
the slides
1% NMP agarose in DPBS;
———————————————
aliquoted and stored at 4◦C
Agarose for embedding the cells
1% LMP agarose in DPBS;
———————————————








1% Triton X-100 (added after)










and neutralisation Neutralisation buffer
0.4 M Tris,
pH = 7.5, in ddH2O
———————————————
stored at 4◦C




10 mM Tris-HCl, pH = 8.0
1 mM EDTA
———————————————
prepared right before use
buffer. The samples were denatured with the electrophoresis buffer for 20 min.
Denaturing of supercoiled DNA is critical for unveiling the lesion sites: the break
containing sites will be relaxed and migrate easier when the electric field is applied.
The electrophoresis was carried out for 20 min at 13 V (0.6V/cm across the platform)
and 300 mA. The amperage was adjusted by adding or removing buffer (if needed).
In this step, if the DNA contains a lesion it will migrate faster depending on the size
of the DNA strand breaks.
After the electrophoresis the slides were placed into a Coplin jar with neutralisa-
tion buffer (4 ml/slide) for 10 min, and then fixed by incubating in absolute ethanol
for 3 min. The fixed slides were then air dried at RT in the dark.
Staining and imaging. The slides were stained using SYBR Gold (Invitrogen)
following the manufacturer’s instructions. An aliquot of SYBR Gold was diluted
10000 times in TE buffer.
The air dried comet slides were incubated with the dye for 10 min at RT, and
immediately imaged on a Nikon TiE-Andor inverted microscope (Nikon) equipped
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with a PLAN APO VC Air 20x 0.75 N.A. (numerical aperture) objective, a Yokogawa
spinning disk confocal. SYBR Gold was excited with the 488 nm laser line and
emission was collected through a 525/30 emission filter. Images were acquired with
an Andor DU-888 X-9984 camera controlled with NIS-Elements software. In total,
10 positions per well were selected using the multipoint acquisition of NIS-Elements
software. A series of z-stack images with 0.2 µm z-stepsize were acquired. An expo-
sure time of 50 ms (optimal for the chosen settings), no binning and no illumination
between acquisitions was used in all experiments.
Figure 2.4: A screenshot of a CASP Lab
software showing the measurement window
and an assayed comet with the correspon-
ding intensity profile in “Profiles”window.
Analysis. The damaged DNA has
a higher mobility and migrates further
when electric field is applied, creating a
configuration similar to a comet (Speit &
Rothfuss, 2012). The head of the comet
corresponds to a circle comprising the
non-damaged DNA, and the tail contains
the migrated damaged DNA. Measuring
the intensity of the head and tail, as well
as the length of the tail provides infor-
mation on the extent of DNA damage
present in the samples.
Before the analysis, maximum intensity projection images were created from the
acquired z-stack images. Then, the DNA comets were analysed using CASPLab
open source software. The program works with either colour or greyscale images of
fluorescently labelled comets saved as a TIFF (tagged image format file), and only
comets oriented with the head on the left and the tail on the right can be analysed
correctly (Końca et al., 2003).
In brief, two frames adjacent to each other are defined, one containing a test
comet, and the other one corresponding to background pixel values. Once the sizes of
the measurement frames are defined and fixed, the same size will be used throughout
the analysis. The measurement consists on the generation of an intensity profile
Figure 2.4) from which the comet total length, head radius, tail length, DNA intensity
in the head and tail, percentage of DNA in the head and tail, TMo (tail moment) and
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Table 2.3: Result parameters and modes of measurement used by CASP
Lab software (Końca, 2015)
Name of parameter Explanation
Name Name of the image file
HeadArea Area of the comet head in pixels (sum of pixels in the head)
TailArea Area of the comet tail in pixels (sum of pixels in the head)
HeadDNA Amount of DNA in the comet head (sum of intensities of pixels in the head)
TailDNA Amount of DNA in the comet tail (sum of intensities of pixels in the tail)
HeadDNA% Per cent of DNA in the comet head
TailDNA% Per cent of DNA in the comet tail
HeadRadius The radius of the comet head (in pixels)
TailLength Length of the comet tail measured from the right border of head area to end of the
tail (in pixels)
CometLength Length of the entire comet from the left border of the head area to end of the tail
(in pixels)
HeadMeanX Centre of gravity of DNA in the head (x coordinate)
TailMeanX Centre of gravity of DNA in the tail (x coordinate)
TailMoment TailDNA% * TailLength ([per cent of DNA in the tail] * [tail length])
OliveTailMoment TailDNA% * (TailMeanX-HeadMeanX) ([per cent of DNA in the tail] * [distance
between the centre of gravity of DNA in the tail and the of the centre of gravity of
DNA in the head in x-direction])
OTM (Olive tail moment; Table 2.3). In general, the different ways of measurement
tail moments aim to integrate the information on the shape, size and intensity of
the comet. The TMo considers only the features of the comet tail. It is derived
by multiplying the tail length with tail intensity and divided by 100. The OTM
takes into consideration the entire shape of the comet and is the product of tail
DNA multiplied by the difference between the gravity centres of the comet head and
comet tail and divided by 100 (Azqueta & Collins, 2014; Langie et al., 2015; Sierra
& Gaivão, 2014). The already analysed comet can be marked as “assayed”, thus
preventing accidental re-measurement of the same comet. Multiple cells per image or
images can be processed. Once all the loaded images have been assayed, the results
are exported as a .txt file.
2.4 Immunofluorescence staining
Asymmetric mitotic spindles, misaligned chromosomes at metaphase and lag-
ging chromosomes at anaphase were assessed by immunofluorescence staining of
mitotic spindles (α-tubulin), centromeres (CENP-B, centromere protein B) and DNA
(Hoechst 33342). The mitotic spindle angle was determined by additionally staining
the centrosomes (γ-tubulin).
HeLa cells were plated on fibronectin (Sigma) coated coverslips (Menzel) in a
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6-well plate (Greiner) and synchronised according to the protocols described above.
For the experiments requiring preservation of MTs, the growth medium was aspirated,
and the cells were first fixed by incubating with 4% paraformaldehyde (pfa) solution
in PHEM buffer (60 mM PIPES, 27 mM HEPES, 10 mM EGTA, 4 mM MgSO4,
pH = 7.0) at RT for 5 min. Afterwards, the pfa solution was replaced by ice-cold
methanol and incubated at -20◦C for additional 5 min. The fixed cells were then
washed three times with DPBS, and stored at 4◦C until usage. For proximity ligation
assay, the cells were only fixed with 4% pfa in PHEM, washed and stored as described
above.
Prior to staining, the fixed cells were rinsed with DPBST (0.1% Tween 20; Sigma)
and blocked with 10% BSA (Sigma) in DPBST for 90 min, to reduce non-specific
binding of antibodies. Primary and secondary antibodies were diluted in the blocking
solution according to Table 2.4.
Afterwards, the coverslips were transferred with the cells facing down onto droplets
of primary antibodies placed on a Parafilm (Sigma-Aldrich) tape in a humidified
chamber and incubated for 2 h at RT, and then the cells were incubated with se-
condary antibodies for 1 h using the same approach, although in the dark to prevent
photobleaching of fluorescently labelled secondary antibodies. Unbound primary and
secondary antibodies were eliminated by washing three times with PBST for 5 min at
RT with gentle agitation. At last, the nuclei were counterstained with 10 µM Hoechst
33342 (Molecular Probes) in ddH2O and rinsed twice with ddH2O. The coverslips
with immunofluorescently-labelled cells were air dried and mounted onto microscope
slides (Thermo Scientific) using Prolong Gold antifade reagent (Invitrogen). The
Table 2.4: List of primary and secondary antibodies used for im-
munoblotting
Antibody Source Dilution Cat.
Number
Manufacturer
γ-Tubulin Goat/polyclonal 1:350 sc-7396 Santa Cruz
Biotechnology
α-Tubulin Mouse/monoclonal 1:700 sc-23948 Santa Cruz
Biotechnology
CENP-B (H-65) Rabbit/polyclonal 1:350 sc-22788 Santa Cruz
Biotechnology
Alexa Fluor 488 anti-mouse
IgG (H+L)
Donkey/polyclonal 1:1000 A-21202 Invitrogen
Alexa Fluor 546 anti-rabbit
IgG (H+L)
Donkey/polyclonal 1:1000 A-11056 Invitrogen
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mounting medium was allowed to polymerise overnight, and on the following day
the slides were visualised on a Leica TCS SP5 II confocal laser scanning microscope
(Leica). Images were acquired using LAS AF (Leica) software, and processed with the
image analysis software ImageJ2 (NIH; Collins, 2007; Rueden et al., 2017; Schneider,
Rasband, & Eliceiri, 2012) and Imaris (Bitplane).
2.4.1 Quantification of asymmetric mitotic spindles,
defective metaphases and lagging chromosomes
A monopolar mitotic spindle usually displays symmetric configuration, meaning
that the length of MTs is equal in all directions, otherwise the monopolar mitotic
spindle will be qualified as asymmetric (Figure 2.5, A).
Metaphases were considered defective when improper alignment of chromosomes
at the metaphase plate was observed (Figure 2.5, B). A lagging chromosome was
defined as an event positive for both CENP-B and Hoechst 33342 staining, located
in the equatorial region of an anaphase cell (Figure 2.5, C). Using a confocal
fluorescent microscope, in total 1500 cells per condition and experiment were counted
manually. Cells with asymmetric mitotic spindles, misaligned chromosomes and
lagging chromosomes were expressed as a percentage of the total number of cells.
2.4.2 Determination of mitotic spindle angle
Mitotic spindle angle was measured in HeLa cells synchronised at metaphase
and visualised as described above. The obtained images were further processed with
Imaris (Bitplane). The processing of the images is depicted in Figure 2.6. In brief,
the location of centrosomes was defined using the measurement points tool, choosing
the channel corresponding to the centrosomal marker used for the staining (red in
this case). The software automatically finds intensity maxima of the selected channel
in the area specified by the user. Three measurement points were created, defined as
a sphere with a diameter of 1.5 µm around the maximum. Two of the points were
located at the centrosomes as shown in Figure 2.6 as point “A” and “B”. The third
point, “C” was generated as the projection of centrosome A at the level of centrosome
B, that is, at (x,y) coordinates of centrosome A, and z-coordinate of centrosome B.
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Figure 2.5: Schematic representation of some mitotic structures. The mechanism of
DME action is explained. Inhibition of Eg5 motor protein leads to a formation of monopolar mitotic
spindles, which are symmetric, unless MT plus-end assembly rates are increased. An example of
a metaphase with misaligned chromosomes (B) and an anaphase with a lagging chromosome are
presented.
Then, the polygon line mode was selected, which yielded three readouts: the distance
between “A” and “B” (the two centrosomes), distance between “B” and “C” (the
centrosome one and the projection of centrosome two), and the angle between the
two distance lines. The distance between “A” and “B” is the interpolar distance,
and the angle is the mitotic spindle angle. The measurements were done on at least
50 cells per condition and experiment.
2.5 Determination of PLK1 enzymatic activity
Polo-like kinase 1 activity was quantitatively measured in cell lysates from HeLa
and hTERT RPE1 cells using CycLex Polo-like kinase 1 Assay/Inhibitor Screening
Kit (Cyclex, MBL).
Before starting with the assay, all the components of the kit were allowed to come
to RT. The 1x Wash Buffer was prepared by diluting the 10x Wash Buffer (contains
Tween-20; CycLex Kit) with ddH2O, and a 1.25 mM ATP solution – by dissolving
the lyophilised 20x ATP (contains sodium salts, CycLex Kit) in 1.6 ml of ddH2O.
Afterwards, the Kinase Reaction Buffer was prepared by adding 10 µl of 1.25 mM
ATP solution to 190 µl of Kinase Buffer (CycLex Kit).
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Figure 2.6: Determination of a mitotic spindle angle. A, Screenshots of the measurement
using Imaris is given (for the details, see the text; in red – γ-tubulin, green – α-tubulin, blue
– Hoechst33342; scale bar, 4 µm). B, The approach for MT angle measurement is explained
schematically.
Once all working solutions were ready, the lysates from synchronised HeLa and
hTERT RPE1 cells were retrieved from -80◦C, and 20 µl of lysate (see “Protein
extraction”) containing 50 µg of protein was added to each microtiter well coated
with recombinant Protein-X as a PLK1 substrate (CycLex Kit). The microtiter
wells were kept on ice between all incubation steps. The reaction was started by
addition of 180 µl of Kinase Reaction Buffer, and the samples were incubated for
2 h at 30◦C. The reaction was stopped by removing the cell lysates from the well;
immediately 200 µl of 1x Wash Buffer was added, and the well content was again
aspirated. The washes were repeated 5 times, followed by the addition of 100 µl of
anti-phosphothreonine antibody (PPT-07, rabbit polyclonal, CycLex Kit) to each
microtiter well and incubated for 1h at 30◦C. If the samples contain an active PLK1,
then the Protein-X substrate will be phosphorylated at its threonine residue, which
will be then recognised by the primary antibody. Afterwards, the wells were washed
as described, and incubated with 100 µl of HRP-conjugated anti-rabbit antibody
(CycLex Kit) for 30 min at 30◦C. Again, the wells were washed as before, and 100 µl
of chromogenic Substrate Reagent (CycLex Kit) was added per well and incubated
for 10 min at RT, protected from light. The chromogenic reaction was stopped by
addition of 100 µl of Stop Solution (CycLex Kit). The absorbance in each well
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was measured using dual wavelengths at 450/540 nm on a Wallac 1420 VICTOR2
microplate reader (PerkinElmer, Inc., USA).
As a positive control, 1 µl of purified recombinant PLK1 (0.004 units/µl; human
full-length recombinant enzyme expressed in E. Coli ; CycLex, MBL) in 19 µl of the
lysis buffer was used. As a negative control only the lysis buffer was used. The lysis
buffer composition is given in “Protein extraction”. All samples were prepared in
duplicates.
The difference of absorbances at 450 nm and 540 nm was calculated for each
sample. Then the absorbance of each sample was normalised against the negative
control.
A450 = (A450sample − A540sample) − (A450neg ctr − A540neg ctr)
2.6 Proximity ligation assay
The possible interaction of Kv10.1 and ORAI1 was studied by means of PLA
(proximity ligation assay). The proximity ligation method relies on the formation
and amplification of DNA circles catalysed by RCA (rolling circle amplification)
when antibodies labelled with compatible oligonucleotides bind to targets located in
proximity (Söderberg et al., 2006).
The method was initially developed by Fredriksson et al. in 2002. They applied
the principle of polymerase chain reaction for the detection of protein targets and
termed it proximity ligation. Initially, pairs of affinity probes, such as DNA aptamers,
simultaneously recognise the target molecules in proximity, generating an intensified
signal (Fredriksson et al., 2002). Later, the technique was generalised by providing
easy protocols to create proximity probes from any poly- or monoclonal antibodies
(Gullberg et al., 2004). Finally, the PLA was further modified by combining it
with RCA for localised readout in fixed samples. This step in combination with
fluorescently labelled oligonucleotides generates multiple DNA circles, covalently
bound to an antibody-antigen complex, and, thus, making them detectable (Söderberg
et al., 2006).
The Duolink PLA kit (Sigma-Aldrich) was used for the detection of interaction of
Kv10.1 and ORAI1 in asynchronously growing HeLa cells following manufacturer’s
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instructions. The cells growing in a 6-well plate on fibronectin-coated coverslips were
fixed (described in “Immunofluorescence staining”), and an area of approximately
1 cm2 was delimited by a hydrophobic pen. A drop of Duolink Blocking Solution
was deposited onto the defined area, and the coverslips were then transferred into a
heated humidity chamber at 37◦C and incubated for 60 min. Meanwhile, a diluted
aliquot (40 µl/sample) of a mixture of primary antibodies was prepared using Duolink
Antibody Diluent: anti-Kv10.1 (mAb62; 1:2000, mouse monoclonal) and anti-ORAI1
(Alomone biolabs; 1:200, rabbit polyclonal). The blocking solution was gently tapped
off the samples, and an aliquot of the primary antibody mixture was added to each
sample, and then incubated for 3 h at RT. Samples treated with the only diluent
were used as a negative control for the assay. Afterwards, the antibody solutions were
removed, and the slides were washed twice for 5 min in 1x Wash Buffer A (Duolink
kit) at RT. During the washes, the PLUS and MINUS PLA probes were vortexed
and diluted 5 times with Duolink Antibody Diluent. Again, the excess of wash
buffer was removed, and 40 µl of the mixture with PLUS and MINUS probes were
added to all samples, including the negative control. The PLA probe incubation was
performed for 60 min in a humidity chamber at 37◦C. Following the incubation with
PLA probes, the samples were washed as above and incubated with 40 µl/sample
Ligase solution (prepared from 1 µl Ligase and 8 µl 5x Ligation buffer) for 30 min
at 37◦C in a humidity chamber. Similarly, the ligase solution was removed, and the
samples were washed twice with Wash buffer A. From this point on, the steps are
light sensitive and were performed under dim light. The amplification solution was
prepared by adding 0.5 µl of Polymerase to 39.5 µl of Amplification buffer. The
samples were incubated with 40 µl of amplification solution for 100 min at 37◦C in a
humidity chamber. The excess of amplification solution was tapped off the samples,
and the samples were washed twice with 1x Wash Buffer B (Duolink kit) for 10 min,
and once with 0.01x Wash Buffer B for 1 min. Finally, the excess of wash buffer
was removed as before and the coverslips were mounted onto slides with a minimal
volume of Duolink PLA Mounting Medium with DAPI. The imaging was done as
described in the “Immunofluorescence staining” section, and after that, the slides
were stored at 4◦C for a short period (up to 4 days) or at -20◦C for extended periods.
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2.7 Live cell imaging
All time-lapse imaging was performed on a Nikon TiE-Andor inverted microscope
(Nikon) equipped with a PLAN APO-TIRF 100x 1.49 N.A. oil immersion objective,
a Yokogawa spinning disk confocal system and the Perfect Focus System (Nikon)
for continuous maintenance of the focal plane. Fluorophores were excited with the
respective laser line from a MultiLaser (Acal), and the emitted light was collected
through a quadruple bandpass dichroic mirror and the appropriate emission filter.
Images were acquired with an Andor DU-888 X-9984 camera controlled with NIS-
Elements software. No binning and no illumination between acquisitions was used
throughout all live cell imaging experiments. Exposure time, interval and duration
were defined and maintained constant for each time-lapse experiment.
2.7.1 Assessment of microtubule dynamics
Tracking of EB3-tdTomato in live cells
MT plus-end assembly rates were determined by overexpressing and tracking EB3
fused to tdTomato (an orange fluorescent protein) in living HeLa and hTERT RPE1
cells. EB3 is an MT plus-end interacting protein (Galjart, 2010), and fluorescently
tagged EB3 allows to identify the growing tips of MTs in living cells. Thus, by taking
time-lapse images it is possible to measure the assembly and disassembly rates of
MTs (reviewed in Zwetsloot, Tut, & Straube, 2018).
HeLa and hTERT RPE1 cells were transfected with pEB3-tdTomato as described
before. To ensure measurements of mitotic spindles in the same mitotic phase, 48
h after transfection 2.5 µM DME (Calbiochem) was applied to the cells growing
in phenol red free DMEM medium (Gibco) supplemented with 10% FCS and 1x
GlutaMAX (Gibco). After 3.5 h of incubation with DME, the cells were transferred to
the microscope and mounted on an environmental chamber with dark panels (Okolab)
for imaging at 37◦C and 5% CO2, and further incubated until total incubation time
of 4 h. The maintenance of temperature at 37◦C without fluctuations is crucial for
the experiment. It has been described that the MT assembly rates depend on the
ambient temperature (Gierke, Kumar, & Wittmann, 2010; Lodish, 2000). Images
were acquired every 0.5 s for 1 min as described above. The EB3-tdTomato was
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excited using the 561 nm laser line (exposure time 200 ms), and the emission was
collected with a 600/52 emission filter.
The MT dynamics were studied under five different conditions.
i) siRNA mediated downregulation of Kv10.1 – a co-transfection of EB3-tdTomato
along with Scr - or KCNH1 -siRNA was performed (see “pDNA and siRNA
co-transfection with jetPRIME”);
ii) overexpression of Kv10.1 – pKCNH1-WT (wild type) or pEmpty were overex-
pressed simultaneously with pEB3-tdTomato in HeLa cells using jetPRIME (see
“pDNA transfection using jetPRIME”);
iii) reduction of Kv10.1 conductance by an inhibitory monoclonal antibody targeting
its pore domain – HeLa cells were transfected with pEB3-tdTomato, and on
the following day the cells were incubated with either mAb56 or a non-specific
isotype IgG κ2b; 5 µg per well of a 4-well µ-ibidi dish) for 24 h at 37◦C and 5%
CO2. The last 4 h-segment of the incubation with antibody was done in the
presence of DME prior to imaging;
iv) inhibition of Kv10.1 conductance with the antihistamine drug astemizole (Garćıa-
Ferreiro et al., 2004a), a potent blocker of channels of the KCNH family – HeLa
cells expressing EB3-tdTomato were treated simultaneously with 2.5 µM DME
and 5 µM astemizole or its isomer norastemizole, which retains antihistamine
activity but has no channel inhibitory activity, or only combination of DME
and the solvent (DMSO), and incubated for 4 h at 37◦C and 5% CO2;
v) AnCoA4-mediated inhibition of calcium influx through ORAI1 (Sadaghiani et
al., 2014) – the treatment was done similarly to astemizole/norastemizole; EB3-
tdTomato expressing HeLa cells were incubated for 4 h with 10 µM AnCoA4
or with the equivalent volume of the vehicle, DMSO, in the presence of 2.5 µM
DME.
Analysis of the time-lapse series
The MT dynamics were analysed with U-Track 2.2.0, a MATLAB based open
source software. This software package automatically tracks, analyses, and visualises
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the time-lapse series of fluorescently-labelled MT plus-ends.
Figure 2.7: An overview of the
MT dynamics analysis using U-
Track.
Despite that the plus-end-binding proteins
trace only MT growth phases, the U-Track 2.2.0
extrapolates the information on the pause and
shrinkage events by linking sequential growth
phases meeting certain criteria. The reconstruc-
tion of full trajectories (Applegate et al., 2011;
Matov et al., 2010) is based on the spatially and
temporally global tracking framework (Jaqaman
et al., 2008).
The analysis workflow is shown in Figure 2.7.
First of all, the .nd2 files generated by NIS-
Elements software were imported into MATLAB.
The size of each image was read from the meta-
data automatically, while the numerical aperture
of the used objective (1.49) and the time interval
(0.5 s) used for imaging had to be entered manu-
ally. Additionally, information on the excitation
wavelength and the fluorophore can be entered. However they are not critical for
further analysis.
Once all the images were loaded, MT tracking was performed using U-Track
control. The analysis consists of three main steps: comet detection, comet tracking
and track analysis. Each of these steps produces statistical and visual outputs. Below
follows the brief description of each parameter and their functions; a more detailed
explanation can be found in the technical report provided with the previous version
of the software, plusTipTracker (Applegate & Danuser, 2010).
Comet detection. The acquired signal from EB3-tdTomato appears as near-
resolution sized comets, which vary in size, shape, and intensity over time and
across regions of the cell. Image background signal also varies, and this together
with the high density of the growing MTs and low signal-to-noise ratio causes that
comets are often difficult to distinguish from the background and adjacent comets,
precluding the use of a global detection threshold. This problem is circumvented by a
64
Materials & Methods
Figure 2.8: The watershed-based method for particle detection in U-Track. A, An
non-processed image of EGFP-EB3-labelled MTs (scale bar, 5µm). B, A Difference-of-Gaussian
image is created from the original image and the intensity landscape is given. C, Schematic
representation of an intensity landscape explaining the watershed particle detection method. The
image is iterated with defined threshold, in this case thrice and is indicated with the horizontal
lines. At each step the peaks are identified and shown in panels (i), (ii), and (iii). The stepwise
thresholding distinguishes the peaks which otherwise would have been misdefined if a regular threshold
approach was applied. Adapted from (Applegate & Danuser, 2010).
combination of image signal enhancement and locally optimal thresholds. The signal
enhancement is achieved by the DoG (Difference of Gaussians) approach (Spring,
K.R., J.C. Russ, M.J. Parry-Hill, T.J. Fellers, 2016). The DoG image is created
by filtering the raw images first with a small Gaussian kernel (σ = 1 pixel), which
eliminates the noise. Then, a larger Gaussian kernel (σ = 3 pixels) is applied, which
removes larger-scale variations in cell background. The high-pass filtered image
is then subtracted from the low-pass filtered image, resulting in DoG images with
relatively uniform background and less noise (Figure 2.8, A).
The detection of comets is tuned by defining the size of the particles, which still
vary significantly in size, shape, and intensity. For accurate identification of comets,
it is necessary to maintain the expression of the fluorescently tagged protein at low
levels, but this implies low intensity of the signal, yet high density of the comets, and
a higher risk of false positive comets detection. To avoid this, a watershed particle
segmentation approach is applied (Figure 2.8, B and C).
The watershed method is based on presenting a two-dimensional image as a three-
dimensional intensity landscape, which is then iteratively segmented with defined
thresholds (Figure 2.8, C). Two parameters are defined: the minimum threshold
and the threshold stepsize. The minimum threshold allows discerning weak signals
from the background, while the background noise fluctuations will not be false
positively accepted as comets. The threshold stepsize defines the accuracy of the
comet detection: it should be small enough in order to resolve two particles with
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close intensity values from each other, but high enough to avoid having false positive
comets. These parameters are derived from the intensity standard deviation of a
DoG image: for each image i, the standard deviations from frames i− 2 to i+2 are
averaged to yield its threshold stepsize. The minimum threshold for each image is
defined as three times the threshold step (Applegate & Danuser, 2010). The defined
segmentation steps are applied to the image collection, and thus the comets are
identified.
Tracking comets. Comet trajectories over time are reconstructed according to the
single-particle tracking framework described by Jaqaman et al. (2008). The tracking
consists of two major steps: i) linking particle (generates sub-tracks) in consecutive
frames and ii) linking the generated sub-tracks (compound tracks).
Particle linking picks the best set of links between particles, taking into account
the entire population of particles in two consecutive frames. In other words, it defines
the positions of the particles in frame i, then taking into account the empirically
defined behaviour of MTs (e.g. the growth directionality is close to linear with
minimal angular changes) and a user-defined search radius, it predicts the position
of the particle in the frame i + 1. If there is a particle in the predicted position,
then they will be linked. Similarly is done between frames i and i− 1. As a result a
sub-track is created using at least three consecutive frames. It should be noted, that
defining smaller search radius decreases the chances of detecting “false” non-linear
sub-tracks, however it also limits the sensitivity of tracking. In any case, if such
non-linear sub-tracks are detected, then they are “quality” controlled: they are split
in two, and if the resulting sub-tracks are shorter than three frames, then the original
sub-track will be discarded.
The candidate sub-tracks are then linked into compound sub-tracks. This step
aims to identify and join together the sub-tracks which belong to the same MT. The
sub-track linking, similar to particle linking, takes into account the entire population
of growth sub-tracks throughout the movie and the linearity of the resulting com-
pound tracks. Also, the time interval between the two selected sub-tracks must be
reasonably short in order to prevent cross-linking with another MT (Applegate &
Danuser, 2010).
Track analysis. In this final step of the analysis, the defined sub-tracks are
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Figure 2.9: Classification of growth sub-tracks. A, An overlay image of track analysis
is given showing the classified groups of sub-tracks (in corresponding colours; scale bar, 10 µm).
B, Spatial maps of growth, fgap, and bgap sub-tracks colour-coded by speed (left column), lifetime
(center column), and displacement (right column) are shown (scale bar, 10 µm). Adapted with
modifications from (Applegate & Danuser, 2010).
classified into growth, fgaps (forward gaps), and bgaps (backward gaps) sub-tracks
within a compound track (Figure 2.9). As described above, the compound tracks
consist of at least two growth sub-tracks. The gaps between these sub-tracks are
coded as fgaps or bgaps, depending on their relative spatial orientation. Fgaps
show pause events, when the MT growth continues after an interruption. Bgaps
are a representation of catastrophe events: switch from growth to shrinkage. The
velocity of each compound track is determined by dividing the displacement between
consecutive frames throughout the considered frames.
Gaps can arise for reasons other than true pause or shrinkage. Fgaps can arise
due to detection failures or comets moving temporarily out of the focal plane. To
exclude such false positive events, the gap speed distributions are stratified according
to the general behaviour of MT. If the plus-end displacement speed during such fgaps
is greater than 70% of the growth speed right before the comet disappearance, it is a
strong indication of fgaps representing a continuation of growth. Therefore, such
fgaps are reclassified as growth phases. The remaining fgaps are assumed to be true
pause events.
Bgaps are also analysed regarding them being a true shrinkage. False bgaps
can arise from an MT polymer or a positional drift. If the speed of MT plus-end
displacement during a bgap is less than the 95th percentile of the speed distribution
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of an fgap classified as a true pause event, then such bgap is considered as a pause
rather than a shrinkage with a confidence of 95%. Therefore, it will be reclassified as
a pause event, and the bgaps which do not fulfil this requirement will be the true
shrinkage events.
After the reclassification of the sub-tracks, a list of phenotypic parameters
(Table 2.5) is calculated.
Table 2.5: The information generated by tracking the MT dynamics
with U-Track 2.2.0 software (Applegate & Danuser, 2010)
Statistics Notes about calculation Field names in projData
structure
Growth statistics
Number of growth sub-tracks Calculated after discarding those
beginning in the first frame or
ending in the last frame
nGrowths
Growth speed median, mean, and
std (µm * min-1)
growth speed median,
growth speed mean std
Growth lifetime median, mean,
and std (s)
growth lifetime median,
growth lifetime mean std
Growth displacement median,
mean, and std (µm)
growth length median,
growth length mean std
Frame-to-frame displacements
(pixels * frame-1)
Distribution of all displacements




Frame pair-to-frame pair details
(pixels) and standard deviation of
this distribution (µm * min-1)
Distribution of the differences




Forward gap (fgap) statistics
Number of fgap sub-tracks nFgaps
Fgap speed median, mean, and
std (µm * min-1)
fgap speed median,
fgap speed mean std
Fgap lifetime median, mean, and
std (s)
fgap lifetime median,
fgap lifetime mean std
Fgap displacement median, mean,
and std (µm)
fgap length median,
fgap length mean std
Fgap frequency, time (s-1) 1/mean(T), where T is the life-
time of the growth sub-track just
prior to the fgap
fgap freq time
Fgap frequency, length (µm-1) 1/mean(L), where L is the length
of the growth sub-track just prior
to the fgap
fgap freq length




Backward gap (bgap) statistics
Number of bgap sub-tracks Calculated after discarding those
bgaps linked to a discarded
growth sub-track (see above)
nBgaps
Bgap speed median, mean, and
std (µm * min-1)
bgap speed median,
bgap speed mean std
Bgap lifetime median, mean, and
std (s)
bgap lifetime median,
bgap lifetime mean std
Bgap displacement median, mean,
and std (µm)
bgap length median,




Bgap frequency, time (s-1) 1/mean(T), where T is the life-
time of the growth sub-track just
prior to the bgap
bgap freq time
Bgap frequency, length (µm-1) 1/mean(L), where L is the length
of the growth sub-track just prior
to the bgap
bgap freq length
% time spent in bgap, individual Average value for all bgap-
containing tracks
avgIndivPercentTimeBgap
Dynamicity (µm * min-1) Collective displacement of all
gap-containing tracks over their
collective lifetimes
dynamicity
% time spent in growth, collective Total time all MTs spend growing
over the total time all tracks exist
percentTimeGrowth
% time spent in fgap, col-lective Total time all MTs spend in fgap
over the total time all tracks exist
percentTimeFgap
% time spent in bgap, col-lective Total time all MTs spend in bgap
over the total time all tracks exist
percentTimeBgap
Tracking statistics
Total track number Includes those beginning in the
first frame and those ending in
the last frame
nTracks
% of all gaps which are fgaps Sum to 100% percentGapsForward
% of all gaps which are bgaps Sum to 100% percentGapsBackward
% growth sub-tracks linked to
fgaps
Sum to 100% percentGrowthLinkedForward
% growth sub-tracks linked to
bgaps
percentGrowthLinkedBackward




ment / nearest neighbour distance
How far an average comet travels
between frames compared to
how close its nearest neighbor is;
this is a measure of how difficult
the tracking problem is (>0.5 is
difficult)
meanDisp2medianNNDistRatio
% fgaps reclassified as growth Reclassification occurs when fgap
speed is ≥70% of the growth
speed prior to comet
disappearance
percentFgapsReclass
% fgaps reclassified as growth Reclassification occurs when fgap
speed is ≥70% of the growth
speed prior to comet
disappearance
percentFgapsReclass
% bgaps reclassified as pause Reclassification occurs when bgap
speed is ≤ the 95th percentile of
remaining fgap speeds
percentBgapsReclass
2.7.2 Intracellular calcium imaging
Intracellular calcium imaging in hTERT RPE1 cells
Intracellular calcium was monitored in hTERT RPE1 cells synchronised at the G0
phase by serum deprivation (see “Synchronisation in G0 phase by serum deprivation”).
Fluo-4AM (Thermo Fischer Scientific) was used as intracellular calcium reporter
in living cells (Gee et al., 2000). The binding to Ca2+ is only accompanied with
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increase in the intensity of the emitted light, no wavelength shift in the emitted light
is observed (Minta, Kao, & Tsien, 1989). Thus, the fluo-dyes are non-ratiometric
and allow to detect only relative changes in cytosolic [Ca2+].
In brief, the hTERT RPE1 cells were plated onto 4-well µ-ibidi plates, and
transfected with either Scr - or KCNH1 -siRNA. The cells were then washed twice
with warm growth medium with no FCS, and incubated with phenol red free DMEM
medium supplemented with 1x GlutaMAX for 60 h. It should be noted that the
number of the cells per well was adjusted to achieve a cell confluency of approximately
80 – 85% after the synchronisation. If allowed to reach full confluency, the growth of
the cells would be contact inhibited (Bodnar et al., 1998; X. R. Jiang et al., 1999).
Figure 2.10: A schematic diagram de-
picts the experimental design of intracellu-
lar calcium imaging.
The synchronised cells were incu-
bated with 10 µM Fluo-4AM in phenol
red free DMEM medium supplemented
with GlutaMAX and without FCS. The
4-well plate was placed for image acqui-
sition in an environmental chamber with
dark panels (Okolab) at 37◦C and 5%
CO2. Image acquisition started at 30
min after addition of Fluo4-AM, which
was present throughout the entire dura-
tion of the experiment.
All images were acquired using a
Nikon TiE-Andor inverted microscope
(Nikon) as described before. Fluo-4 was excited with the 488 nm laser line and
emission was collected through a 525/30 emission filter. Laser power was set to 15%,
and exposure time to 60 ms. In total, 10 positions per well were selected using the
multipoint acquisition feature of NIS-Elements software. The timing of the image
acquisition is depicted in Figure 2.10. First, the selected positions were imaged in the
absence of FCS for 60 min at 10 s intervals. Afterwards, without removing the plate,
55 µl FCS was added to the imaged well to achieve 10% FCS final concentration.
After careful addition of FCS without disturbing the defined positions, imaging was
immediately resumed and continued for an additional 60 min. The time interval
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between the last image without FCS and the first image with FCS was fixed to 40 s
throughout all the experiments.
Analysis of relative changes in intracellular [Ca2+]
The analysis of the obtained intracellular calcium imaging was done in three
steps: i) processing of the recorded time-lapse series; ii) background subtraction and
calculation of corrected total cell fluorescence (CTCF); iii) analysis of the oscillatory
behaviour of the recorded signal.
Processing of time-lapse series. The changes in the intensity of the emitted light
were measured using the NIS-Elements software (Nikon). In each recorded image, ten
cells were manually selected as regions of interest (ROIs). Only the cells that stayed
in the defined ROI throughout the experiment were used for analysis. In addition
to sample ROIs, three background ROIs of constant size were identified. These
background ROIs were later used for Mean Background Fluorescence calculation.
Once the ROIs were defined, using time measurement tool of NIS-Elements software
the intensity values were measured for each ROI over time. The data was then
exported into an Excel file.
Background subtraction and CTCF calculation. The generated Excel files were
reorganised using R-studio open source software (RStudio, Inc). In brief, the script
(kindly provided by J. Seidel; see Appendix) first reorganises the file by combining
the recorded values for each ROI into following columns, e.g. Time ID, Time (sec),
SUM of Intensities 1, Area of ROI 1. Afterwards, CTCF values are calculated using
the following formula:
CTCF = Integrated Density – (Area of selected cell
∗Mean Background Fluorescence)
The CTCFs were calculated for each ROI and time point separately, and the
resulting values were exported into a .txt file.
Analysis of the oscillatory behaviour of the recorded signal. The fluctuations
in intracellular [Ca2+], also known as calcium oscillations, encode information on
diverse biological processes. A cell is capable of differentiating these signals by
decoding the frequency and the amplitude of the calcium oscillations (Parekh, 2011;
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Samanta & Parekh, 2017; Smedler & Uhlén, 2014). Calcium oscillations are reflected
in fluctuations in Fluo-4 intensity that can be quantified.
The frequency of the oscillations of the acquired images was defined using an
open source MATLAB-based tool “Spectral analysis of calcium oscillations”, version
3.0 (Uhlen, 2004). This tool deploys the Fourier transform principle: the time and
frequency domains are swapped (Fourier, 1822), and as an output creates a power
spectrum. The detailed explanation and the script can be found in Uhlen (2004). In
brief, collected and calculated values from each ROI were divided into five temporal
segments: i) total duration (-3600 – 3600 sec); ii) before FCS addition (-3600 – 00
sec); iii) after FCS addition (00 – 3600 sec); iv) the first peak observed immediately
upon FCS addition (00 – 60 sec); and v) after FCS addition excluding the first peak
(60 – 3600 sec). The power spectrum for each segment was generated and the mean
frequency value defined.
In addition to frequency, prominence and FWHM (full width at half maximum)
were calculated for the above-listed segments in the frequency domain, and the total
Figure 2.11: Identification of peaks in
the single-sided amplitude spectrum of in-
tracellular [Ca2+].
number of peaks and total AUC (area
under the curve) – in the time domain.
The prominence shows how much a given
peak stands out of its neighbour peaks
due to its intrinsic height and location
relative to other peaks. Thus a low iso-
lated peak can be more prominent than
one that is higher but is an otherwise un-
remarkable member of a tall range (The
MathWorks, 2018). A new MATLAB-
based script similarly to the above men-
tioned one and using Fourier transform
was developed. In brief, this second
script first fits a linear function to the
“Before FCS” segment in order to com-
pensate for the baseline drift in the collected data. This drift results from a combi-
nation of on one hand photobleaching, and, on the other, continuous loading of the
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cells with Fluo-4AM. The resulting line is extrapolated to the entire duration of the
experiment and then subtracted from the measured values, resulting in a normalised
CTCFs.
The peaks in the CTCF spectrum are identified and indexed with their time
values using the “findpeaks” function in MATLAB. This function identifies local
maxima (peaks) of the input signal vector by comparing value i in the given spectrum
with value i− 1 and value i+ 1. If the value i is larger than the two neighbours than
it will be considered as a peak. In addition to the peak values, the function also
returns a vector with the locations of the peaks in the time or frequency domain, the
prominence and the FWHM (Figure 2.11). The AUC values in the CTCF spectrum
are also defined.
The second part of the script repeats the aforementioned “Spectral analysis of
calcium oscillations”, but this newly developed script identifies number, prominence
and location (in relation to the frequency domain) of peaks, and also FWHM. The
new script, given in the Appendix, is simplified due to its length and depicts the
analysis of only one cell and segment.
2.8 Statistical analysis
All data were statistically analysed using GraphPad Prism software v8 (GraphPad
Software, Inc.). Two-tailed Student’s t-test was used for the experiments with only
two conditions. The MT dynamics and comet assay experiments with three groups
and one variables were analysed using one-way ANOVA (analysis of variance). For the
analysis of the synchronisation and immunoblotting experiments, two-way ANOVA
with Bonferroni-adjusted post hoc tests were used. All data are shown as mean
standard deviation (SD) or standard error of the mean (SEM), where P value < 0.05







We have previously shown that Kv10.1 expression is temporally restricted to a
short time window during the G2 and M phases of cell cycle, and that downregulation
of Kv10.1 induces accumulation of cells in that phase (Urrego et al., 2016). Therefore,
we speculated that Kv10.1 plays a role in the regulation of processes happening in
the G2/M phase.
As already discussed in the “Introduction”, two major checkpoints function in
G2 and M phases of cell cycle: the DNA damage-induced checkpoint and the spindle
assembly checkpoint (SAC), respectively (Lodish, 2000). Activation of either of
these checkpoints, which share some components, will lead to an arrest in cell cycle
progression. I therefore first characterised the status of both of the checkpoints using
two models: mammalian normal and cancer cells.
As a human cancer cell model system, we continued to use HeLa cells as in
our previous work. The line is one of the most widely used for cell cycle research
(Bowey-Dellinger et al., 2017; Masters, 2002), because HeLa cells can efficiently be
synchronised at different phases of cell cycle (Ma & Poon, 2011); HeLa cells have
high expression of Kv10.1 (Pardo et al., 1999) without completely losing the cell
cycle-dependent expression pattern (Urrego et al., 2016).
As a non-cancer cell line, hTERT RPE1 cells were used. Likewise, hTERT RPE1
cells express Kv10.1 at G2/M phase (A. Sánchez, Urrego, & Pardo, 2016b). Despite
being immortalised with the introduction of the TRT oncogene (human telomerase
reverse transcriptase), these cells retain a normal, non-tumour phenotype: they
display contact inhibition of growth (X. R. Jiang et al., 1999) and primary cilia when
deprived of growth factors (Plotnikova, Pugacheva, & Golemis, 2009).
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3.1 Kv10.1 and DNA damage-induced
checkpoint
3.1.1 Downregulation of Kv10.1 partially activates DNA
damage-induced checkpoint
As stated previously arrest in G2 can be due to the activation of the DNA damage-
induced checkpoint, which in mammalian cells consists mainly of the ATM(ATR)/
CHK2(CHK1)–p53/MDM2-p21 pathway (Nyberg et al., 2002). We therefore investi-
gated the activity of the DNA damage-induced checkpoint upon Kv10.1 downregu-
lation. HeLa cells were synchronised using a double thymidine block protocol and
samples were collected as described above. The abundance of DDR proteins was
subsequently determined by immunoblotting. Analysis of the images revealed that
some of the DDR components are elevated in Kv10.1-deficient HeLa cells (Figure 3.1).
The total level of CHK2 was clearly increased in Kv10.1-deficient HeLa cells.
The increase reached approximately 70% at 0 – 8 h after block release (expression
normalised to actin: 0.24 ± 0.01 vs 0.14 ± 0.01 in the control). Kv10.1 downregu-
lation conferred cell-cycle dependence to CHK2 levels, which were stable in the
control over time, but increased to a peak at 8 h after release from thymidine block
and decayed thereafter in KD cells to the levels of the control cells. Interestingly,
the active phosphorylated forms of CHK1 (Ser345, a phosphorylation site for ATR;
K. Jiang et al., 2003; Zhao & Piwnica-Worms, 2001) and ATR (Ser428, an activa-
ting phosphorylation site; J. Smith, Mun Tho, Xu, & A. Gillespie, 2010; Vauzour,
Vafeiadou, Rice-Evans, Cadenas, & Spencer, 2007) were also upregulated in Kv10.1
KD cells. The total level of p-CHK1 was increased by 60% relative to the control
group (0.09 ± 0.02 vs 0.14 ± 0.03), whereas the total amount of p-ATR in KD cells
doubled that of the control (0.41 ± 0.03 vs 0.20 ± 0.01, respectively). However, no
significant differences in the total amount of p-BRCA1 (breast cancer 1, early onset;
Ser1524, a phosphorylation site for ATR; S.-Y. Lin, Li, Stewart, & Elledge, 2004),
CHK1, p21 and phospho-histone H2A.X (γH2A.X; Ser139, phosphorylated by ATM;
Burma, Chen, Murphy, Kurimasa, & Chen, 2001) or ATR (DeLoughery, Luczak,
Ortega-Atienza, & Zhitkovich, 2015) were observed.
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Figure 3.1: Kv10.1 downregulation induces accumulation of some proteins involved
in DNA damage-induced checkpoint in HeLa cells. Hela cells were transiently transfected
with either Scr- or KCNH1-siRNA, synchronised with double thymidine block at the G1/S border,
and subsequently released from the block. The samples were collected every 2 h between 0 – 6 h
and 10 – 14 h, and every 1 h during 6 – 10 h after the release from the block; the abundance of
proteins in the samples was analysed by immunoblot. A, Representative images of immunoblots.
B, Densitometry analysis of all immunoblot repeats. The time interval corresponding to Kv10.1
expression is indicated in pink (n = 3 of independent synchronisation experiments, mean ± SEM
is shown; two-way ANOVA, repeated measures, the given P value shows the significance of total
difference between the two groups, and “*” – between each time point, *P = 0.05).
Taken together, these results suggest a possible activation of DDR; in particular,
the upstream part of the pathway appears activated in KD cells.
3.1.2 The activation of DDR in Kv10.1-deficient cells does
not obey actual DNA damage
The activation of the DNA damage-induced checkpoint can happen both in the
presence (Shaltiel et al., 2015) or absence of DNA damage (Baumann, 2014; Burgess,
Burman, Kruhlak, & Misteli, 2014; Cipressa & Cenci, 2013; Eliezer, Argaman,
Kornowski, Roniger, & Goldberg, 2014; Kidiyoor, Kumar, & Foiani, 2016; Lawrence,
Chau, & Engebrecht, 2015). I, therefore, studied the presence and extent of DNA
lesions to identify the conditions for DDR activation. To this end, I used one of the
methods that detects DNA lesions at low levels, single-cell gel electrophoresis (also
known as comet assay). In particular, the alkaline variation of the method detects
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Figure 3.2: Partial activation of DNA damage-induced checkpoint in HeLa cells
upon Kv10.1 downregulation is not due to increase in DNA damage. Hela cells were
transiently transfected with either Scr- or KCNH1-siRNA, allowed to reach approximately 70%
confluency, harvested and immediately used for single-cell gel electrophoresis (comet assay). A,
The DNA comets were stained with SYBR-Gold and visualised with a fluorescence microscope.
Representative images are given (max intensity projection, z-stepsize 0.2 µm, scale bar, 200 µm).
B-C, The comets were analysed with CASPLab software and Head DNA% and Olive Tail Moment
are plotted in B for HeLa cells and in C for hTERT RPE1 cells (n = 5 independent experiments
with > 750 comets per condition; one-way ANOVA, median and 25 and 75 percentiles are shown,
*P = 0.05).
SSBs, DSBs and alkaline labile sites (Singh et al., 1988; Speit & Rothfuss, 2012).
The alkaline comet assay in asynchronously growing HeLa and hTERT RPE1
cells did not reveal any significant differences in DNA damage levels between control
and Kv10.1 deficient cells (Figure 3.2) after analysis of DNA comets with CASPLab
software (Końca et al., 2003). Therefore, the changes in protein levels upon Kv10.1
depletion are not caused by DNA damage.
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3.2 Kv10.1 and Spindle Assembly Checkpoint
3.2.1 SAC is activated in Kv10.1-deficient HeLa cells
The spindle assembly checkpoint is a surveillance mechanism that delays anaphase
onset until all chromosomes are correctly attached in a bipolar fashion to the mitotic
spindle (May & Hardwick, 2006). An increasing body of evidence indicates that
DDR proteins also have a mitotic role in regulating the spindle assembly checkpoint
(SAC; Eliezer et al., 2014; Lawrence et al., 2015). Therefore, the accumulation of
DDR proteins that we observe could reflect activation of SAC.
To test this, HeLa cells were transfected with either Scr - or KCNH1 -siRNA
and synchronised at the G1/S border using double thymidine block. Samples of
synchronised cells were collected every 2 h and analysed by WB (Figure 3.3, A).
Densitometry analysis of the immunoblots showed a statistically significant increase
in total levels of MAD2L1 and CDC20 in Kv10.1 KD cells (Figure 3.3, B). MAD2L1
total protein levels were 27% higher in Kv10.1-deficient HeLa cells (0.26 ± 0.02
compared to 0.19 ± 0.02 in control cells). Only a moderate 20% increase in CDC20
was observed in Kv10.1 KD cells (0.28 ± 0.05 vs 0.23 ± 0.04). No differences were
observed in BUB3 levels, another component of the SAC; nevertheless, SAC appears
to be at least partially more active in KD cells.
Aurora B, one of the critical regulators of cell cycle, was downregulated by 35%
in Kv10.1-deficient HeLa cells (0.29 ± 0.03 vs 0.40 ± 0.06 in the control cells). It
is important to note that Aurora B needs to be relocated at the kinetochores to
exert its function; such localisation of Aurora B requires MAD2 (Shandilya, Medler,
& Roberts, 2016), and CHK1-mediated phosphorylation of Aurora B increases its
activity at centromeres (Zachos et al., 2007). As already demonstrated above, Kv10.1
KD induces an increase in both p-CHK1 (Figure 3.1) and MAD2L1 (Figure 3.3).
Therefore, although Aurora B is overall less abundant, the conditions for more
efficient activation of Aurora B at the kinetochores are present in Kv10.1 KD cells.
pVHL, the von Hippel-Lindau protein, is also involved in SAC. pVHL is a
tumour suppressor protein, and its mutation leads to von Hippel-Lindau syndrome,
a condition characterised by benign tumours in different locations with a tendency
to malignisation (Varshney et al., 2017). The role of pVHL in response to hypoxia
79
Results
Figure 3.3: Kv10.1 deficiency leads to accumulation of SAC proteins in mitosis
in HeLa cells. Hela cells were transiently transfected with either Scr- or KCNH1-siRNA, and
synchronised with double thymidine block at G1/S border, and subsequently released from the block.
The samples were collected every 2 h between 0 – 6 h and 10 – 14 h, and every 1 h during 6 – 10
h and applied to immunoblot analysis. A, Representative images of immunoblots are shown. B,
Densitometry analysis of all immunoblot repeats are given with the time interval corresponding to
Kv10.1 expression highlighted in pink (n = 3 independent synchronisation experiments; two-way
ANOVA, repeated measures, mean ± SEM is shown, the given P value shows the significance of
total difference between the two groups, and “*” – between each time point, *P = 0.05).
and HIF1α homeostasis (Q. Zhang & Yang, 2012) is well established. pVHL has
been also shown to reduce chromosome instability via increase of MAD2 levels (Hell,
Duda, Weber, Moch, & Krek, 2014; Thoma et al., 2009), which in turn enhances SAC
response (Subramanian & Kapoor, 2013). Immunoblot analysis showed a moderate,
but statistically significant increase in total levels of pVHL in Kv10.1 KD cells (0.34
± 0.03 vs 0.27 ± 0.02 in control Figure 3.3, A). Therefore, our results in combination
with those reported in the literature allow us to speculate that the SAC response in
Kv10.1 knockdown cells is possibly stronger.
Interestingly, the APC/C protein CDC27 was downregulated in Kv10.1 KD cells
(0.24 ± 0.02) by 20% with respect to the control group (0.30 ± 0.03). Notably,
the most significant difference between the groups was observed at 6 h after the
release (by 60%: 0.45 ± 0.09 in control vs 0.28 ± 0.05 in KD cells). This observation
may point out that Kv10.1-deficient cells transition from metaphase-to-anaphase
at later time points than the control cells. In this scenario, a shift in the peak of
CDC27 towards later time points in Kv10.1 KD cells should be observed. However,
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the timepoint corresponding to the peak of CDC27 is the same as in both groups
(Figure 3.3, B).
The lack of CDC27, which is required for APC/C activity (King et al., 1995),
could be compensated by upregulation of other factors. A plausible candidate is
WEE1, a kinase responsible for CDK1-Cyclin B1 complex inactivation both at
the entry into mitosis (Schmidt et al., 2017) and at the metaphase-to-anaphase
transition (Chow, Poon, & Ma, 2011). Overexpression of Swe1 (the paralog of
WEE1 in budding yeast), results in the arrest of cells with reduced APC activity in
metaphase in vitro and in vivo (Lianga et al., 2013). When we studied the profile of
WEE1 expression during cell cycle progression on the protein level, we observed an
upregulation in total WEE1 protein in Kv10.1 deficient cells (0.16 ± 0.01) by 30%
in comparison to the control group (0.12 ± 0.01, Figure 3.3, B). This upregulation
of WEE1 may compensate for by taking over the inhibition of cyclin B1/CDK1
complex and thus trigger the metaphase-to-anaphase transition (reviewed in Schmidt
et al., 2017; Visconti, Palazzo, Della Monica, & Grieco, 2012). Alternatively, WEE1
may prevent the premature activation of APC/C and consequently the formation
of lagging chromosomes. However, slightly broader peaks of CDC20 and WEE1 at
G2/M phase (7 – 12h after thymidine block), as well as our previous observations
(Urrego et al., 2016) speak against the former possibility and hint to extended and
stronger SAC activity and prevention of premature activation of APC/C.
3.2.2 Activation of SAC in Kv10.1-deficient cells prevents
the formation of lagging chromosomes during
anaphase onset
SAC is a surveillance mechanism that delays anaphase onset until all chromosomes
are correctly attached in a bipolar fashion to the mitotic spindle (May & Hardwick,
2006). We observed an upregulation of major components of SAC in synchronised
HeLa cells depleted of Kv10.1, an observation that raises two questions. i): Is the
upregulation of SAC components due to a delay in the chromosomal alignment? And
ii): Is the stronger and longer SAC in Kv10.1 KD cells more efficient in decreasing
the occurrence of lagging chromosomes?
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Figure 3.4: Kv10.1 depletion in HeLa cells does not affect the chromosomal align-
ment at metaphase and decreases the occurrence of lagging chromosomes. HeLa cells
were transiently transfected with the indicated siRNAs and synchronised at prophase with double
thymidine and nocodazole treatments. Afterwards, nocodazole was removed and the cells were released
into either fresh medium for 50 min (anaphase) or fresh medium containing 15 µM MG132 for 2
h (metaphase). The cells were fixed with 2% pfa in PHEM (see “Immunofluorescence staining”)
and permeabilised with ice-cold methanol. The mitotic spindle was visualised by α-tubulin staining
(green), each chromosome kinetochore through CENP-B staining (red), and DNA was stained using
Hoechst 33342 (blue; scale bar, 10 µm). A, A metaphase is considered defective when chromosomes
(overlap of CENP-B and Hoechst stains) are not properly aligned (indicated with arrows) or damaged
DNA (only Hoechst positive) is present. Example images of normal and defective metaphases are
shown. The percentage of defective metaphases from the total number of metaphases was calculated
and plotted in B (600 metaphases per experiment, n = 4 independent synchronisation experiments;
unpaired two-tailed Student’s t-test, mean ± SEM is shown). C, Lagging chromosomes in anaphase
are detected as CENP-B- and Hoechst-positive signal located at the middle part rather than at the
vertices of the spindle (arrows). D, The graph shows the percentage of anaphases with lagging
chromosomes from the total number of anaphases (400 anaphases per experiment, n = 4 independent
synchronisation experiments; unpaired two-tailed Student’s t-test, mean ± SEM is shown).
We approached these questions using again HeLa cells transfected with either
Scr - or KCNH1 -siRNA and synchronised at metaphase, to assess the alignment of
chromosomes, and at anaphase, to assess the occurrence of lagging chromosomes. The
synchronised cells were fixed and the bipolar mitotic spindle, kinetochores and DNA
were visualised on a confocal fluorescence microscope (Figure 3.4, A). Quantification
of so-called “defective metaphases”, i.e., metaphases with misaligned chromosomes
or with damaged DNA (negative for CENP-B, a kinetochore marker), showed no
differences between the studied groups (Figure 3.4, B).
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Nevertheless, the question of whether the stronger and longer SAC affects the
occurrence of lagging chromosomes still remains. As expected, HeLa cells transfected
with KCNH1 -siRNA had approximately 20% less lagging chromosomes (29.32 ±
0.45% vs 35.78 ± 0.45%, Figure 3.4, D). Therefore, the detected increase in SAC
in Kv10.1-deficient HeLa cells facilitates proper chromosome segregation during
anaphase.
3.2.3 Kv10.1 knockdown results in higher PLK1 activity
During mitosis, sister chromatids must become bioriented on the mitotic spindle,
i.e., one chromatid is attached by its kinetochore region to MTs growing from one
spindle pole, and its sister chromatid to the MTs of the opposite pole. Once this
configuration is achieved for every single chromatid pair, SAC will be inactivated
and allow the cell to transition from metaphase-to-anaphase. Since kinetochore-MT
interactions form stochastically, the whole process must be supervised and regulated
to ensure that improper attachments are continually removed in a process termed
error-correction (Saurin, 2018). Thus, an alteration in kinetochore-MT attachments
in HeLa cells deficient of Kv10.1 can explain the accumulation of SAC proteins and
the decrease in the number of lagging chromosomes.
Recently, a novel pathway involving the Aurora B-PLK1-MCAK axis has been
suggested to regulate the accuracy of kinetochore-MT attachments (Shao et al.,
2015). In the previous paragraphs, we speculated the possibility of more efficient
activation of Aurora B at the kinetochores despite lower amounts of total Aurora B
in Kv10.1 KD cells (Figure 3.3). To further assess the involvement of the Aurora
B-PLK1-MCAK pathway, we tested the changes in PLK1 over time in synchronised
HeLa cells transiently transfected with either a Scr - or KCNH1 -siRNA (Figure 3.5,
A and B). Total PLK1 level was 30% lower in cells lacking the channel (0.11 ±
0.01) than in the control cells (0.16 ± 0.02) based on the densitometry analysis of
the immunoblots. However, this did not correlate with the increased PLK1 activity.
When measuring the enzymatic activity of PLK1 in HeLa cell lysates collected at
the G1/S border (double thymidine protocol) and prophase (thymidine-nocodazole
protocol), the cells in prophase with downregulated Kv10.1 had moderately higher
PLK1 activity (Figure 3.5, C). Similarly, higher activity of PLK1 was observed in
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Figure 3.5: PLK1 enzymatic activity is higher in Kv10.1 depleted cells despite
lower abundance of total PLK1 protein. A-B, HeLa cells were transiently transfected with the
respective siRNA and synchronised at the G1/S border via double thymidine block. Synchronised cell
aliquots were collected every 2 h between 0 – 6 h and 10 – 14 h, and every 1 h during 6 – 10 h after
the release from the block; isolated protein samples were subjected to immunoblot analysis. A, A
representative image of such immunoblots is given (50 µg protein per lane, actin served as a reference
protein). B, Densitometry analysis of immunoblot images (n = 3 independent synchronisation
experiments; two-way ANOVA, repeated measurements, mean ± SEM is shown). C, HeLa cells
were synchronised at G1/S with double thymidine block and G2/M with thymidine-nocodazole block.
Samples were collected at the corresponding phases of the cell cycle and PLK1 enzymatic activity was
measured using an ELISA-based approach. The absorbance of the reaction mixture was measured and
plotted (n = 2 independent synchronisation experiments; two-way ANOVA, repeated measurements,
mean ± SEM is shown).
Kv10.1-depleted hTERT RPE1 cells synchronised in prophase (Figure 3.5, D).
Thus, despite the decreased level of total protein, the enzymatic activity of PLK1
is higher in Kv10.1 deficient cells. Therefore, we can speculate that, indeed, SAC
stays active over more extended period in the KD cells, resulting in a more efficient
error-correction. It should nevertheless be noted that this observation should be
treated carefully, as the disruption of the dynamic balance of activities of any of




Figure 3.6: An altered mitotic spindle angle is observed in Kv10.1-depleted HeLa
cells. HeLa cells were transfected with siRNA and synchronised in metaphase by consecutive
treatment with thymidine, nocodazole and MG132. A, Maxima projections of z-stacks (0.2 µm
stepsize) of mitotic cells in metaphase (scale bar, 50 µm), where B, the spindle angle was determined
(>50 events per experiment, n = 5 independent synchronisation experiments; Student’s t-test, two-
tailed, mean ± SEM are shown).
3.2.4 Altered mitotic spindle angle is observed upon loss
of Kv10.1
PLK1 has been described to regulate mitotic spindle orientation by modulating
the nucleation and growth of astral MTs from the centrosomes (Hanafusa et al.,
2015; Miyamoto et al., 2017; Sana, Keshri, Rajeevan, Kapoor, & Kotak, 2018).
Moreover, pVHL (also increased in Kv10.1 KD cells) has been described to regulate
the proper orientation of the mitotic spindle by stabilisation of astral MTs (Hell et
al., 2014; Hergovich, Lisztwan, Barry, Ballschmieter, & Krek, 2002; Lolkema et al.,
2007; Thoma et al., 2009). Interestingly, single HeLa cells with greater tilting of
the mitotic spindle required more time for biorientation of sister kinetochores due
to prolonged activation of the spindle checkpoint (Charnley, Anderegg, Holtackers,
Textor, & Meraldi, 2013). Hence, we checked whether mitotic spindle orientation
might also be altered in the absence of Kv10.1.
Similarly to the assessment of defective metaphases, control and with transient
downregulation of Kv10.1 HeLa cells were synchronised at metaphase, fixed and the
mitotic spindle was visualised on a confocal microscope (Figure 3.6, A). As expected,
the mitotic spindle angle was greater in the Kv10.1 KD HeLa cells than in the control
cells with mean angle values of 20.14 ± 0.89 and 15.41 ± 0.74 degrees, respectively
(Figure 3.6, B).
Hence, we conclude that the changes in the mitotic spindle angle may be the
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cause for the observed increase in PLK1 and pVHL activities, and subseqently
extended SAC – a compensatory mechanism deployed by the cell to rescue the
correct positioning of the mitotic spindle by influencing the astral MT dynamics.
Hence, experiments aiming to observe the behaviour of MT dynamics globally should
be performed.
3.3 Kv10.1 and microtubule dynamics
3.3.1 Downregulation of Kv10.1 increases the occurrence
of asymmetric monopolar mitotic spindles in HeLa
cells
In previous paragraphs we showed that the cells with less Kv10.1 have stronger
and longer SAC, a bigger spindle angle and less lagging chromosomes during anaphase.
Both SAC and spindle orientation, as mentioned above, are highly dependent on MT
dynamics and can influence or be influenced by them (Kotak, 2019; Saurin, 2018;
H.-Y. Wu et al., 2017). Therefore, we questioned whether the described phenotypic
and biochemical changes are due to alterations in MT dynamics when Kv10.1 is lost.
A pilot experiment using DME-assay (Ertych et al., 2014) was performed to answer
this question.
DME is a small molecule that inhibits the kinesin Eg5 motor protein resulting
in a formation of monopolar spindles (Mayer et al., 1999; Müller et al., 2006).
Interestingly, cells with altered MT dynamics form asymmetric monopolar spindles.
It should be noted that the treatment with DME itself does not affect the assembly
rates of MT plus-tips (Ertych et al., 2014). HeLa cells were treated with 2.5 µM
DME and the mitotic spindles were visually checked under a fluorescence microscope
(Figure 3.7, A). The monopolar mitotic spindles were manually counted and the
percentage of asymmetric events out of all the monopolar spindles was calculated. As
shown in Figure 3.7, B, the percentage of asymmetric monopolar spindles was higher
in Kv10.1 KD HeLa cells than in the control cells. Thus, this result already indicates
alterations in MT dynamics in Kv10.1 deficient cells, which, however, should be
further validated by directly measuring MT dynamics in live cells.
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Figure 3.7: Increased MT plus end growth rate is observed upon Kv10.1 downregu-
lation in Hela cells. HeLa cells were transiently transfected with a respective siRNA, grown until
70% confluency and treated with 2.5 µM DME for 4 h, enriching the cells in monopolar mitotic
spindles. The cells were fixed with 2% pfa in PHEM, permeabilised with ice-cold methanol. Mitotic
spindle were visualised via α-tubulin staining (green), each chromosome kinetochore – CENP-B
(red), and DNA – Hoechst 33342 (blue; scale bar, 10 µm). A, Representative images of monopolar
spindles are shown. B, The percentage of asymmetric monopolar spindles from total number of
monopolar spindles was calculated and plotted (1500 monopolar spindle per condition per experiment,
n = 3 independent synchronisation experiments; unpaired two-tailed Student’s t-test, mean ± SEM
is shown).
3.3.2 The absence of Kv10.1 results in an increased MT
plus-end growth
To confirm the preliminary data obtained using DME-assay, we measured the
MT plus-end growth rates directly in living cells expressing EB3-tdTomato. The
cells were transiently transfected with either Scr - or KCNH1 -siRNA, and growing
MTs were monitored. MT plus-end growth speed, length and lifetime were measured
with U-Track software (Figure 3.8, A, supplementary video 1 – 4).
Strikingly, all measured parameters differed between the control and KD cells
both in HeLa (Figure 3.8, B) and hTERT RPE1 (Figure 3.8, C). The growth speed
was increased both in Kv10.1 KD HeLa (18.80 ± 0.22 µm * min-1 compared to 17.68
± 0.24 in control cells) and KD hTERT RPE1 (19 ± 0.47 µm * min-1 vs 14.86 ±
0.39 in control) cells by 1 µm * min-1 and 4.2 µm * min-1, respectively. Similarly,
the growth length, which is the displacement of a growing tip during the recording
time (1 min), was increased by 0.02 µm in Kv10.1 KD HeLa (0.58 ± 0.01), and
almost by 0.08 µm in KD hTERT RPE1 cells (0.58 ± 0.01) relative to their controls:
0.56 ± 0.01 µm and 0.50 ± 0.01 µm, respectively. The increase in growth speed
and length was accompanied by lesser growth lifetime in both cell lines upon Kv10.1
loss. In HeLa cells, the difference in growth lifetime between the two groups was not
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Figure 3.8: Increased microtubule plus-end growth rates are observed upon Kv10.1
downregulation. The cells were transiently co-transfected with the respective siRNAs and pEB3-
tdTomato and treated 48 h post-transfection with 2.5 µM DME for 4 h. The MT growth was tracked
by taking images every 500 ms for 1 min, and analysed with the MATLAB-based U-Track software
(Jaqaman et al., 2008). A, The images represent constitutive series of analysed videos, where red
“comets” mark length increase from lapse to lapse. Parameters calculated by the software are plotted
in B, for HeLa and in C, for hTERT RPE1 cells (25 mitotic cells per experiment per condition, n
= 3 independent synchronisation experiments; unpaired two-tailed Student’s t-test, median and 25
and 75 percentiles are shown).
significant, whereas in hTERT RPE1 cells with silenced Kv10.1 (1.91 ± 0.03 s) it
was decreased by 0.23 s compared to the control cells (2.15 ± 0.05 s).
Furthermore, dynamicity, the frequency rate of switching from growth to shrinkage
and vice-versa (Burbank & Mitchison, 2006), was measured. The MTs were more
dynamic in both cell lines when Kv10.1 was downregulated. In HeLa cells, the
difference in dynamicity of MTs between KD (13.08 ± 0.19 µm * min-1) and control
cells (12.42 ± 0.19 µm * min-1) was 0.67 µm * min-1. In hTERT RPE1 KD (15.57 ±
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0.45 µm * min-1) and control cells (12.31 ± 0.29 µm * min-1) it was 3.26 µm * min-1.
In conclusion, Kv10.1 downregulation leads to increased MT dynamics both in
HeLa and hTERT RPE1 cells, thus confirming the results obtained from DME-assay.
3.3.3 Overexpression of Kv10.1 has opposite effects to
Kv10.1 knockdown on MT dynamics in HeLa cells
In order to understand whether the observed increase in MT dynamics is, indeed,
due to the lack of Kv10.1, we repeated the MT dynamics experiment overexpressing
WT Kv10.1 (pKCNH1-WT) in HeLa cells. As a control, cells were transfected with
an empty plasmid with the same backbone used for pKCNH1-WT.
Overexpression of Kv10.1 in HeLa cells affected the MT dynamics (Figure 3.9,
supplementary video 5 – 6) opposite to the downregulation of the channel (Figure 3.8,
B). The growth speed in cells overexpressing the channel was decreased from 17.56 ±
0.15 µm * min-1 (pEmpty) to 16.73 ± 0.15 µm * min-1 (pKCNH1-WT). The growth
length was also reduced to 0.61 ± 0.01 µm * min-1 in pKCNH1-WT expressing cells
relative to the control cells (0.64 ± 0.01 µm * min-1). In agreement with the findings
upon downregulation, overexpression of Kv10.1 had no effect on growth lifetime in
HeLa cells. Finally, the MTs in the cells with upregulated Kv10.1 were less dynamic
(14.48 ± 0.18 µm * min-1) than the control cells (15.28 ± 0.23 µm * min-1).
The results described up to now lead us to propose that the delay of G2/M
and activation of SAC are mainly due to the effects Kv10.1 has on MT dynamics.
Figure 3.9: Overexpression of Kv10.1 in HeLa cells results in suppressed MT dy-
namics. HeLa cells were transiently co-transfected with respective pDNA and pEB3-tdTomato, and
48 h post-transfection treated with 2.5 µM DME for 4 h. The MT growth was tracked by taking
images every 500 ms for 1 min, and the MT growth was analysed with MATLAB-based U-Track
software (Jaqaman et al., 2008). Parameters calculated by the software are plotted (25 mitotic cells
per experiment per condition, n = 3 independent synchronisation experiments; unpaired two-tailed
Student’s t-test, median and 25 and 75 percentiles are shown, *P = 0.05).
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Although the differences we observe are quantitatively small, it is important to keep
in mind that the experiments were performed using transient downregulation or
overexpression of the channel, where the efficiency is subject to variability from
experiment to experiment.
3.4 Kv10.1 and ORAI1 functional interaction
3.4.1 Kv10.1 and ORAI1 are in close proximity to each
other
Until this point, the canonic function of the channel as a pathway for the flow of
K+ ions has not been taken into account. It could however have a relevant role in
modifying the microenvironment by changing the ionic composition in a given cell
compartment. In particular, the influence of different ions on the polymerisation
of MTs in vitro and in vivo has been intensively studied (reviewed in Hepler, 2016;
Safinya et al., 2016). Of special interest, although, are Ca2+ ions. MTs switch from
growth phase to shrinkage when exposed to a high concentration of Ca2+ (Nishida et
al., 1979; Sandoval & Weber, 1978). However, the effect is highly dependent on the
set of MAPs present on the growing tips of MTs (Berkowitz & Wolff, 1981; V. Buljan
et al., 2009). Furthermore, CaM has also been described to influence the growth
rate of MTs (Erneux et al., 1984; Y. C. Lee & Wolff, 1982). In addition, it has
recently been suggested that Kv10.1 colocalises with ORAI1 based on fluorescence
microscopy, and silencing of Kv10.1 or ORAI1 reduced Ca2+ influx, but without an
additive effect, indicating a functional coupling between the channels (Badaoui et
al., 2018).
Therefore, we checked the possible functional colocalisation of Kv10.1 and ORAI1
using PLA. If two proteins are in proximity, PLA probes bound to each of the target
proteins will be able to interact with the connector oligonucleotide and start the
RCA. As shown in Figure 3.10, A, PLA using Kv10.1 and ORAI1 antibodies gave
rise to a signal, indicating proximity. There was no signal in the negative control for
the assay (no primary antibody added; Figure 3.10, B). Thus, we could confirm that
the previous indications using immunofluorescence approaches (Badaoui et al., 2018)
obey physical proximity between the two channels.
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Figure 3.10: Kv10.1 and ORAI are in close proximity. Asynchronously growing HeLa
cells were fixed with 2% pfa in PHEM, amd ORAI1 and Kv10.1 colocalisation was checked using in
situ proximity ligation assay: a positive signal can only be detected when both proteins are in close
proximity. A, Example images showing Kv10.1/ORAI1 PLA foci in asynchronous cells (scale bar,
50 µm) and in a mitotic cell (inlet, scale bar 10 µm) are given (Kv10.1/ORAI1 PLA – red, nuclei -
blue). B, A negative control (no primary antibodies) is represented (scale bar, 50 µm).
3.4.2 Silencing of Kv10.1 decreases the intracellular [Ca2+]
in hTERT RPE1 cells
We showed that these two channels are in proximity, giving rise to the possibility
that Kv10.1 activity results in an increase of [Ca2+] through ORAI1. This would
give rise to a self-limited loop since the increase of [Ca2+] leads to closing of Kv10.1
through calcium/CaM (Ziechner et al., 2006).
To determine the presence of such a functional interaction, we measured changes
of intracellular [Ca2+] after silencing Kv10.1 in hTERT RPE1 cells. hTERT RPE1
cells were synchronised in G0 phase and preloaded with Fluo-4AM. The cells were first
imaged in the absence of FCS for 60 min, then FCS was added and the Fluo-4 signal
was immediately recorded from the same cells for another 60 min (Figure 3.11, A,
supplementary video 7 – 10). The recorded signal was normalised for photobleaching
and for continuous slow loading of the cells with Fluo-4AM, which was present
throughout the imaging (Figure 3.11, B). The area under the curve (AUC) and the
number of local maxima in the spectrum were calculated. As shown in Figure 3.11,
91
Results
Figure 3.11: Kv10.1 downregulation decreases the intracellular [Ca2+] and spiking
in hTERT RPE1 cells. hTERT RPE1 cells were synchronised at G0 with serum deprivation
protocol, and prior to the imaging, the cells were incubated with Fluo-4AM. The time-lapse images
were taken with 10 s interval, first, in the absence of growth factors (-3600 – 00 sec), then continued
after addition of FCS (00 – 3600 sec), and changes in the intensity of Fluo-4 were recorded. A,
Maxima projection images of time-lapse series of Scr- and KCNH1-siRNA treated cells are shown
before and after FCS addition with colour-coded intensity of Fluo-4 (“red fire” LUT is applied, scale
bar, 100 µm). B, The measured intensity was normalised for bleaching and the relative changes
in Fluo-4 intensity are plotted over time. An example of normalised spectra with identified local
maxima (peaks, marked with circles) are given (the arrow marks the time of FCS addition). C and
D, The total area under the recorded spectrum (C) and number of peaks (D) were determined for
the entire duration and after FCS addition with MATLAB and analysed with GraphPad Prism 8
(200 cells per condition per experiment; n = 3 independent synchronisation experiments; unpaired
two-tailed Student’s t-test, median and 25 and 75 percentiles are shown, *P = 0.05).
C, the mean AUC, which indicates the relative amount of intracellular [Ca2+], was
significantly smaller in KCNH1 -treated cells: by 17% both for the entire duration
(-3600 – 3600 sec) and after addition of FCS (00 – 3600 sec) respective to the Scr -
siRNA treated cells. The total number of local maxima (peaks) was decreased by




3.4.3 Loss of Kv10.1 reduces the frequency of cytosolic
calcium oscillations
It is well established that calcium signals are not only encoded in the absolute
magnitude of changes but also the frequency and amplitude of cytosolic calcium
oscillations (Parekh, 2011; Samanta & Parekh, 2017). In the previous section, we
showed a decrease in total intracellular [Ca2+] and also in the number of peaks in
the intensity spectrum upon downregulation of Kv10.1. In particular, the latter may
indicate a potential change in the oscillatory behaviour of cytosolic calcium upon
Kv10.1 loss.
Therefore, using the same normalised recordings described in Figure 3.11, we
calculated the changes in the frequency by converting the time domain of the signal
into the frequency domain using fast Fourier transform (Figure 3.12, A). Four regions
were isolated for the analysis: i) “before” (-3600 – 00 sec) and ii) “after” (00 – 3600
sec) FCS addition; iii) shortly after addition of FCS, the prominent peak region
(00 – 60 sec) and iv) the region “after the peak” (60 – 3600 sec). As depicted in
Figure 3.12, B, no significant differences were found between the control and KD cells
in “before”, unlike the “after” FCS region. That is, Kv10.1 loss did not affect the
behaviour of Ca2+ oscillations at rest. The frequency of cytosolic calcium oscillations
was decreased by almost 40% in the “after” FCS region of Kv10.1-depleted cells
(0.37 ± 0.02 mHz) relative to the control group (0.59 ± 0.04 mHz).
The frequency rates in the “peak” region were 3.97 ± 0.15 mHz for Kv10.1 KD
and 5.01 ± 0.28 mHz for the control hTERT RPE1 cells. The frequency rates in the
“after the peak” were 2.17 ± 0.16 mHz and 2.72 ± 0.16 mHz, respectively.
Next, we studied in more detail the properties of the frequency signal. We
measured the prominence and FWHM of each local maximum within the frequency
domain (Figure 3.13, A). These parameters give an idea about the strength of each
spike (prominence) and its duration (FWHM). Three regions were analysed: i) entire
duration (-3600 – 3600 sec); ii) after FCS addition (00 – 3600 sec) and iii) the “peak”
(00 – 60 sec, Figure 3.13, B).
Globally, the signal strength in Kv10.1 depleted cells was reduced. The promi-
nence and FWHM were reduced by 13% and 5%, respectively, in the KD cells in
comparison with the control group. After FCS addition, no significant change was
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Figure 3.12: Kv10.1 downregulation decreases the frequency rate of intracellular
[Ca2+] oscillations. hTERT RPE1 cells were synchronised at G0 with serum deprivation, and
prior to the imaging, the cells were incubated with Fluo-4AM. The time-lapse images were taken with
10 s intervals, first, in the absence of growth factors (-3600 – 00 sec), then continued after addition
of FCS (00 – 3600 sec). The recorded changes of intensity of Fluo-4 over time were converted
into a frequency domain. A, An example of single-sided amplitude spectrum of relative changes of
intracellular [Ca2+] from one cell/condition recording is shown. B, The frequency was determined
for the given regions (“00 sec” marks the point of FCS addition) with MATLAB and analysed with
GraphPad Prism 8 (200 cells per condition per experiment; n = 3 independent synchronisation
experiments; unpaired two-tailed Student’s t-test, median and 25 and 75 percentiles are shown, *P
= 0.05).
observed in FWHM values, but the mean prominence was again smaller by 10% in
the KD cells. Interestingly, the strength of the peak observed right after the addition
of FCS (Figure 3.13, B, 00 – 60 sec), was affected by the downregulation of Kv10.1
the most – 20%, however the FWHM was reduced moderately, only by 3%.
In conclusion, here we give indirect evidence of functional interaction of Kv10.1
and ORAI1: silencing of Kv10.1 leads to the reduction in frequency, strength and
duration of oscillations of cytosolic calcium, which is reflected in the global decrease
of intracellular [Ca2+]. In addition, based on our initial findings on MT dynamics in
Kv10.1-downregulated cells, which display increased growth speed and dynamicity,
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Figure 3.13: Weaker spikes of intracellular [Ca2+] are observed upon the loss of
Kv10.1 in hTERT RPE1 cells. The recorded changes of intensity of Fluo-4 over time were
converted into a frequency domain. The prominence and full width at half maximum (FWHM) were
defined in the single-sided amplitude spectrum with MATLAB as shown in A for the given regions
(“00 sec” marks the point of FCS addition). B, The obtained values were analysed with GraphPad
Prism 8 (200 cells per condition per experiment; n = 3 independent synchronisation experiments;
unpaired two-tailed Student’s t-test, median and 25 and 75 percentiles are shown, *P = 0.05).
global decrease of intracellular [Ca2+] was expected; as already mentioned the poly-
merisation rate of MTs is negatively correlated with [Ca2+], at least in vitro (Nishida
et al., 1979; Sandoval & Weber, 1978).
3.5 Importance of conductance of Kv10.1 and
ORAI1 in the regulation of MT dynamics
3.5.1 Astemizole-mediated blockade of Kv10.1
conductance reduces MT dynamics in HeLa cells
In order to see whether the already described effects of Kv10.1 downregulation on
MT dynamics are explicitly due to its conductance, rather than interactions of the
cytoplasmic domains of the full-length Kv10.1, as well its splice-variants with other
proteins, experiments involving specific blockers of the channel should be performed.
An antihistamine drug astemizole has been described to specifically block Kv10.1
current (Garćıa-Ferreiro et al., 2004b). Therefore, we decided to utilise the same
approach as before and study the effect of blockade of Kv10.1 conductance with the
antihistamine drug astemizole on MT dynamics.
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Figure 3.14: Blocking Kv10.1 conduc-
tance in HeLa cells with astemizole res-
cues the effect of norastemizole on MT dy-
namics. HeLa cells, transiently expressing EB3-
tdTomato, 24 h prior to the imaging were incu-
bated with 10 µM of either astemizole or norastemi-
zole and the last 4h – with 2.5 µM DME. The MT
growth was tracked by taking images every 500
ms for 1 min, and analysed with MATLAB-based
U-Track software (Jaqaman et al., 2008). Param-
eters calculated by the software are plotted (30
mitotic cells per experiment per condition, n =
3 independent synchronisation experiments; one-
way ANOVA, multiple comparison Tukey’s test;
median and 25 and 75 percentiles are shown, *P
= 0.05).
HeLa cells overexpressing EB3-
tdTomato were treated with either
astemizole or its isomer norastemizole,
which retains antihistamine activity
but has no channel inhibitory activity
(Garćıa-Ferreiro et al., 2004a) or only
the vehicle (DMSO). The analysis of the
acquired time-lapse series revealed un-
expected results (Figure 3.14, supple-
mentary video 11 – 13). Norastemi-
zole had a significant impact on the MT
growth properties, while no significant
differences were observed between astem-
izole and DMSO-treated cells. First of
all, norastemizole treatment increased
MT dynamics in HeLa cells by 0.87 µm
* min-1 compared to the negative control
(only DMSO; 12.70 ± 0.30 µm * min-1)
and by 1.11 µm * min-1 in relation to
the astemizole group (12.46 ± 0.17 µm
* min-1).
The growth speed was also higher in the norastemizole (16.22 ± 0.27 µm * min-1)
vs the DMSO (15.18 ± 0.30 µm * min-1) or astemizole (14.72 ± 0.14 µm * min-1)
treated cells. The MTs were shorter living in norastemizole (2.230 ± 0.03) than
the DMSO (2.356 ± 0.03) treated cells, but we observed no changes between the
astemizole and norastemizole groups. Interestingly, no significant changes in growth
length were detected between norastemizole and DMSO-treated groups, whereas
the astemizole effect on the growth length was notable – it was shorter by 0.045
µm and by 0.057 µm relative to DMSO and norastemizole groups, respectively. No




In summary, astemizole treatment had no noticeable effects with respect to the
DMSO group, but MT dynamics were remarkably different between the astemizole
and norastemizole groups. Astemizole interacts not only with the histamine receptor
but also cytochrome P450 (Renwick, 1999). Importantly, the effects of astemizole
were opposite to those of Kv10.1 downregulation and similar to Kv10.1 overexpres-
sion.
The effects of astemizole on cell physiology are pleiotropic, and reducing the
difference between astemizole and norastemizole to only channel inhibition may be
an oversimplification. However, our data indicate that blocking Kv10.1 conductance
decreases the MT dynamics, similarly to overexpression of the channel (Figure 3.9),
and opposite to its downregulation (Figure 3.8). Given this unexpected result, we
set out for experiments using a more specific channel blocker.
3.5.2 Monoclonal antibody-mediated blockade of Kv10.1
conductance decreases MT dynamics in HeLa cells
The interpretation of norastemizole and astemizole effect on the MT dynamics
is ambiguous. Therefore, we approached this question from another perspective:
instead of a chemical agent, we used a monoclonal antibody (mAb56) directed against
the pore loop of Kv10.1. mAb56 has been shown to inhibit Kv10.1 currents with
high specificity and effectiveness (Gomez-Varela et al., 2007). Analysis of the time-
lapse series showed a decrease in MT dynamics in mAb56-treated cells (Figure 3.15,
supplementary video 14 – 15). The growth speed in the mAb56 cells (18.01 ± 0.08
µm * min-1) was decreased by 0.51 µm * min-1 versus the isotype IgG-treated control
group (18.52 ± 0.11 µm * min-1). The effect of mAb56 treatment on growth length
and lifetime was insignificant. However, the cells treated only with IgG displayed
more dynamic MTs (16.34 ± 0.11 µm * min-1) than the mAb56 treated cells (15.83
± 0.08 µm * min-1).
These results confirm the role of Kv10.1 currents in the regulation of MT dy-
namics, although opposite to the downregulation of the channel. To a certain extent,
the blockade with antibody repeats the pattern of MT dynamics in the presence of
astemizole. Nevertheless, it is clear that both the conductance of Kv10.1 and the
presence of the actual channel is important for maintaining proper mitotic dynamics.
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Figure 3.15: Blocking Kv10.1 conductance in HeLa cells with mAb56 decreases
MT dynamics. HeLa cells, transiently expressing EB3-tdTomato, 24 h prior to the imaging
were incubated with 5 µg of either mAb56 or IgG (κ2b) and the last 4h – with 2.5 µM DME.
The MT growth was tracked by taking images every 500 ms for 1 min, and the MT growth was
analysed with MATLAB-based U-Track software (Jaqaman et al., 2008). A, The images represent
maxima intensity projection of time-lapse series of EB3-tdTomato expressing cells with colour-coded
intensity (scale bar, 10 µm). B, Parameters calculated by the software are plotted (50 mitotic cells
per experiment per condition, n = 5 independent synchronisation experiments; unpaired two-tailed
Student’s t-test, median and 25 and 75 percentiles are shown).
3.5.3 Inhibition of ORAI1 conductance mimics the effects
of inhibition of Kv10.1 current on MT dynamics
After confirming the physical proximity of Kv10.1 and ORAI1, a logical question
would be whether the effects on MT dynamics observed by inhibiting Kv10.1 are due
to this interaction, that is, that Kv10.1 affects MTs through a change in intracellular
[Ca2+] due to modulation of ORAI1 activity. Hence, we used AnCoA4, a drug known
to inhibit ORAI1 current (Sadaghiani et al., 2014).
HeLa cells were transiently transfected with EB3-tdTomato and, prior to imaging,
incubated with AnCoA4 and DME for 4 h (Figure 3.16, A, supplementary video
16 – 17). Analysis of the time-lapse series showed that MT dynamicity was lower
by 1.66 µm * min-1 in the cells exposed to AnCoA4 (13.31 ± 0.14 µm * min-1) as
compared to the DMSO-treated ones (14.97 ± 0.16 µm * min-1, Figure 3.16, B).
The growth speed in these cells was decreased by 1.15 µm * min-1 compared to the
DMSO-treated cells (16.90 ± 0.13 µm * min-1). Similarly, the growth length was
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Figure 3.16: Blocking ORAI1 conductance in HeLa cells with AnCoA4 decreases
MT dynamics. HeLa cells, transiently expressing EB3-tdTomato, 24 h prior to the imaging were
incubated with 10 µM AnCoA4 or DMSO (equivalent volume), and the last 4h – with 2.5 µM DME.
The MT growth was tracked by taking images every 500 ms for 1 min, and the MT growth was
analysed with MATLAB-based U-Track software (Jaqaman et al., 2008). A, The images represent
maxima intensity projection of time-lapse series of EB3-tdTomato expressing cells with colour-coded
intensity (scale bar, 10 µm). B, Parameters calculated by the software are plotted (50 mitotic cells
per experiment per condition, n = 3 independent synchronisation experiments; unpaired two-tailed
Student’s t-test, median and 25 and 75 percentiles are shown).
shorter in AnCoA4 treated cells (0.54 ± 0.01 µm) than in the control group (0.63 ±
0.01 µm). The lifetime of growing MT tracks was shortened by 0.11 s relative to the
control group (2.21 ± 0.02 s).
In conclusion, we show here that MT behaviour is altered when ORAI1 current
is inhibited. Moreover, this inhibition mimics the behaviour of MTs observed upon
inhibition of Kv10.1 with mAb56 (Figure 3.15). Although the results of Kv10.1
knockdown and overexpression on one hand and inhibition of Kv10.1 and ORAI1
currents, on the other, are opposing each other, some proteins involved in the
regulation of MT dynamics are described to have a dual effect (Cirillo, Gotta, &
Meraldi, 2017; Su et al., 2011). Most likely, the channel as well exerts a dual effect on
the MT behaviour. It causes oscillations in intracellular [Ca2+] through modulation
the ORAI1 activity. At the same time besides the full-length Kv10.1, short splice
variants of Kv10.1 resulting from exon-skipping events (E65 and E70) are present
in human brain and cancer cell lines and can activate CDK1 (Ramos Gomes et
al., 2015), which has been described to negatively regulate the MT growth rate







Prolonged and increased expression of Kv10.1, a voltage-gated potassium channel
initially thought to be restricted to the central nervous system, has been detected
in over 70% of all human tumour tissues. Presence of Kv10.1 in tumours correlates
with poorer prognosis. Kv10.1 is known to be important for cell proliferation and
angiogenesis. Recently, we showed that Kv10.1 is expressed in peripheral tissues,
specifically during the G2/M phase of the cell cycle, and that downregulation of the
channel extends the G2/M phase duration both in tumour and non-tumour cells
(Urrego et al., 2016). Hence, this project aimed to elucidate the mechanisms of
Kv10.1-mediated regulation at the G2/M phase. We studied the activation state of
two checkpoints functioning in G2 and M phases.
4.1 Kv10.1 knockdown results in the partial
activation of DNA damage-induced
checkpoint in the absence of DNA damage
The main checkpoint mechanism throughout the entire cell cycle is the DNA
damage-induced checkpoint. As already described in the “Introduction”, the DNA
damage-induced checkpoint utilises the DDR machinery. Therefore, we analysed the
expression pattern of major proteins of DDR throughout the different phases of the
cell cycle. Interestingly, we found that only the upper part of the pathway, ATR,
CHK1 and CHK2, were activated in Kv10.1-depleted cells (Figure 3.1). Moreover,
direct measurement of the level of DNA damage revealed no differences between the
groups (Figure 3.2). Therefore, we conclude that the partial activation of DDR we
observed should have other origins, rather than unresolved DNA lesions.
Interestingly, some DNA checkpoint proteins, including ATM, ATR, BRCA1,
CHK1 and CHK2 are localised to centrosomes, a location compatible with their
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implication in the SAC (S. Zhang, Hemmerich, & Grosse, 2007). ATM is needed for
kinetochore localisation of MDC1 (Mediator of DNA damage checkpoint protein 1),
and activation of MCC (Eliezer et al., 2014); ATM supports the activation of SAC
also through phosphorylation of MAD1 (Yang et al., 2014).
Proper timing of the mitotic spindle formation has been linked to centrosome-
associated CHK1 by preventing the unscheduled activation of centrosomal CDK1
(Krämer et al., 2004). Moreover, it has been suggested that CHK1 is required
for the optimal regulation of Aurora B (possibly through direct phosphorylation)
and BUBR1 when kinetochores produce a weakened signal (Zachos et al., 2007).
In good agreement with this, haploinsufficiency of CHK1 in mice causes multiple
mitotic defects and enhances binucleation due to the mislocalisation of Aurora
B (Peddibhotla, Lam, Gonzalez-Rimbau, & Rosen, 2009). In U2OS cells, CHK1
depletion results in the failure to activate SAC and decrease of MAD2 and BUBR1
levels after spindle disruption by nocodazole (Carrassa, Sanchez, Erba, & Damia,
2009). These studies suggest that CHK1 enhances the strength of SAC through
direct effects on centrosomes or SAC proteins, such as Aurora B, and indirect effects
through CDKs; CHK1 deficiency leads to mislocalisation of Aurora B, BUBR1 and
MAD1 proteins, resulting in spindle checkpoint failure (Enders, 2008; Patil, Pabla,
& Dong, 2013).
Besides ATM and CHK1, a number of publications have reported the implication
of CHK2 and BRCA1 in the regulation of mitotic events in the unperturbed cell
cycle (Chabalier-Taste, Racca, Dozier, & Larminat, 2008; Ertych, Stolz, Valerius,
Braus, & Bastians, 2016; Golan et al., 2010; Shang et al., 2014; Stolz et al., 2010). It
has also been shown that MPS1 (monopolar spindle 1), a SAC protein that senses
the unattached kinetochores, requires CHK2-mediated phosphorylation at Thr288
for the correct kinetochore localisation (Yeh, Yu, Chen, Cheng, & Shieh, 2014).
In summary, in unperturbed cells, the role of DDR is broader than merely a
mechanism for DNA lesions detection and repair. Therefore, upregulation of CHK2,
CHK1 and ATR when Kv10.1 is downregulated can indicate the activation of SAC.
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4.2 Kv10.1 downregulation enhances the SAC
response and prevents the formation of
lagging chromosomes
As discussed above, the observed increase in the DDR proteins can be due to the
alteration in the strength of SAC response. Indeed, analysis of the expression levels
of SAC proteins in Kv10.1-deficient cells showed upregulation of some of them, such
as MAD2, CDC20 and pVHL (Figure 3.3). MAD2 and CDC20 make up the MCC, a
central effector of SAC (Poon, 2016). MCC sequesters CDC20 and thus prevents the
activation of APC/C and delays the metaphase-to-anaphase transition (Musacchio
& Salmon, 2007). It is important to mention that the SAC response is graded, and it
depends primarily on the amount of MAD2 protein present in a cell (Subramanian
& Kapoor, 2013). Hence, the increase of MAD2 along with CDC20 may induce a
stronger SAC response in Kv10.1-depleted cells.
Another protein described to be involved in SAC is pVHL, mutation of which
leads to von Hippel-Lindau (VHL) syndrome characterised by the presence of benign
and malignant tumours (reviewed in Varshney et al., 2017). pVHL has been shown
to reduce chromosomal instability through an increase of MAD2 levels (Hell et al.,
2014; Thoma et al., 2009). We showed that Kv10.1 downregulation increases the
levels of pVHL (Figure 3.3), thus supporting the idea of stronger SAC response in
these cells.
Aurora B appears to occupy an upstream position in the pathway of recruitment of
SAC components, as its inhibition prevents kinetochore recruitment of all other SAC
components. Although total Aurora B was downregulated in Kv10.1-deficient cells
(Figure 3.3), it is still possible that it is more abundant at the effective localisation,
since Aurora B needs to be relocated at the kinetochores for exerting its CPC-related
functions. MAD2 has been described to be crucial for Aurora B localisation at the
kinetochores (Shandilya et al., 2016). CHK1 mediated phosphorylation of Aurora
B increases its activity at centromeres (Zachos et al., 2007). We showed that both
MAD2 and phosphorylated CHK1 are upregulated in Kv10.1 KD cells (Figure 3.3).
Therefore, MAD2 and CHK1 may facilitate Aurora B localisation and activation at
the kinetochores in these cells. Hence, although we observe a decrease in total Aurora
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B in Kv10.1-deficient cells, we can speculate that the amount of “effective” Aurora
B may be higher in them. However, this hypothesis requires further investigation.
PLK1 is shown to support SAC in several ways. PLK1 phosphorylates MPS1
and enhances its catalytic activity as well as the recruitment of the SAC components
MAD1/C-MAD2 and BUB3/BUBR1 to kinetochores (Ikeda & Tanaka, 2017; von
Schubert et al., 2015). Besides, PLK1 has been described to regulate the formation
of proper kinetochore-MT attachments, generating tension between two sister chro-
matids (Shao et al., 2015). PLK1 colocalises with CLIP-170 at the kinetochores
during early mitosis and ensures the maintenance of the kinetochore-MT stability
(Amin, Itoh, Iemura, Ikeda, & Tanaka, 2014). When PLK1 is inhibited, improper
kinetochore-MT attachments are no longer resolved, resulting in abnormal anaphase
with chromosome bridges (Shao et al., 2015). Even subtle loss in PLK1 activity have
been described to impair chromosome congression (Lera & Burkard, 2012). Overall,
increased PLK1 activity upon Kv10.1 loss (Figure 3.5) can thus contribute to the
strength of SAC by modulating the kinetochore-MT attachments and by facilitating
the recruitment of MCC to kinetochores.
Mechanistically, inactivation of SAC requires the presence of the tension between
the sister chromatids that is achieved by the formation of proper kinetochore-MT
interactions in a process termed “error-correction” (Saurin, 2018). This ensures that
all the chromosomes are correctly attached to the mitotic spindle in a bipolar fashion
(May & Hardwick, 2006). If SAC fails, then lagging chromosomes or chromosome
bridges are observed during anaphase. We showed that the occurrence of such
structures is less frequent in Kv10.1 KD cells, once again supporting the idea of
enhanced SAC in these cells.
In addition to SAC activation, we also investigated the status of APC/C acti-
vation. APC/C requires both binding of CDC20 to its subunit (King et al., 1995;
Matyskiela & Morgan, 2009; Peters, 2006) and hyperphosphorylation for full activa-
tion (S. Zhang et al., 2016). In vitro experiments have demonstrated that the APC/C
complex can be phosphorylated by cyclin B1/CDK1 and PLK1 (Golan, Yudkovsky,
& Hershko, 2002). Interestingly, CDC20 itself is an APC/C substrate (Prinz, Hwang,
Visintin, & Amon, 1998). We show here that upon loss of Kv10.1 CDC27 protein
is downregulated (Figure 3.3), while CDC20 is upregulated. Although, we observe
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high PLK1 activity in Kv10.1-depleted cells, it has been shown that PLK1 is not
required for APC/C activation in vivo (Kraft et al., 2003), but rather the opposite.
PLK1 is capable of preventing APC/C activation. Phosphorylation of CDC20 by
BUB1–PLK1 inhibits APC/C(CDC20) activity in vitro and is required for checkpoint
signalling in human cells (Ikeda & Tanaka, 2017; Jia, Li, & Yu, 2016). Therefore, we
can conclude that APC/C activity is lower in Kv10.1 KD cells.
Nevertheless, the lack of CDC27 can be compensated by upregulation of other
factors. A plausible candidate is WEE1, a kinase responsible for cyclin B1/CDK1
complex inactivation both at the entry into mitosis (Schmidt et al., 2017) and at
the metaphase-to-anaphase transition (Chow et al., 2011). Overexpressing Swe1
(the paralog of WEE1 in budding yeast) results in the arrest of cells with reduced
APC activity in metaphase in vitro and in vivo (Lianga et al., 2013). When we
profiled WEE1 protein expression throughout the cell cycle progression, we observed
upregulation of total WEE1 protein in Kv10.1-deficient cells (Figure 3.3, B). This
upregulation of WEE1 may compensate for the decreased APC/C activity by taking
over the inhibition of cyclin B1/CDK1 complex, thus triggering the metaphase-
to-anaphase transition (reviewed in Schmidt et al., 2017; Visconti et al., 2012).
Alternatively, WEE1 may prevent the premature activation of APC/C and conse-
quently the formation of lagging chromosomes. Slightly broader peaks of CDC20 and
WEE1 at G2/M phase (7 – 12 h after release from thymidine block), as well as our
previous observations (Urrego et al., 2016) speak against the former possibility and
hint to extended and stronger SAC activity and prevention of premature activation
of APC/C.
In summary, we show that downregulation of Kv10.1 increases the protein level
and activity of some of DDR and SAC regulators. This, in turn, results in a stronger
SAC response and delays the metaphase-to-anaphase transition. The latter allows
the cell to have more time for correcting erroneous kinetochore-MT attachments.
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4.3 Kv10.1-deficient cells display tilted mitotic
spindle orientation
Interestingly, both PLK1 and pVHL are involved in the positioning of the mitotic
spindle. The positioning of the mitotic spindle defines the angle of cell division,
which is critical for cell differentiation, tissue organisation and morphology and
EMT (epithelial-to-mesenchymal transition; Bergstralh & St Johnston, 2014; Pease
& Tirnauer, 2011). pVHL promotes proper spindle orientation through stabilisation
of astral MTs via interaction with kinesin-2 (Hell et al., 2014; Hergovich et al., 2002;
Lolkema et al., 2007, 2004; Thoma et al., 2009). PLK1 promotes astral MT nucleation
(Hanafusa et al., 2015; Miyamoto et al., 2017) and regulates the enrichment of cell
cortex with dynein (Kiyomitsu & Cheeseman, 2012; Sana et al., 2018), stabilising the
spindle orientation. Since we observed an increase in both pVHL and PLK1 activity in
Kv10.1-downregulated cells, a logical question was whether the lack of Kv10.1 affects
the orientation of the mitotic spindle. Indeed, measurement of the mitotic spindle
angle revealed larger values for Kv10.1-depleted cells (Figure 3.6). Interestingly, it is
known that single HeLa cells with greater tilting of the mitotic spindle require more
time for biorientation of sister kinetochores, which possibly results in the activation
of SAC, while disruption of the spindle checkpoint activation does not correlate with
the shape-dependent differences in spindle orientation (Charnley et al., 2013).
It is intriguing to find out whether Kv10.1 participates in positioning the mitotic
spindle within tissue and so can influence the fate of the newly formed daughter
cells. In particular, this is of great interest in the context of EMT, which is known
to underlie metastasis (Aiello et al., 2018; Heerboth et al., 2015; Li & Balazsi,
2018; Mittal, 2018; Reichert et al., 2018). Nevertheless, we can conclude that most
probably the changes in the MT behaviour, which led to an alteration in mitotic
spindle positioning, may be the cause for the observed increase in PLK1 and pVHL
activities, and subsequently extended SAC.
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4.4 Microtubule dynamics increase when Kv10.1
is downregulated
Both SAC and spindle orientation are highly dependent on MT dynamics and can
influence or be influenced by them (Kotak, 2019; Saurin, 2018; H.-Y. Wu et al., 2017).
Therefore, we questioned whether the phenotypic and biochemical changes observed
in Kv10.1-depleted cells could be attributed to the alterations in MT dynamics.
Preliminary assessment of the MT plus-end assembly rates using the DME assay
(Stolz, Ertych, & Bastians, 2015) showed that, as expected, the MT growth was
affected upon loss of Kv10.1. Interestingly, the same approach has recently been
proposed as a screening assay for determining mitotic spindle orientation changes
(Glaubke & Bastians, 2018). The authors observed a high correlation between cells
harbouring defects in spindle orientation and the formation of asymmetric monopolar
mitotic spindles. Thus, the increased number of asymmetric spindles observed in
Kv10.1 KD cells in prometaphase (Figure 3.7) correlates also with the directly
measured increased spindle angle in metaphase (Figure 3.6). These results were
further confirmed by the assessment of MT dynamics in the live HeLa and hTERT
RPE1 cells. Downregulation of Kv10.1 increased MT dynamics (Figure 3.8), whereas
upregulation had an opposite effect (Figure 3.9), strongly suggesting that the effect
is specific for Kv10.1.
Besides PLK1, whose role in assuring the needed stability of kinetochore-MT
attachments we have already discussed, CHK2 also regulates MT dynamics. The
CHK2-BRCA1 axis restrains oncogenic Aurora A activity during mitosis (Ertych
et al., 2016). Downregulation of CHK2 or overexpression of Aurora A increases the
assembly rate of MT plus-end (Ertych et al., 2014). In general, Aurora A promotes
MT polymerisation and maintains MT flux ensuring proper bipolar spindle assembly
(L.-h. Wang et al., 2008). Aurora A inhibition decreases MT shrinkage, growth rate,
frequency rescue and nucleation (Lorenzo, Liao, Hardwicke, & Ducommun, 2009).
We show a strong upregulation of global CHK2, but not of phospho-Thr68 CHK2,
needed for activation of BRCA1, in Kv10.1-deficient cells (Figure 3.1). However,
since we have not checked for the corresponding phosphorylation of BRCA1, it is




Although we could not directly document changes in Aurora A protein expression,
it is tempting to speculate that Aurora A activity is also altered in Kv10.1-depleted
cells. There are several reasons for us to think so. Aurora A activation at the
centrosomes is mediated by cyclin A2/CDK1-Bora axis, which also activates PLK1
(Asteriti, De Mattia, & Guarguaglini, 2015; Mac̊urek et al., 2008; Macurek, Lindqvist,
& Medema, 2009; Parrilla et al., 2016; Thomas et al., 2016; Van Horn et al., 2010;
Vigneron et al., 2018). Previously, we have reported an accumulation of cyclin A2
in Kv10.1-deficient cells (Urrego et al., 2016). Interestingly, one of the splice forms
of Kv10.1, E65, found in human brain and cancer cell lines, activates CDK1 when
injected into Xenopus oocytes (Ramos Gomes et al., 2015). Silencing of Kv10.1
will result in a reduction of both full length and the spliced forms of the channel,
thus preventing E65-mediated CDK1 activation, and therefore reducing activation of
Aurora A. On the other hand, here we reported an increase in PLK1. An intensive
interplay between Aurora A and PLK1 exists, which can contribute to Aurora A
activation at distinct subcellular sites (Asteriti et al., 2015). Nevertheless, this
all together indicates that Aurora A activation at G2/M phase may be altered in
Kv10.1-deficient cells, but this remains to be unequivocally documented.
Overall, the net activity of PLK1, Aurora B, pVHL, CHK2 and Aurora A
contribute to the increased MT dynamicity in Kv10.1 KD cells. However, it is still
unclear how the manipulation of a single channel can have such global effects.
4.5 Kv10.1 and ORAI1 team up: downregulation
of Kv10.1 reduces the cytosolic calcium
concentration and oscillations
In search of a global messenger which may be generated by Kv10.1, we looked
at the question from another perspective. Until now, we had neglected the canonic
function of the channel – a pathway for the flow of K+ ions. Changing the ionic
composition in a given cell compartment at a given time point can be the missing
piece of the puzzle. Since the net activity of different proteins discussed before leads
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to specific MT behaviour, we decided to use it as a screening tool for finding the
potential effector messenger. Different ions influence the polymerisation of MTs both
in vitro and in vivo (reviewed in 2016; 2016). K+ promotes tubulin polymerisation in
vitro, although the presence of MAPs diminishes the ion selectivity for the reaction
(Wolff, Sackett, & Knipling, 1996).
In terms of MT growth regulation, Ca2+ ions are of particular interest. MTs
switch from growth phase to shrinkage when exposed to a high concentration of
Ca2+ (Nishida et al., 1979; Sandoval & Weber, 1978). Moreover, CaM has also been
described to influence the growth rate of MTs (Erneux et al., 1984; Y. C. Lee &
Wolff, 1982). However, most importantly, it has recently been suggested that Kv10.1
colocalises with ORAI1 in immunofluorescence images, and that silencing of Kv10.1
and ORAI1 reduces Ca2+ influx without an additive effect, indicating a functional
coupling between the channels (Badaoui et al., 2018).
Here, we tested the hypothesis of generating Ca2+ as the messenger by the cou-
pled function of Kv10.1 and ORAI1, which could be responsible for the described
phenotype. Indeed, using PLA, we directly showed the proximity of Kv10.1 and
ORAI1, which may also imply the existence of a functional interaction between the
two channels. Progression through different phases of the cell cycle appears to be
regulated by transient changes in cytosolic [Ca2+] (Kahl & Means, 2003; Roderick &
Cook, 2008), in particular, during metaphase-to-anaphase transition (Kao, Alderton,
Tsien, & Steinhardt, 1990; Poenie, Alderton, Steinhardt, & Tsien, 1986; Ratan, Max-
field, & Shelanski, 1988; Tombes & Borisy, 1989; Whitaker & Larman, 2001). For
example, injection of micromolar concentrations of Ca2+ accelerates the transition
(Izant, 1983), whereas restriction of calcium flux from the extracellular compartment
prolongs metaphase (Hepler, 1985). It is generally accepted that K+ channels are
important for Ca2+ influx. The hyperpolarisation generated by the activation of K+
channels increases the driving force for Ca2+ influx (Ouadid-Ahidouch & Ahidouch,
2013). We tested this model for Kv10.1 and ORAI1 by silencing Kv10.1. If the
activity of Kv10.1 is required for Ca2+ influx (not necessarily through ORAI1),
then silencing it will reduce the cytosolic [Ca2+]. Indeed, downregulation of Kv10.1
decreased the total cytosolic [Ca2+] in hTERT RPE1 cells after stimulation with
FCS, and this decrease can explain the extended G2/M in Kv10.1-depleted cells
109
Discussion
(Urrego et al., 2016).
Mechanistically, changes in cytosolic [Ca2+] can influence the metaphase-to-
anaphase transition in several ways. Earlier in the discussion, we suggested that
APC/C might be less active in Kv10.1 KD cells, based on immunoblot analysis.
Interestingly, the activation of APC/C is blocked by Ca2+ chelators (Xu, Luo, &
Chang, 2003). Therefore, when downregulating the channel, the cytosolic [Ca2+]
is also reduced and so is APC/C activity. Depletion of Ca2+ during mitosis also
reduces kinetochore-MT stability due to the elimination of CENP-F from the kineto-
chore (Phengchat et al., 2016), which in the case of Kv10.1-depleted cells might be
compensated by higher PLK1 activity. Ca2+/CaM has been shown to interact with
and transiently activate Aurora A (Plotnikova, Pugacheva, Dunbrack, & Golemis,
2010) both during mitosis and ciliary disassembly (Plotnikova et al., 2012). CaM
also interacts and activates PLK1 in a calcium-dependent fashion during the G2/M
transition (Dai et al., 2013). Since we show a decrease in total cytosolic [Ca2+] in
Kv10.1 depleted cells, decreased PLK1 activity could have been expected. However,
we observe the opposite, meaning that possibly Kv10.1 KD leads to alternative ways
of PLK1 activation (Asteriti et al., 2015; Lindqvist et al., 2009). Nevertheless, this
further supports our suggested model. The phenotype of Kv10.1 KD cells, which
consists of extended G2/M, stronger SAC, fewer lagging chromosomes and altered
MT behaviour, can be adequately explained as the result of calcium transient changes,
possibly generated by a teamwork of Kv10.1 and ORAI1.
Mounting evidence indicates that Ca2+ signals are often presented to cells in the
form of Ca2+ oscillations, with signalling information encoded in both amplitude
and frequency of the Ca2+ spikes (Parekh, 2011; Samanta & Parekh, 2017). Different
molecules have been described as calcium oscillation decoders. These decoders have
defined affinity for Ca2+ binding, meaning that depending on the amplitude and the
frequency of the signal only some of them will bind Ca2+, become activated and
initiate a signalling pathway (reviewed in Smedler & Uhlén, 2014). For example,
activation of CaMKII is dependent on the frequency of cytosolic Ca2+ oscillations
(Smedler & Uhlén, 2014). Although our experimental set-up in terms of image acqui-
sition rate was not optimal for exact determination of the frequency of oscillations, we
were still capable of distinguishing that knockdown of Kv10.1 reduces the frequency
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and the amplitude of calcium oscillations in hTERT RPE1 cells when stimulated
with FCS. It is appealing to think that Aurora A and PLK1 might react to the
oscillations as well since both are activated by binding to calcium/CaM and serve as
another example of signal decoders. This might also indicate a potential differential
activation of any other given target sensitive to cytosolic calcium oscillations.
Overall, modulation of cytosolic [Ca2+] in a functional complex with ORAI1
might be the missing piece of our puzzle that explains the extended duration of the
G2/M phase with activated SAC and altered MT dynamics.
4.6 Inhibition of the conductance of either
Kv10.1 or ORAI1 reduces MT dynamics
Changes in MT dynamics due to the oscillations in cytosolic [Ca2+] is expected.
As mentioned before the tubulin polymerisation is inhibited in the presence of Ca2+
in vitro. However, the protein make-up of MT ends defines the net action of Ca2+.
Interestingly, in the presence of both MAPs and Ca2+, MTs are longer and more
curved in vitro, which is explained by the possibility of Ca2+ binding to several
different classes of binding sites in the MT–MAPs system (V. Buljan et al., 2009).
Moreover, using fluorescently-labelled tubulin, it has been demonstrated that the
mitotic spindle structure in most of the Ca2+ chelator-treated cells gradually deforms
with time (Xu et al., 2003).
In order to determine whether the effects of Kv10.1 downregulation on MT
dynamics are explicitly due to its conductance, experiments involving specific blockers
of the channel were performed. The antihistamine drug astemizole efficiently blocks
Kv10.1 current (Garćıa-Ferreiro et al., 2004a). Contrary to our expectations, blocking
the channel conductance with astemizole did not show any effect when compared
to DMSO treated cells. At the same time, its isomer norastemizole, which retains
antihistamine activity but has no channel inhibitory activity (Garćıa-Ferreiro et al.,
2004b), showed increased MT dynamics. However, both compounds are implicated
in the regulation of cytosolic calcium (Fischer et al., 1997), making the interpretation
of the observed results ambiguous. Nevertheless, comparing norastemizole and
astemizole conditions only and considering the specificity of the drugs for Kv10.1
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inhibition is the only difference between the two, we can conclude that possibly
Kv10.1 current inhibition decreases MT dynamicity (Figure 3.14). To discard the
possible effects of the drugs unrelated to their action on Kv10.1, we used a blocking
monoclonal antibody (mAb56) directed against the pore loop of Kv10.1 (Gomez-
Varela et al., 2007). Like in the case of norastemizole/astemizole inhibition of Kv10.1
currents with mAb56 resulted in decreased MT dynamics (Figure 3.15). Moreover,
inhibition of ORAI1 mimicked the effect of mAb56 on the MT dynamics: decrease
in growth rate, growth length and dynamicity (Figure 3.16).
On a first look, it may seem that these results are contradictory with our initial
observation that silencing of Kv10.1 increases MT dynamics. However, as already
mentioned, Kv10.1 is characterised by large cytosolic domains and localises to the
centrosomes, as the vast majority of the cell cycle regulators. This creates a unique
opportunity for Kv10.1 to interact or may even serve as a scaffold for the initiation of
a signalling cascade. An attractive option will be interaction with PLK1 or Aurora
A. Additionally, one of the splice forms of Kv10.1 (E65) triggers CDK1 activation
(Ramos Gomes et al., 2015). Therefore, our data point to a dual effect of Kv10.1
on MT dynamics: on one hand, through a mechanism unrelated to permeation, it
promotes the dynamicity of MTs, while on the other hand, its function as a channel
promotes stability. Therefore, when inhibiting the conductance of the channel, we





We show here that downregulation of Kv10.1 modulates the behaviour of MT
during mitosis, leading to activation of SAC and delay in metaphase-to-anaphase
transition. The extended metaphase and enhanced SAC prevent the formation of
lagging chromosomes, commonly observed in cancer cells.
The described phenotype is achieved partially by functionally interacting with
ORAI1 and changing the cytosolic Ca2+ behaviour, both in terms of global concen-
tration and in the properties of calcium oscillations. As a result, downstream targets
such as Aurora A, PLK1 and MT dynamics are altered, and SAC is activated. Kv10.1
also influences MT dynamics independently of its conductance, suggesting that it
possesses a dual effect: On one side, predominantly through its canonical function as
an ion channel, it promotes the dynamicity of MTs; on the other hand, probably
through its intracellular domains and splice variants, it promotes MT stability. By
inhibiting the conductive function of the channel, we were capable of dissecting these
opposing effects.
Future experiments should focus on better understanding the functional interac-
tion between Kv10.1 and ORAI1 and the function of the complex in the regulation
of calcium oscillations, and on the identification of the decoders of the signal, likely
Aurora A or PLK1. As a priority for future experiments, we should mention the
study of calcium dynamics upon inhibition of Kv10.1 using a mAb56 monoclonal
antibody, that should be studied with higher temporal resolution. An already known
mutant form of the channel whose conductance has been abolished, together with
the short splice variants should also help to dissect the dual effect that Kv10.1 exerts
on MTs.
In general, understanding of how Kv10.1 modulates the MT architecture within a
tissue, especially when positioning the mitotic spindle, will help to find out whether
Kv10.1 is also essential for cell differentiation or EMT and, globally, how a cancer
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Brüggemann, A., Stühmer, W., & Pardo, L. A. (1997, jan). Mitosis-promoting
factor-mediated suppression of a cloned delayed rectifier potassium channel
expressed in Xenopus oocytes. Proc. Natl. Acad. Sci. U. S. A., 94 (2), 537–42.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9012819
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Stühmer, W. (1999, oct). Oncogenic potential of EAG K+ channels. EMBO J.,
18 (20), 5540–5547. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
10523298 doi: 10.1093/emboj/18.20.5540
Pardo, L. A., & Stühmer, W. (2013, dec). The roles of K+ channels in cancer.
Nat. Rev. Cancer , 14 (1), 39–48. Retrieved from http://www.nature.com/
doifinder/10.1038/nrc3635 doi: 10.1038/nrc3635
Parekh, A. B. (2011, feb). Decoding cytosolic Ca2+ oscillations. Trends Biochem.
Sci., 36 (2), 78–87. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
20810284 doi: 10.1016/j.tibs.2010.07.013
Parrilla, A., Cirillo, L., Thomas, Y., Gotta, M., Pintard, L., & Santamaria, A.
(2016, dec). Mitotic entry: The interplay between Cdk1, Plk1 and Bora.
Cell Cycle, 15 (23), 3177–3182. Retrieved from https://doi.org/10.1080/
15384101.2016.1249544 doi: 10.1080/15384101.2016.1249544
Patil, M., Pabla, N., & Dong, Z. (2013, nov). Checkpoint kinase 1 in DNA
damage response and cell cycle regulation. Cell. Mol. Life Sci., 70 (21), 4009–
21. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23508805 doi:
10.1007/s00018-013-1307-3
Pease, J. C., & Tirnauer, J. S. (2011, apr). Mitotic spindle misorientation in
cancer – out of alignment and into the fire. J. Cell Sci., 124 (7), 1007 LP
– 1016. Retrieved from http://jcs.biologists.org/content/124/7/1007
.abstract doi: 10.1242/jcs.081406
Peddibhotla, S., Lam, M. H., Gonzalez-Rimbau, M., & Rosen, J. M. (2009,
mar). The DNA-damage effector checkpoint kinase 1 is essential for chro-
149
REFERENCES
mosome segregation and cytokinesis. Proc. Natl. Acad. Sci., 106 (13), 5159–
5164. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19289837 doi:
10.1073/pnas.0806671106
Perry, J. A., & Kornbluth, S. (2007, may). Cdc25 and Wee1: analogous opposites?
Cell Div., 2 , 12. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/
17480229 doi: 10.1186/1747-1028-2-12
Peters, J.-M. (2006, aug). The anaphase promoting complex/cyclosome: a machine
designed to destroy. Nat. Rev. Mol. Cell Biol., 7 , 644. Retrieved from
https://doi.org/10.1038/nrm1988
Phengchat, R., Takata, H., Morii, K., Inada, N., Murakoshi, H., Uchiyama, S., &
Fukui, K. (2016, dec). Calcium ions function as a booster of chromosome
condensation. Sci. Rep., 6 (1), 38281. Retrieved from http://www.nature.com/
articles/srep38281 doi: 10.1038/srep38281
Phua, S. C., Chiba, S., Suzuki, M., Su, E., Roberson, E. C., Pusapati, G. V.,
. . . Inoue, T. (2017, jan). Dynamic Remodeling of Membrane Composition
Drives Cell Cycle through Primary Cilia Excision. Cell , 168 (1-2), 264–279.e15.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28086093 doi: 10
.1016/j.cell.2016.12.032
Plotnikova, O. V., Nikonova, A. S., Loskutov, Y. V., Kozyulina, P. Y., Pugacheva,
E. N., & Golemis, E. A. (2012, jul). Calmodulin activation of Aurora-A kinase
(AURKA) is required during ciliary disassembly and in mitosis. Mol. Biol. Cell ,
23 (14), 2658–70. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
22621899 doi: 10.1091/mbc.E11-12-1056
Plotnikova, O. V., Pugacheva, E. N., Dunbrack, R. L., & Golemis, E. A. (2010, sep).
Rapid calcium-dependent activation of Aurora-A kinase. Nat. Commun., 1 (6), 1–
8. Retrieved from http://www.nature.com/doifinder/10.1038/ncomms1061
doi: 10.1038/ncomms1061
Plotnikova, O. V., Pugacheva, E. N., & Golemis, E. A. (2009). Primary cilia and the
cell cycle. Methods Cell Biol., 94 , 137–60. Retrieved from http://www.ncbi
.nlm.nih.gov/pubmed/20362089 doi: 10.1016/S0091-679X(08)94007-3
Poenie, M., Alderton, J., Steinhardt, R., & Tsien, R. (1986, aug). Calcium rises
abruptly and briefly throughout the cell at the onset of anaphase. Science,
150
REFERENCES
233 (4766), 886–9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
3755550
Poon, R. Y. C. (2016). Cell Cycle Control: A System of Interlinking Oscillators. In
Methods mol. biol. (Vol. 1342, pp. 3–19). Retrieved from http://www.ncbi
.nlm.nih.gov/pubmed/26254915 doi: 10.1007/978-1-4939-2957-3 1
Prinz, S., Hwang, E. S., Visintin, R., & Amon, A. (1998, jun). The regulation
of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27
during S phase and early mitosis. Curr. Biol., 8 (13), 750–60. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/9651679
Pugacheva, E. N., Jablonski, S. A., Hartman, T. R., Henske, E. P., & Golemis,
E. A. (2007, jun). HEF1-Dependent Aurora A Activation Induces Disas-
sembly of the Primary Cilium. Cell , 129 (7), 1351–1363. Retrieved from
http://ac.els-cdn.com/S0092867407005466/1-s2.0-S0092867407005466
-main.pdf?{ }tid=8b10bda2-7870-11e7-bff7-00000aab0f6c{&}acdnat=
1501781222{ }bd21ee15a07fd7df966137c8ca2d0e52 doi: 10.1016/
j.cell.2007.04.035
Qin, T., Li, J., Yuan, M., & Mao, T. (2012, jul). Characterization of the role of
calcium in regulating the microtubule-destabilizing activity of MDP25. Plant
Signal. Behav., 7 (7), 708–10. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/22751329 doi: 10.4161/psb.20336
Ramos Gomes, F., Romaniello, V., Sánchez, A., Weber, C., Narayanan, P., Psol, M.,
& Pardo, L. A. (2015, dec). Alternatively Spliced Isoforms of KV10.1 Potassium
Channels Modulate Channel Properties and Can Activate Cyclin-dependent
Kinase in Xenopus Oocytes. J. Biol. Chem., 290 (51), 30351–65. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/26518875 doi: 10.1074/jbc.M115
.668749
Ratan, R. R., Maxfield, F. R., & Shelanski, M. L. (1988, sep). Long-lasting and
rapid calcium changes during mitosis. J. Cell Biol., 107 (3), 993–9. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/3417787
Reed, S. I. (1997). Control of the G1/S transition. Cancer Surv., 29 , 7–23. Retrieved
from http://www.ncbi.nlm.nih.gov/pubmed/9338094
Reed, S. I. (2006). The ubiquitin-proteasome pathway in cell cycle control. Results
151
REFERENCES
Probl. Cell Differ., 42 , 147–81. Retrieved from http://www.ncbi.nlm.nih
.gov/pubmed/16903211
Reichert, M., Bakir, B., Moreira, L., Pitarresi, J. R., Feldmann, K., Simon, L.,
. . . Rustgi, A. K. (2018, jun). Regulation of Epithelial Plasticity Deter-
mines Metastatic Organotropism in Pancreatic Cancer. Dev. Cell , 45 (6), 696–
711.e8. Retrieved from https://www.sciencedirect.com/science/article/
pii/S1534580718304180 doi: 10.1016/J.DEVCEL.2018.05.025
Reiter, J. F., & Leroux, M. R. (2017, jul). Genes and molecular pathways underpin-
ning ciliopathies. Nat. Rev. Mol. Cell Biol., 18 (9), 533–547. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/28698599 doi: 10.1038/nrm.2017
.60
Renwick, A. G. (1999, jul). The metabolism of antihistamines and drug interactions:
the role of cytochrome P450 enzymes. Clin. Exp. Allergy , 29 Suppl 3 , 116–24.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10444225
Rettig, J., Heinemann, S. H., Wunder, F., Lorra, C., Parcej, D. N., Dolly, J. O., &
Pongs, O. (1994, may). Inactivation properties of voltage-gated K+ channels
altered by presence of beta-subunit. Nature, 369 (6478), 289–94. Retrieved
from http://www.nature.com/articles/369289a0 doi: 10.1038/369289a0
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., . . . Goldberg,
A. L. (1994, sep). Inhibitors of the proteasome block the degradation of most
cell proteins and the generation of peptides presented on MHC class I molecules.
Cell , 78 (5), 761–71. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
8087844
Roderick, H. L., & Cook, S. J. (2008, may). Ca2+ signalling checkpoints in
cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat.
Rev. Cancer , 8 (5), 361–375. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/18432251 doi: 10.1038/nrc2374
Ronca, R., Benkheil, M., Mitola, S., Struyf, S., & Liekens, S. (2017, nov). Tumor
angiogenesis revisited: Regulators and clinical implications. Med. Res. Rev.,
37 (6), 1231–1274. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
28643862 doi: 10.1002/med.21452
Roshak, A. K., Capper, E. A., Imburgia, C., Fornwald, J., Scott, G., & Marshall, L. A.
152
REFERENCES
(2000). The human polo-like kinase, PLK, regulates cdc2/cyclin B through
phosphorylation and activation of the cdc25C phosphatase. Cell. Signal., 12 (6),
405–411.
Rueden, C. T., Schindelin, J., Hiner, M. C., DeZonia, B. E., Walter, A. E., Arena,
E. T., & Eliceiri, K. W. (2017, dec). ImageJ2: ImageJ for the next generation of
scientific image data. BMC Bioinformatics , 18 (1), 529. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/29187165 doi: 10.1186/s12859-017-1934-z
Russa, A. D., Ishikita, N., Masu, K., Akutsu, H., Saino, T., & Satoh, Y.-i. (2008, dec).
Microtubule remodeling mediates the inhibition of store-operated calcium entry
(SOCE) during mitosis in COS-7 cells. Arch. Histol. Cytol., 71 (4), 249–63.
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19359807
Sadaghiani, A. M., Lee, S. M., Odegaard, J. I., Leveson-Gower, D. B., McPherson,
O. M., Novick, P., . . . Park, C. Y. (2014, oct). Identification of Orai1 Channel
Inhibitors by Using Minimal Functional Domains to Screen Small Molecule
Microarrays. Chem. Biol., 21 (10), 1278–1292. Retrieved from http://www
.ncbi.nlm.nih.gov/pubmed/25308275 doi: 10.1016/j.chembiol.2014.08.016
Safinya, C. R., Chung, P. J., Song, C., Li, Y., Ewert, K. K., & Choi, M. C. (2016, jun).
The effect of multivalent cations and Tau on paclitaxel-stabilized microtubule
assembly, disassembly, and structure. Adv. Colloid Interface Sci., 232 , 9–
16. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26684364 doi:
10.1016/j.cis.2015.11.002
Samanta, K., & Parekh, A. B. (2017, may). Spatial Ca2+ profiling: decrypting the
universal cytosolic Ca2+ oscillation. J. Physiol., 595 (10), 3053–3062. Retrieved
from http://doi.wiley.com/10.1113/JP272860 doi: 10.1113/JP272860
Sana, S., Keshri, R., Rajeevan, A., Kapoor, S., & Kotak, S. (2018, dec). Plk1 regulates
spindle orientation by phosphorylating NuMA in human cells. Life Sci. Alliance,
1 (6), e201800223. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
30456393 doi: 10.26508/lsa.201800223
Sánchez, A., Urrego, D., & Pardo, L. A. (2016a, may). Cyclic expression of the voltage-
gated potassium channel K <sub>V</sub> 10.1 promotes disassembly of the





Sánchez, A., Urrego, D., & Pardo, L. A. (2016b). Cyclic expression of the voltage-
gated potassium channel KV10.1 promotes disassembly of the primary cilium.
EMBO Rep., 17 (5), 708–23. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/27113750 doi: 10.15252/embr.201541082
Sánchez, I., & Dynlacht, B. D. (2016, jun). Cilium assembly and disassembly. Nat.
Cell Biol., 18 , 711. Retrieved from https://doi.org/10.1038/ncb3370
Sandoval, I. V., & Weber, K. (1978). Calcium-Induced Inactivation of Microtubule
Formation in Brain Extracts Presence of a Calcium-Dependent Protease Act-
ing on Polymerization-Stimulating Microtubule-Associated Proteins. Eur. J.
Biochem, 92 , 463–470. Retrieved from https://onlinelibrary.wiley.com/
doi/pdf/10.1111/j.1432-1033.1978.tb12768.x
Santella, L. (1998, mar). The Role of Calcium in the Cell Cycle: Facts and Hypotheses.
Biochem. Biophys. Res. Commun., 244 (2), 317–324. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/9514855 doi: 10.1006/bbrc.1998.8086
Sataric, M. V., Sekulic, D. L., Sataric, B. M., & Zdravkovic, S. (2015, nov).
Role of nonlinear localized Ca 2+ pulses along microtubules in tuning the
mechano–sensitivity of hair cells. Prog. Biophys. Mol. Biol., 119 (2), 162–
174. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26208473 doi:
10.1016/j.pbiomolbio.2015.07.009
Saurin, A. T. (2018). Kinase and Phosphatase Cross-Talk at the Kinetochore.
Front. cell Dev. Biol., 6 , 62. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/29971233 doi: 10.3389/fcell.2018.00062
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M.
(1990, dec). The E6 oncoprotein encoded by human papillomavirus types 16
and 18 promotes the degradation of p53. Cell , 63 (6), 1129–36. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/2175676
Schlaitz, A.-L. (2014, jul). Microtubules as key coordinators of nuclear envelope
and endoplasmic reticulum dynamics during mitosis. Bioessays, 36 (7), 665–
71. Retrieved from http://doi.wiley.com/10.1002/bies.201400022 doi:
10.1002/bies.201400022
Schmidt, M., Rohe, A., Platzer, C., Najjar, A., Erdmann, F., & Sippl, W. (2017, nov).
154
REFERENCES
Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases.
Molecules, 22 (12), 2045. Retrieved from http://www.ncbi.nlm.nih.gov/
pubmed/29168755 doi: 10.3390/molecules22122045
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012, jul). NIH Image to
ImageJ: 25 years of image analysis. Nat. Methods , 9 (7), 671–5. Retrieved from
http://www.ncbi.nlm.nih.gov/pubmed/22930834
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R code for calcium data processing






df0 <- read.xlsx("File.xlsx", sheet=X)[1:9386,]
#df0 <- df0[1:9386,]
#f0$RoiID <- factor(df0$RoiID)







library(reshape2) data sum <- dcast(df1, FieldID + AcqTime RoiID,
value.var="SumIntensity", fun.aggregate = mean)
data area <- dcast(df1, FieldID + AcqTime RoiID, value.var="ROIArea",
fun.aggregate = mean)
colnames(data sum) <- c("Time ID", "Time, sec", "Sum Intensity 1", "Sum
Intensity 2", "Sum Intensity 3", "Sum Intensity 4", "Sum Intensity 5",
"Sum Intensity 6", "Sum Intensity 7", "Sum Intensity 8", "Sum Intensity 9",
"Sum Intensity 10", "Background Mean Intensity 11 ", "Background Mean
Intensity 12", "Background Mean Intensity 13")
colnames(data area) <- c("Time ID", "Time, sec", "ROI Area 1", "ROI Area
2", "ROI Area 3", "ROI Area 4", "ROI Area 5", "ROI Area 6", "ROI Area 7",
"ROI Area 8", "ROI Area 9", "ROI Area 10", "Background Mean Intensity 11",
"Background Mean Intensity 12", "Background Mean Intensity 13") df <-
cbind(data sum, data area[,-c(1, 2, 13, 14, 15)])
df <- df[, c(1, 2, 3, 16, 4, 17, 5, 18, 6, 19, 7, 20, 8, 21, 9, 22, 10,
23, 11, 24, 12, 25)]
### Sum of Sum Intensity & Sum of ROI Area:
df1 <- df
df1$"Sum of Sum Intensity" <- rowSums(df[,c(3, 5, 7, 9, 11, 13, 15, 17,
19, 21)])
df1$"Sum of ROI Area" <- rowSums(df[,c(4, 6, 8, 10, 12, 14, 16, 18, 20,
22)])
### Mean Intensities for Background ROIs:
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x <- df0[df0$RoiID==11,]
x <- x[,c(3, 4, 21, 11)]
y <- df0[df0$RoiID==12,]
y <- y[,c(3, 4, 21, 11)]
z <- df0[df0$RoiID==13,]
z <- z[,c(3, 4, 21, 11)]
df1 <- cbind(df1, setNames(data.frame(x[,4]), c("Mean Intensity 11")),
setNames(data.frame(y[, 4]), c("Mean Intensity 12")),
setNames(data.frame(z[, 4]), c("Mean Intensity 13")))
df1$"Avg Mean Int" <- rowMeans(df1[, 25:27])
df1$‘Avg Mean Int‘ <- round(df1$‘Avg Mean Int‘, 2)
### CTCF for each Sum Intensity for each ROI Area: Sum Intensity[i] - ROI
Area[i] * Avg Mean INT
df1$CTCF ALL <- df1[,23] - df1[,24] * df1[,28]
df1$CTCF1 <- df1[,3] - df1[,4] * df1[,28]
df1$CTCF2 <- df1[,5] - df1[,6] * df1[,28]
df1$CTCF3 <- df1[,7] - df1[,8] * df1[,28]
df1$CTCF4 <- df1[,9] - df1[,10] * df1[,28]
df1$CTCF5 <- df1[,11] - df1[,12] *df1[,28]
df1$CTCF6 <- df1[,13] - df1[,14] * df1[,28]
df1$CTCF7 <- df1[,15] - df1[,16] * df1[,28]
df1$CTCF8 <- df1[,17] - df1[,18] * df1[,28]
df1$CTCF9 <- df1[,19] - df1[,20] * df1[,28]
df1$CTCF10 <- df1[,21] - df1[,22] * df1[,28]
#-------------------------------------------------------------------------------
# save final file: library(xlsx) write.xlsx2(df1,
"File R.xlsx",sheetName="X",append=TRUE, row.names=FALSE, col.names=TRUE)
detach("package:xlsx") rm(list = ls())
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%% loading of the file and assigning x and y values
data = load (’file.txt’);
t = data(:,1);
all01 = data(:,2);






axis([0 7300 -inf inf]);
xticks(0:600:7300);
title (’Relative Changes of Ca signal’);
xlabel(’time, sec’);
ylabel (’Relative CTCF’);





trend01 = polyfit(ttrend, nofcs01,degree);
%% plotting the trendline
trendline01 = polyval(trend01, t);
plot (t,trendline01,’k’);
%% subtracting the trendline
All01 = all01 - polyval(trend01,t);







axis([0 7300 -inf inf]);
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xticks(0:600:7300);
grid on;
set(gcf, ’Position’, get(0, ’Screensize’));
%% smoothing the signal, finding, plotting all peaks, calculating the








title (’Relative Changes of Ca signal,normalised’);
xlabel(’time, sec’);
ylabel (’Relative CTCF’);
axis([0 7300 -inf inf]);
xticks(0:600:7300);
grid on;
set(gcf, ’Position’, get(0, ’Screensize’));




%% making a table of the peaks with corresponding time values
table01 = horzcat(t(locs01), pks01,widths01,proms01);
%% number of the peaks




%% Computing the two-sided spectrum P2 and then the single-sided spectrum
P1 based on P2 and the even valued signal length L.
P2 01 = abs(G01/N);
P1 01 = P2 01(1:N/2+1);
P1 01(2:end-1) = 2*P1 01(2:end-1);
%% Define the frequency domain f spectrum P1.
dt = 10; % Sampling period: 1 sampled every 10 s
Fs = 1/dt; % Sampling frequency
f = Fs*(0:(N/2))/N;
%% Finding the peaks and locs, calculating the AUCs and plotting the
174
MATLAB code for calcium oscillations analysis




AUCP1 01=trapz(P1 01); %#ok<*NASGU>




plot(f,P1 01,’k’,f(locsP1 01),pksP1 01,’or’);





set(gcf, ’Position’, get(0, ’Screensize’));
figure(3)
hold on





h.FaceColor = [0 0.5 0.5];
h.EdgeColor = ’w’;
grid on
title(’Frequency of Single-Sided Amplitudes’)
xlabel(’bins’)
ylabel(’counts’)




%% making a table of the peaks with corresponding time values
tableP1 01 = horzcat(f(locsP1 01).’,
pksP1 01.’,widthsP1 01.’,promsP1 01.’);
%% making a table of the counts and centers
centersandbinsP1 01=horzcat(countsP1 01.’, centersP1 01.’);
%% number of the peaks
allpeaksP1 01 = size (tableP1 01,1);
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%% write all the tables
%% clearing the workspace
close all
clear
clc
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